text,target,icd10_diag,icd10_proc,icd10_long_title,_id,num_words,num_targets,2,None,1,5,0
"**Clinical Discharge Summary**

Patient Name: [Redacted for Confidentiality]

Date of Birth: [Redacted for Confidentiality]

Date of Admission: [Date]

Date of Discharge: [Date]

Reason for Admission: The patient was admitted to our hospital with a variety of medical conditions and underwent several procedures. Upon review of the patient's chart, it is evident that they were diagnosed with multiple health issues, including:

* A history of hypertension (high blood pressure) and hyperlipidemia (elevated cholesterol levels), which led to the development of coronary artery disease.
* Chronic kidney disease, characterized by decreased renal function and elevated serum creatinine levels.
* Anemia, specifically a reduction in red blood cell count and hemoglobin levels.
* A history of chronic pain related to musculoskeletal disorders.
* Recent gastrointestinal issues, including inflammatory bowel disease.
* Cardiovascular disease, with evidence of myocardial infarction (heart attack) in the past.

During their hospital stay, the patient underwent several procedures, including:

* Angioplasty and stenting for coronary artery disease
* Dialysis to manage chronic kidney disease
* Blood transfusions to address anemia
* Physical therapy and pain management interventions for musculoskeletal disorders
* Endoscopy and bowel surgery to manage gastrointestinal issues

The patient has made significant progress during their hospital stay, and we are confident that they will continue to receive excellent care upon discharge. Our interdisciplinary team has worked closely with the patient to develop a comprehensive plan of care, addressing all aspects of their medical needs.

As the patient prepares to return home, we have provided them with necessary instructions and follow-up appointments to ensure continued management of their conditions. The patient is advised to:

* Adhere to their medication regimen as prescribed by their healthcare provider
* Attend regular follow-up appointments with their primary care physician and specialists
* Monitor their blood pressure and cholesterol levels closely
* Engage in regular physical activity and maintain a healthy diet

The patient's family members are also encouraged to support their loved one's recovery by providing emotional support, assisting with daily activities, and helping them adhere to their treatment plan.

**Discharge Summary**

The patient has been discharged from our hospital in stable condition. We wish the patient all the best on their journey towards full recovery and encourage them to reach out to us if they have any further questions or concerns.

Signature: [Physician's Signature]

Date: [Date]","['0WQF0ZZ', '07B50ZX', '0HRV077', 'C50.911', 'E66.3', 'K42.9', 'R11.0', 'Z68.33', 'Z87.891']","['C50.911', 'E66.3', 'K42.9', 'R11.0', 'Z68.33', 'Z87.891']","['0WQF0ZZ', '07B50ZX', '0HRV077']","['Repair Abdominal Wall, Open Approach', 'Excision of Right Axillary Lymphatic, Open Approach, Diagnostic', 'Supplement Gastric Vein with Autologous Tissue Substitute, Open Approach', 'Replacement of Bilateral Breast using Deep Inferior Epigastric Artery Perforator Flap, Open Approach', 'Malignant neoplasm of unspecified site of right female breast', 'Overweight', 'Umbilical hernia without obstruction or gangrene', 'Nausea', 'Body mass index (BMI) 33.0-33.9, adult', 'Personal history of nicotine dependence']",0,386,9,2,,1,5,0
"**Clinical Discharge Summary**

**Patient Information:**
Name: [Insert Patient Name]
Date of Birth: [Insert Date of Birth]
Admission Date: [Insert Admission Date]

**Chief Complaint and History of Present Illness:**
The patient presented with symptoms of fatigue, weight loss, and general malaise. Physical examination revealed an enlarged spleen (splenomegaly) and signs of liver dysfunction.

**Past Medical History:**
The patient has a history of chronic hepatitis B infection, which was diagnosed [number] years ago. They have also experienced recurrent bouts of liver inflammation and have been managed with antiviral therapy.

**Surgical Procedures:**
During the current admission, the patient underwent a liver biopsy (G47.33) to assess for potential liver cancer or cirrhosis. The procedure was performed under local anesthesia due to the patient's history of bleeding disorders.

**Medications:**
The patient is currently taking antiviral medication for hepatitis B (B211YZZ), proton pump inhibitors for gastrointestinal issues (B24CZZ4), and medications to manage their bleeding disorder (G25.81).

**Lab Results and Diagnostics:**
Laboratory results revealed anemia (M10.9) and thrombocytopenia (Z96.651). Liver function tests showed elevated liver enzymes, suggesting ongoing liver damage. Imaging studies did not reveal any evidence of liver cancer or cirrhosis.

**Surgical Findings:**
The liver biopsy report indicated chronic hepatitis B infection with mild to moderate liver inflammation. The spleen was found to be enlarged (splenomegaly) due to portal hypertension, a complication of chronic liver disease.

**Procedure Outcomes:**
The patient tolerated the liver biopsy well and did not experience any complications during or after the procedure.

**Discharge Instructions:**
The patient will be discharged on [insert date] with instructions to continue their antiviral medication regimen and follow up with their primary care physician in [number] weeks for monitoring of their liver function. The patient is also advised to maintain a healthy diet, exercise regularly, and avoid alcohol consumption to manage their chronic liver disease.

**Progressive Care Plan:**
The patient will be followed up with regular appointments to monitor their liver function, adjust medications as necessary, and provide education on managing their chronic condition.","['027034Z', '4A023N7', 'B211YZZ', 'B246ZZ4', 'B24BZZ4', 'B24CZZ4', 'G47.33', 'I12.9', 'G25.81', 'Z66.', 'M10.9', 'Z96.651', 'I35.0', 'I25.10', 'I21.4', 'E03.9', 'R33.8', 'M31.0', 'I25.2', 'I25.5', 'N18.4', 'E78.5', 'Z85.038', 'I50.23', 'N17.9', 'Z90.49', 'N40.1', 'Z79.82', 'D63.1']","['G47.33', 'I12.9', 'G25.81', 'Z66.', 'M10.9', 'Z96.651', 'I35.0', 'I25.10', 'I21.4', 'E03.9', 'R33.8', 'M31.0', 'I25.2', 'I25.5', 'N18.4', 'E78.5', 'Z85.038', 'I50.23', 'N17.9', 'Z90.49', 'N40.1', 'Z79.82', 'D63.1']","['027034Z', '4A023N7', 'B211YZZ', 'B246ZZ4', 'B24BZZ4', 'B24CZZ4']","['Dilation of Coronary Artery, One Artery with Drug-eluting Intraluminal Device, Percutaneous Approach', 'Measurement of Cardiac Sampling and Pressure, Left Heart, Percutaneous Approach', 'Fluoroscopy of Multiple Coronary Arteries using Other Contrast', 'Ultrasonography of Right and Left Heart, Transesophageal', 'Ultrasonography of Heart with Aorta, Transesophageal', 'Ultrasonography of Pericardium, Transesophageal', 'Obstructive sleep apnea (adult) (pediatric)', 'Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease', 'Restless legs syndrome', 'Do not resuscitate', 'Gout, unspecified', 'Presence of right artificial knee joint', 'Nonrheumatic aortic (valve) stenosis', 'Atherosclerotic heart disease of native coronary artery without angina pectoris', 'Non-ST elevation (NSTEMI) myocardial infarction', 'Hypothyroidism, unspecified', 'Other retention of urine', 'Hypersensitivity angiitis', 'Old myocardial infarction', 'Ischemic cardiomyopathy', 'Chronic kidney disease, stage 4 (severe)', 'Hyperlipidemia, unspecified', 'Personal history of other malignant neoplasm of large intestine', 'Acute on chronic systolic (congestive) heart failure', 'Acute kidney failure, unspecified', 'Acquired absence of other specified parts of digestive tract', 'Benign prostatic hyperplasia with lower urinary tract symptoms', 'Long term (current) use of aspirin', 'Anemia in chronic kidney disease']",1,326,29,2,,1,5,0
" 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Seizures 
 
Major Surgical or Invasive Procedure:
___ Intubation
 
History of Present Illness:
This is a ___ yoM with a history of ETOH abuse/withdrawal 
seizures, depression/anxiety, HTN, distant hernia repair, 
?stented CAD, who presents with recurrent, seizures.  

 The patient was found at the bottom of a flight of stairs 
yesterday by his mother (12 stairs, unclear how many he fell 
down, no thud heard). EMS found him to be having ___ 
seizures, lasted about 18 minutes requiring 10 mg of IV diazepam 
before breaking. He was brought to ___ where he had 
another ___ min seizure and was loaded with a gram of Keppra and 
more diazepam. At that time the patient was complaining of 
shortness of breath, hypoxic to the high ___ on a NRB. He was 
intubated and started on propofol. He had 2 episodes of 
breakthrough seizures while at ___ and en route and required 
10 mg of diazepam each (succ/etom/morphine, 8 ET).  

 The patient's parents have been staying with him recently, has 
been complaining of neck and R shoulder/back pain after a ski 
accident 2 weeks ago. Prior to the event was last seen 90 min 
prior, was reportedly lucid. 4 days ago he complained of chest 
pressure that has since resolved. Had a HA 4 days ago as well, 
not complaining of any since, no blurry vision.  

 Recent history notable for 2 admissions for seizures in the 
last week, 1 to ___ and one to ___. On ___ the pt 
presented to ___ after being found be EMS to be dyspneic and 
intoxicated in his bathtub. Had been sober for several months 
but over the last month has been drinking 1L vodka daily, 
unclear if he has made any attempts to cut down. Found to be 
hypoxic to the ___, apneic in the ED, and intubated. ETOH level 
was 378. ___ reportedly negative. Clinically they did not 
suspect seizure but was given CIWA/benzo taper. Extubated 
quickly to RA and was unable to be convinced to stay and go to 
detox, discharged with diazepam prn. Then had ___ 
activity 2 days PTA and was sent to ___ ED, reportedly fell 
down ___ stairs after drinking a pint of vodka (unclear if 
seizure activity before or after) but EMS saw tonic/clonic 
activity, broke with 5 IV valium, discharged after trauma 
imaging was negative.  

 The patient was apparently admitted to a ___ facility ___ 
after a withdrawal seizure and had been sober until 1 month ago. 
 
 In the ED, pt was hemodynamically stable, hypertensive to the 
170s. Labs with lactate 2.3, tox with pos benzos, opiates, ETOH 
91. Imaging with neg head CT, CT Cspine with likely DJD C4 
retrolisthesis. CT torso with basilar infiltrates c/w 
aspiration, steatotic liver. Oxygenating well on AC vent 
settings. He received 1L IVF, propofol gtt. Neurology 
recommended MICU admission for likely ETOH withdrawal seizure.  

 On arrival to the MICU, the patient is intubated/sedated, off 
propofol able to follow basic commands.  

 Review of systems: Unable to obtain.  

 
Past Medical History:
Alcohol withdrawal related seizures, last detox ___  
Depression/anxiety  
HTN  
Hernia repair  
?CAD: per father, may have been stented in the past  

 
Social History:
___
Family History:
No family history of seizures 
 
Physical Exam:
ADMISSION PHYSICAL EXAM: 
========================
VS: BP: 124/69 P: 90 RR: 16 Sp02: 99% on 30% Fi02 intubated.  
GENERAL: Intubated/sedated  
 HEENT: Sclera anicteric, MMM, ETT and OG in place  
 NECK: ___ J collar in place  
 LUNGS: Transmitted vent sounds  
 CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
 ABD: soft, ___, bowel sounds present, no 
rebound tenderness or guarding, no organomegaly  
 EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema. No obvious traumatic injuries.  
 SKIN: Erythema at PIV site (now removed), diffuse faint 
blanching erythema  
 NEURO: Sedated, awakes off propofol, moves ext x4 to command, 
PERRL  
 ACCESS: PIVs  

DISCHARGE PHYSICAL EXAM: 
========================
Physical exam
___  145/89 HR 64 RR 18  95% RA
General:  in NAD, sitting in chair
HEENT:  OP moist, no LAD.
Lungs CTA B, no rales, wheezes
CV RRR without murmurs
Abdomen soft, NT, ND, NABS
Ext:  left arm on pillow. Pain with palpation of collarbone as
well as shoulder itself.  EXam limited by pain.
Neuro:  alert/oriented X3, no tremor.  Decreased sensation
medially on right thigh.  Decrease strength with hamstrings on
left. 
Back not tender.

 
Pertinent Results:
ADMISSION LABS: 
===============
___ 05:40AM BLOOD ___ 
___ Plt ___
___ 11:19AM BLOOD ___ 
___ Im ___ 
___
___ 05:40AM BLOOD ___ ___
___ 05:40AM BLOOD Plt ___
___ 05:40AM BLOOD ___
___ 11:19AM BLOOD ___ 
___
___ 11:19AM BLOOD ___ LD(LDH)-309* 
CK(CPK)-724* ___
___ 11:19AM BLOOD ___ cTropnT-<0.01
___ 11:19AM BLOOD ___
___ 05:40AM BLOOD ___ 
___
___ 05:46AM BLOOD ___ Tidal ___ 
___ Base ___ REQ 
___
___ 05:48AM BLOOD ___ TOP
___ 05:46AM BLOOD ___
___ 05:46AM BLOOD O2 ___
___ 05:48AM BLOOD ___

MICROBIOLOGY: 
=============
___ Blood Culture x 2: pending
___ MRSA Screen: pending

___ 11:19AM BLOOD ___ 
___

PERTINENT IMAGING/STUDIES: 
==========================
___ CXR (Portable): 
IMPRESSION:  
In comparison with the earlier study of this date, the 
monitoring and support devices are unchanged.  The a OG tube 
extends to the upper stomach, though the side port appears to be 
at the level of the esophagogastric junction.  The tube should 
be pushed forward several cm for optimal positioning. The 
patient has taken a better inspiration.  Opacification at the 
left base most likely represents atelectasis.  Opacification at 
the right base medially could also represent atelectatic 
changes.  However, either or both of these could represent 
developing aspiration pneumonia in the appropriate clinical 
setting. 
 
___ CT HEAD W/O CONTRAST: 
IMPRESSION:  No evidence for acute intracranial abnormalities. 

___ CT SPINE W/O CONTRAST: 
1. No evidence for a fracture. 
2. Minimal retrolisthesis of C4 on C5 is most likely 
degenerative, though 
there are no comparison exams to confirm chronicity. 
3. Mild multilevel degenerative disease. 

___ CT CHEST ABD/PELVIS W/ CONTRAST: 
IMPRESSION:  
1.  No fracture or acute traumatic injury. 
2.  Bilateral aspiration in lower lobes of lungs. 
3.  Hepatic lesions enhancing similar to portal vein could be 
large 
hemangiomas.  Recommend further evaluation with ultrasound. 
4.  Hepatosteatosis. 

___ Shoulder and knee xrays - no fracture

Abdominal ultrasound ___:
1. Echogenic liver consistent with steatosis. Other forms of 
liver disease 
including steatohepatitis, hepatic fibrosis, or cirrhosis cannot 
be excluded on the basis of this examination. 
2. A 2.2 cm hypoechoic lesion in the right lobe liver dome 
likely corresponds to one of the hyperenhancing lesions seen on 
prior CT.  Appearance is not the typical echogenic appearance of 
hemangioma.  Differential includes atypical appearance of 
hemangioma, hematoma, or other primary liver lesions.  
___ MRI is recommended for further characterization. 
  
RECOMMENDATION(S):  ___ MRI is recommended for further 
characterization. 

___ Lumbar MRI:
IMPRESSION: 
  
  
1. Mild degenerative changes throughout the lumbar spine with no 
significant 
spinal canal or neural foraminal stenosis. 
2. Disc bulge at ___ abuts but does not displace the 
transiting right S1 
nerve root.  Recommend correlation with right S1 radiculopathy. 
3. ___ and incompletely imaged/characterized oblong, 
oval signal 
abnormality in the left psoas muscle, with no enhancement seen 
on the recently performed CT, potentially representing a small 
intramuscular hematoma in the setting of trauma, however there 
is no significant surrounding edema pattern and the lesion does 
appear fairly ___.  Recommend a ___ 
___ with ___ lumbar spine MRI 2 document the 
absence of an underlying mass lesion. 
  
RECOMMENDATION(S):  ___ lumbar spine MRI for 
further 
evaluation. 

DISCHARGE LABS:
===============
___ 07:19AM BLOOD ___ 
___ Plt ___
___ 07:19AM BLOOD ___ 
___
___ 07:19AM BLOOD ___

 
Brief Hospital Course:
Mr. ___ is a ___ man with a history of ETOH abuse and 
withdrawal seizures, depression, anxiety, and hypertension, who 
presented with ETOH intoxication, seizures, and respiratory 
failure. He was intubated in the ED due to concern for airway 
protection in the setting of seizure activity and ETOH 
withdrawal, now extubated and on phenobarbital taper.

# ETOH ABUSE & WITHDRAWAL
Recurrent, heavy use c/b withdrawal seizures. Recent 
psychosocial stressor includes divorce. He was started on the 
Phenobarb protocol with Ativan for breakthrough while in the 
ICU. He was also given IV thiamine, folate, and MVI. Social work 
was consulted for additional support. Depression and anxiety 
were treated, as below.  Upon arrival to the floor, he has no 
further symptoms of withdrawal.

# SEIZURES:
Patient presented with ___ activity, thought to be due 
to recurrent ETOH withdrawal in the setting of recent heavy use. 
Head CT and MRI showed no evidence of structural disease. No 
other metabolic cause was identified. Neurology was consulted, 
and he was placed on EEG. While in the ICU, he had ___ 
activity x1, but EEG was consistent with pseudoseizures. He was 
initially started on Keppra 500mg BID, which was weaned off on 
___. Neurology recommended that patient be monitored with 
continuous video EEG monitoring until off phenobarbital.  
Suspect pseudoseizure, especially given that patient had high 
EtOH and was placed on phenobarb making breakthrough seizure 
less likely.  No antiepileptic medications were recommended at 
discharge.  No driving for 6 months.

# HYPOXEMIC RESPIRATORY DISTRESS:
Patient was extubated on ___ without difficulty, and was 
transitioned to nasal cannula. He was treated for CAP, as below.

# Community acquired pneumonia: 
Patient aspirated during seizures, and had evidence of pneuomina 
on admission CXR, so he was treated with a ___ course of 
CTX/Azithro (Day 1 was ___. 

# TRAUMA with left shoulder pain.
Patient had been found at the bottom of a flight of stairs, 
parents do not think he fell down many since no thud heard but 
history unclear. CT torso and Cspine imaging without clear 
injury. After extubation, he had left shoulder pain. This in 
fact predated this injury as he timed it to a recent skiing 
accident.Shoulder ___ showed no acute fracture. He was left 
in ___ collar but then subsequently cleared by orthopedics 
on ___. His pain was controlled with Toradol, and 
Acetaminophen, with Morphine, but with inadequate pain control.  
He was transitioned to oxycodone (given one week supply), 
flexeril and ibuprofen at the day of discharge.  He was advised 
to follow up with orthopedics after discharge.

# Right leg weakness.
On neurologic exam, he was found to have right leg weakness, as 
well as right inner thigh numbness.  The neurology team 
localized this to a possible L1 injury.  He underwent lumbar MRI 
which showed a possible S1 disk protrusion, but no L1 injury.  
He was discharged with neurology follow up in 2 weeks for 
___ and consideration of EMG if his weakness is persistent.

# DEPRESSION / ANXIETY
Psychiatry was consulted and recommended Seroquel 12.5 BID for 
anxiety.  As his follow up was not clear, this was not continued 
at discharge, and psychiatric care can be pursued as an 
outpatient.  

# Hepatic hemangiomas and steatosis: LFTs were monitored. 

# HTN: amlodipine restarted on ___, restarted hctz/lisinopril 
at discharge.

Transitional issues:
Alcoholism - advised not to drive for 6 months after unclear 
seizure.  Seen by social work and advised to follow up for 
therapy
Left shoulder pain - orthopedic evaluation in 1 week
Right leg weakness, foot drop, numbness - neurologic evaluation 
in 2 weeks
Abnormality on lumbar MRI - needs follow up MRI within 2 months.
Abnormality on liver ultrasound - needs follow up MRI.
New PCP - established with new PCP ___ 1 week.  

CODE: FULL  
Dispo:pending improvement in symptoms  

 [x ] Discharge documentation reviewed, pt is stable for 
discharge  
 [ ] >30 minutes was spent on day of discharge on coordination 
of care and counseling
 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Omeprazole 20 mg PO BID 
2. Diazepam 10 mg PO Q8H:PRN withdrawal symptoms 
3. ___ mg oral DAILY 
4. Amlodipine 10 mg PO DAILY 
5. Fluticasone Propionate NASAL 2 SPRY NU DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
EtOH abuse, intoxication
Seizures
Left shoulder pain
Right leg weakness

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to ___ for evaluation after a fall, with a  
subsequent seizure.  This was likely related to your alcohol 
abuse.  It is essential that you reduce your alcohol intake.  
Please follow up with your outpatient providers.

You cannot drive for 6 months due to your seizure.

You will need a follow up MRI in ___ months - either your new 
PCP ___ Dr. ___ help arrange this.

You need to remain sober to reduce risk of further worsening of 
your health.

 
Followup Instructions:
___
","['5A1945Z' 'J69.0' 'F41.9' 'M25.512' 'I10.' 'F32.9' 'J96.91' 'G40.89'
 'K76.0' 'R33.9' 'F10.239' 'Z91.81' 'D18.03' 'M21.371' 'R53.1' 'Z23.'
 'Z78.1' 'R20.0']","['J69.0' 'F41.9' 'M25.512' 'I10.' 'F32.9' 'J96.91' 'G40.89' 'K76.0'
 'R33.9' 'F10.239' 'Z91.81' 'D18.03' 'M21.371' 'R53.1' 'Z23.' 'Z78.1'
 'R20.0']",['5A1945Z'],"['Respiratory Ventilation, 24-96 Consecutive Hours'
 'Pneumonitis due to inhalation of food and vomit'
 'Anxiety disorder, unspecified' 'Pain in left shoulder'
 'Essential (primary) hypertension'
 'Major depressive disorder, single episode, unspecified'
 'Respiratory failure, unspecified with hypoxia' 'Other seizures'
 'Fatty (change of) liver, not elsewhere classified'
 'Retention of urine, unspecified'
 'Alcohol dependence with withdrawal, unspecified' 'History of falling'
 'Hemangioma of intra-abdominal structures' 'Foot drop, right foot'
 'Weakness' 'Encounter for immunization' 'Physical restraint status'
 'Anesthesia of skin']",2,2092,18,2,,1,5,0
" 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Amiodarone / Protamine / piperacillin
 
Attending: ___.
 
Chief Complaint:
weakness
 
Major Surgical or Invasive Procedure:
___ Placement of BiV pacemaker

 
History of Present Illness:
This is a ___ year old man with PMH most significant for atrial
flutter and atrial arrhythmia s/p CTI line and PVI, DCCV, HFrEF
thought to be tachyarrythmia induced, MGUS, CKS, PAD, and recent
pseudomonas osteomyelitis complicated by fungemia who presents 
to
the ED with lower extremity weakness. 

Mr ___ reports that he was  non-weightbearing at rehab for an
extended period of time and has felt very weak in his legs after
returning home 1.5 weeks ago. He reports falling down frequently
a few days prior to admission. He denies headstrike or syncope,
bu has a generalized sense of weakness. He attributes these 
falls
to weak legs as he was able to lower himself to the ground.
 
Past Medical History:
AFib/ATach s/p flutter ablation and PVI with persistent atrial
tachycardia  
 CHF  
 HLD  
 HTN  
 OSA on CPAP  
 Gout  
 T2DM  
 GERD  
 CKD  
 Anemia 
 MGUS 
 Acute interstitial nephritis on zosyn
 R foot osteomyelitis x2

 
Social History:
___
Family History:
Family history is notable for dementia in his father with onset
in his ___. His father also had a myocardial infarction and
stroke. His mother had borderline diabetes. A brother had
substance abuse problems in the past.
 
Physical Exam:
Admission:
VS: 97.4 (Tm 97.4), BP: 137/82, HR: 104, RR: 20, O2 sat: 100%, 
O2
delivery: RA 
GENERAL: Well developed, well nourished man in NAD. Oriented x3.
Mood, affect appropriate.  
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI.
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa.
No xanthelasma.  
NECK: Supple. JVP elevated
CARDIAC: PMI located in ___ intercostal space, midclavicular
line. Regular rate and rhythm. Normal S1, S2. No murmurs, rubs,
or gallops. no thrills or lifts.  
LUNGS: No chest wall deformities or tenderness. Respiration is
unlabored with no accessory muscle use. Crackles to the mid lung
fields bilaterally.
ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No
splenomegaly.  
EXTREMITIES: 2+ edema to the sacrum. RLE with chronic, dry, 
wound
over the lateral aspect of the R foot. 
SKIN: No significant skin lesions or rashes.

Discharge:
VS: Temp: 97.2 (Tm 98.3), BP: 122/84 (116-133/69-90), HR: 89
(88-90), RR: 17 (___), O2 sat: 100% (98-100), O2 delivery: ra 

GENERAL: Well developed, well nourished man in NAD. Oriented x3.
Mood, affect appropriate.  
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI.
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa.
No xanthelasma.  
NECK: Supple. no JVD
CARDIAC: PMI located in ___ intercostal space, midclavicular
line. Regular rate and rhythm. Normal S1, S2. No murmurs, rubs,
or gallops. no thrills or lifts.  
LUNGS: No chest wall deformities or tenderness. No swelling or
chest wall outpouching enlargement near pacemaker site.
Respiration is unlabored with no accessory muscle use. No
crackles.
ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No
splenomegaly.  
EXTREMITIES: RLE with chronic, dry, wound over the lateral 
aspect
of the R foot. ___ edema in the foot. 
SKIN: No significant skin lesions or rashes.   
 
Pertinent Results:
Admission:
___ 02:22PM BLOOD WBC-7.0 RBC-3.81* Hgb-11.0* Hct-36.3* 
MCV-95 MCH-28.9 MCHC-30.3* RDW-17.2* RDWSD-59.7* Plt ___
___ 02:22PM BLOOD Neuts-71.4* Lymphs-10.9* Monos-13.2* 
Eos-2.4 Baso-1.0 Im ___ AbsNeut-5.02 AbsLymp-0.77* 
AbsMono-0.93* AbsEos-0.17 AbsBaso-0.07
___ 02:22PM BLOOD Glucose-248* UreaN-43* Creat-2.5* Na-138 
K-5.5* Cl-106 HCO3-20* AnGap-12
___ 02:22PM BLOOD Calcium-8.7 Phos-2.9 Mg-1.7

CXR ___:
Lungs are low volume with bibasilar atelectasis.  Bilateral 
effusions are
unchanged.  Cardiomediastinal silhouette is stable.  Left-sided 
pacemaker is
also unchanged.  No pneumothorax is seen.

Discharge:
___ 07:00AM BLOOD WBC-6.8 RBC-3.16* Hgb-9.0* Hct-30.1* 
MCV-95 MCH-28.5 MCHC-29.9* RDW-15.9* RDWSD-55.8* Plt ___
___ 07:00AM BLOOD Glucose-101* UreaN-32* Creat-2.3* Na-143 
K-4.4 Cl-104 HCO3-26 AnGap-13
 
Brief Hospital Course:
TRANSITIONAL ISSUES
======================
[] Would recommend close monitoring of heart rate and titration 
of beta blocker as needed. He is near the maximum dose of 
metoprolol, so if atrial tachycardia reoccurs, could consider 
diltiazem as he responded well to that when briefly on this as 
an inpatient (however would avoid if possible given systolic 
heart failure).

[] Please monitor volume exam and adjust diuretic dose as 
needed.

[] The patient has had recent falls at home. ___ evaluation here 
noted unstable gait and falls risk; recommended discharge to 
rehabilitation, but the patient refused. He was deemed to have 
capacity to make such a decision, so patient was discharged 
home. Please continue to assess falls risk, continue discussions 
with patient regarding safety at home.

[] INR subtherapeutic on day of discharge. According to his 
pharmacy, his home dose is 5mg per day. We administerd 7.5mg on 
day of discharge (___) with instructions to take 5mg per day 
thereafter. Please monitor INR and dose warfarin accordingly.

SUMMARY
=========
Mr. ___ is a ___ year old man with PMH most significant for 
atrial
flutter and atrial arrhythmia s/p CTI line and PVI, DCCV, HFrEF
thought to be tachyarrythmia induced, MGUS, CKS, PAD, and recent
pseudomonas osteomyelitis complicated by fungemia who presented 
with lower extremity weakness and falls. This was felt to be 
secondary to atrial tachycardia with frequent pauses. A 
biventricular pacemaker was placed and rate control agents 
titrated. He was also slightly fluid overloaded, so the patient 
was diuresed to euvolemic.

ACUTE ISSUES
==============
# Symptomatic pauses s/p BiV PPM
# Atrial tachycardia
The patient has a history of afib/flutter with RVR, s/p prior 
ablations. He presented with weakness and telemetry monitoring 
was revealing for alternating atrial tachycardia and sinus 
rhythm with symptomatic conversion pauses. A biventricular 
pacemaker was placed on ___. He was continued on warfarin 
per his outpatient cardiologist, Dr. ___. Rate control 
medications were titrated and the patient was ultimately 
discharged on his prior metoprolol succinate dose of 200mg BID. 
Of note, telemetry showed that he was in NSR for several days 
prior to discharge.

# Acute on chronic systolic and diastolic heart failure 
Prior echocardiography with EF 21%, mild-mod MR, and mild TR. 
The patient presented with mild volume overload as evidenced by 
___ edema in ___, elevated JVP, and crackles over the lung 
fields, as well as 4 kg above his previous discharge weight. He 
was diuresed down ___ with improvement of his physical exam. 
The patient was discharged on 40mg PO Lasix (increased from 
prior home dose of 10mg daily), metoprolol as discussed above, 
as well as home hyrdralazine and Isordil.

# Anemia 
Patient with documented hypoproliferative anemia and MGUS. 
Previously requiring blood transfusions during last admission. 
H/H this admission slightly lower than baseline but overall 
stable. Labs were consistent with mixed picture of mildly 
hypoproliferative marrow, anemia of chronic disease, and iron 
deficiency, without any signs of hemolysis. Hbg was 9.0 on day 
of discharge.

CHRONIC ISSUES
====================
# CAD
There was no ischemia noted on a recent nuclear stress test 
___, although there was akinesis of the basal inferoseptum, 
basal-mid inferior and inferolateral walls on a ___ TTE. 
The patient was continued on home pravastatin 40mg and ASA 81mg.

# Stage 4 CKD
Baseline Cr 2.5. Chemistries and renal function were trended 
throughout admission. The patient was continued on home sodium 
bicarbonate 650 mg BID.

# PAD
S/p R AT angioplasty on ___. Per chart review, vascular 
surgery recommended post-op clopidogrel for one month 
post-operatively, but clopidogrel has been continued without 
clear indication. Per the patient's outpatient cardiologist, 
Plavix was discontinued.

# IDDM 
The patient was continued on long acting glargine, prandial 
insulin, and an insulin sliding scale. 

# BPH
The patient was continued on home finasteride and tamsulosin.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 
2. Finasteride 5 mg PO DAILY 
3. Furosemide 10 mg PO DAILY 
4. Metoprolol Succinate XL 200 mg PO BID 
5. Multivitamins W/minerals 1 TAB PO DAILY 
6. Pantoprazole 40 mg PO Q12H 
7. Pravastatin 40 mg PO QPM 
8. Sodium Bicarbonate 650 mg PO BID 
9. Tamsulosin 0.4 mg PO QHS 
10. Vitamin D 1000 UNIT PO DAILY 
11. Warfarin 3.75-5 mg PO DAILY16 
12. Isosorbide Dinitrate 20 mg PO TID 
13. Glargine 9 Units Breakfast
Humalog 4 Units Breakfast
Humalog 4 Units Lunch
Humalog 4 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
14. Diltiazem 60 mg PO Q12H 
15. HydrALAZINE 25 mg PO TID 
16. Clopidogrel 75 mg PO DAILY 

 
Discharge Medications:
1.  Furosemide 40 mg PO DAILY 
RX *furosemide 40 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
2.  Glargine 9 Units Breakfast
Humalog 4 Units Breakfast
Humalog 4 Units Lunch
Humalog 4 Units Dinner
Insulin SC Sliding Scale using HUM Insulin 
3.  ___  MD to order daily dose PO DAILY16 
5mg daily, titrate per INR  
4.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB  
5.  Ferrous Sulfate 325 mg PO EVERY OTHER DAY  
6.  Finasteride 5 mg PO DAILY  
7.  HydrALAZINE 25 mg PO Q8H  
8.  Isosorbide Dinitrate 20 mg PO TID  
9.  Metoprolol Succinate XL 200 mg PO BID  
10.  Multivitamins W/minerals 1 TAB PO DAILY  
11.  Pantoprazole 40 mg PO Q12H  
12.  Pravastatin 40 mg PO QPM  
13.  Sodium Bicarbonate 650 mg PO BID  
14.  Tamsulosin 0.4 mg PO QHS  
15.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Intermittent atrial tachycardia with symptomatic conversion 
pauses
Acute on chronic systolic and diastolic heart failure 
Anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___. 

WHY WAS I ADMITTED TO THE HOSPITAL?
- You were admitted to the hospital because your legs were weak 
and you were having a hard time maintaining your balance at 
home.

WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
- We found that your heart is sometimes in an irregular rhythm. 
We implanted a pacemaker that can help the heart to beat 
properly.
- We adjusted your cardiac medications to help control your 
heart rate and keep you from gaining extra fluid in your body.

WHAT SHOULD I DO WHEN I GO HOME?
- You should continue to take your medications as prescribed. 
- You should attend the appointments listed below. 

We wish you the best!
Your ___ Care Team 

 
Followup Instructions:
___
","['02H43JZ' '02H63JZ' '02HK3JZ' '0JH607Z' 'I25.10' 'E11.40' 'Z79.4' 'N40.0'
 'Z79.01' 'E11.51' 'F17.290' 'E11.22' 'I50.43' 'Z82.49' 'I49.5' 'E78.2'
 'N18.4' 'I47.1' 'I08.1' 'I13.0' 'I48.91' 'Z45.018' 'Z82.3' 'D63.1']","['I25.10' 'E11.40' 'Z79.4' 'N40.0' 'Z79.01' 'E11.51' 'F17.290' 'E11.22'
 'I50.43' 'Z82.49' 'I49.5' 'E78.2' 'N18.4' 'I47.1' 'I08.1' 'I13.0'
 'I48.91' 'Z45.018' 'Z82.3' 'D63.1']",['02H43JZ' '02H63JZ' '02HK3JZ' '0JH607Z'],"['Insertion of Pacemaker Lead into Coronary Vein, Percutaneous Approach'
 'Insertion of Pacemaker Lead into Right Atrium, Percutaneous Approach'
 'Insertion of Pacemaker Lead into Right Ventricle, Percutaneous Approach'
 'Insertion of Cardiac Resynchronization Pacemaker Pulse Generator into Chest Subcutaneous Tissue and Fascia, Open Approach'
 'Atherosclerotic heart disease of native coronary artery without angina pectoris'
 'Type 2 diabetes mellitus with diabetic neuropathy, unspecified'
 'Long term (current) use of insulin'
 'Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye'
 'Benign prostatic hyperplasia without lower urinary tract symptoms'
 'Long term (current) use of anticoagulants'
 'Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene'
 'Nicotine dependence, other tobacco product, uncomplicated'
 'Type 2 diabetes mellitus with diabetic chronic kidney disease'
 'Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure'
 'Family history of ischemic heart disease and other diseases of the circulatory system'
 'Sick sinus syndrome' 'Mixed hyperlipidemia'
 'Chronic kidney disease, stage 4 (severe)' 'Supraventricular tachycardia'
 'Rheumatic disorders of both mitral and tricuspid valves'
 'Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease'
 'Unspecified atrial fibrillation'
 'Encounter for adjustment and management of other part of cardiac pacemaker'
 'Family history of stroke' 'Anemia in chronic kidney disease']",3,1716,24,2,,1,5,0
" 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
allopurinol / Statins-Hmg-Coa Reductase Inhibitors
 
Attending: ___.
 
Chief Complaint:
BRBPR
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ female with history of CAD, CKD (s/p multiple 
stents), HFrEF(44%), IDDM, AF on coumadin, recently hospitalized 
for ___ presenting from home for evaluation of painless 
but large quantity bright red blood per rectum. She was taking 
senna/colace for constipation when she started having looser 
stools. Overnight, pt notes waking up in a large pool of red 
blood. She has never had a colonoscopy. Her father died in his 
___ of colon cancer. 

Patient denies epigastric pain, chest pain, shortness of breath, 
weakness, or other preceding symptoms. Woke in a large pile of 
bright red blood per rectum. Has had at least several episodes 
since initial evaluation.

Patient recently had a 3 week admission at ___ for 
AMS (thought to be from oxycodone, marijuana) and NSTEMI now s/p 
suspected DES to LCx (___) on aspirin, prasugrel, and 
Coumadin. Her course was complicated by ___ and bronchitis. 

In the ED, initial vitals:  97.3 88 114/55 16 100% RA 
- Exam notable for:
Awake, alert
Clear to auscultation bilaterally
Nontender abdomen
Visible red blood, no melena, grossly guaiac positive
- Labs notable for: Anemia to 7.2 (baseline ~9),  Cr to 2.2 
(recent baseline ~2.0), recent ferritin to 170s, Tsat 8%, INR 
3.5
- Pt given: IV 10mg vitamin K, Kcentra, 1L NS, and 1u blood, IV 
pantoprazole 40mg
- Vitals prior to transfer: 97.9 86 ___ 99% RA   

On arrival to the floor, pt reports pain in her left foot from 
previously dropping a telemetry box on it. She is unsure of her 
medications since leaving rehab. She recounts and confirms the 
above story. I have also corroborated her previous hospital 
course with cardiologist on-call at ___. 
 
Past Medical History:
HTN, labile  
HLD  
HYPOTHYROIDISM  
RETINAL ARTERY OCCLUSION - BRANCH  
MIGRAINE EQUIVALENT  
CAD/MI (MIs in ___ and ___
CHF (EF 60-65% in ___  
OBESITY,  
insulin-dependent DMII  
Gout  
Renal artery stenosis  
CKDIII  
Anemia  
afib on anticoagulation  
Depression 
 
Social History:
___
Family History:
Father died of colon cancer in ___.
 
Physical Exam:
ADMISSION
Vitals:  97.2 PO 124 / 91 91 20 100 2L NC 
General: Alert, oriented, no acute distress  
HEENT: Pale conjunctivae, MMM, oropharynx clear  
Neck: supple, JVP 12cm, no LAD  
Lungs: CTAB anteriorly, crackles posterior bases
CV: ___, Nl S1, S2, II/VI systolic murmur 
Abdomen: soft, NT/ND bowel sounds present, no rebound tenderness 
or guarding, no organomegaly  
GU: no foley  
Ext: 2+ pitting edema ___ 
Neuro: CN2-12 intact, no focal deficits 

DISCHARGE
Vitals:  97.5 PO 150 / 97 88 18 100 Ra  
General: Alert, oriented, no acute distress  
HEENT: Pale conjunctivae, MMM, oropharynx clear  
Neck: supple, JVP 12cm, no LAD  
Lungs: CTAB anteriorly, crackles posterior bases
CV: ___, Nl S1, S2, II/VI systolic murmur 
Abdomen: soft, NT/ND bowel sounds present, no rebound tenderness 
or guarding, no organomegaly  
GU: no foley  
Ext: 2+ pitting edema ___, PICC in place, left foot with soft 
tissue edema and ecchymosis. 
Neuro: face symmetric, MAE, no dysarthria 
 
Pertinent Results:
ADMISSION
___ 04:50AM BLOOD WBC-9.0 RBC-2.54* Hgb-7.2* Hct-24.1* 
MCV-95 MCH-28.3 MCHC-29.9* RDW-18.1* RDWSD-61.3* Plt ___
___ 04:50AM BLOOD ___ PTT-41.1* ___
___ 04:50AM BLOOD Ret Aut-3.5* Abs Ret-0.09
___ 04:50AM BLOOD Glucose-170* UreaN-68* Creat-2.2* Na-137 
K-4.5 Cl-96 HCO3-30 AnGap-16
___ 04:50AM BLOOD Calcium-8.4 Phos-3.4 Mg-2.1
___ 04:50AM BLOOD Digoxin-0.2*
___ 04:59AM BLOOD Lactate-1.8

DISCHARGE 
___ 04:59AM BLOOD WBC-9.8 RBC-2.76* Hgb-8.3* Hct-26.9* 
MCV-98 MCH-30.1 MCHC-30.9* RDW-19.9* RDWSD-58.7* Plt ___
___ 04:59AM BLOOD Glucose-157* UreaN-76* Creat-2.4* Na-139 
K-3.9 Cl-98 HCO3-30 AnGap-15
___ 04:59AM BLOOD Calcium-8.7 Phos-3.4 Mg-2.2

L Foot XR 
No acute fracture. 

 
Brief Hospital Course:
___ y/o F with  DES to LCx 1 month ago, HFrEF, AFib on coumadin, 
IDDM, CKD, and chronic anemia who presents with hematochezia and 
anemia.

# Acute Blood Loss on Chronic Anemia: Patient presented with 
hematochezia which worsened chronic anemia. Patient was 
supratherapeutic on admission. Suspected source as 
diverticulosis/LGIB but patient has never had colonoscopy. 
Initial plan for endoscopy deferred per patient's wishes. Hct 
stable s/p 2u pRBC. Supratherapeutic INR was reversed with 
vitamin K and Kcentra. Baseline anemia likely from to be 
AICD/CKD with component of iron deficiency. Patient's bleed 
stabilized off warfarin. Risk/benefit discussion was offered 
regarding restarting Coumadin, holding Coumadin, or a trial of 
heparin to watch for re-bleed. Patient prefers to hold Coumadin 
until seeing PCP. She expressed understanding of the risk of 
stroke. She received a b12 shot on ___ and was started on daily 
folic acid as well. 

# CAD s/p stenting: Patient had recent DES to LCx at ___. 
___ on ___. She was continued on ASA81 and 
prasugrel. Metoprolol XL 200mg was continued. 
Isordil/hydralazine was continued by discharge. She continues on 
enzetimibe given statin intolerance 

# Acute on Chronic Systolic Heart Failure HFrEF (44%), 
biventricular
# Mod posteriorly directed MR
# Pulm HTN
She was continued on torsemide 60mg BID, as well as 
isordil/hydral and metoprolol XL. Spironolactone was held in 
setting of mild ___ on CKD. Her discharge weight was:
She has a follow up appointment with At___ Cardiology on 
___ 4:30 ___ with Dr ___.

# Left foot pain: A telemetry box at a previous hospitalization 
was dropped on her left foot. Xrays were previously negative. 
The foot caused her significant pain with notable. A repeat XR 
was negative for fracture as well. She had significant soft 
tissue swelling, ecchymosis. Supportive care with elevation and 
ice was offered. Podiatry recommended a surgical shoe and can 
follow up as an outpatient. Patient's oxycodone frequency was 
increased to q4h. 

# Depression
- continued wellbutrin 150mg

# ___ on CKD: Patient's base line CR 2.0-2.2. Discharged at 2.4, 
which has been stable.

# A-Fib: Warfarin was reversed with K-centra and vitamin K as 
above. Per patient preference, she wanted to discuss restarting 
anticoagulation with her PCP. She was continued on digoxin and 
metoprolol

# Diabetes  
- Continued home Glargine + ISS  

# Gout  
- Continued home Febuxostat  
- Continued home Methylprednisolone 4mg  

# Hypothyroidism  
- Continued home Levothyroxine  

#CODE: presumed full  
#COMMUNICATION:  daughter, ___ ___

TRANSITIONAL ISSUES:
Discharge weight: 195.3 lbs
Discharge Cr: 2.4
[ ] continue to evaluate weights daily and metabolic panels 
weekly for whether patient's diuretic regimen can be changed. 
Discharged on 60 mg Torsemide PO BID
[ ] Please monitor CBCs weekly for anemia
[ ] Note patient is a difficult lab draw. She had a PICC line in 
place for her hospitalization. 
[ ] Discuss re-starting Coumadin for Afib.  In setting of recent 
bleed, would suggest avoiding triple therapy. Per WOEST trial, 
could consider Clopidogrel/Coumadin or by extension, 
prasugrel/Coumadin
[ ] Patient adamantly refuses colonoscopy. Consider alternative 
method of colon cancer screening given family history. 
[ ] Encourage supportive measures to reduce foot swelling
[ ] Titrate oxycodone back to q6hrs or even further spaced out 
as foot swelling resolves
[ ] Consider restarting spironolactone if creatinine stable
[ ] Attempt to stop omeprazole after 1 month

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN sob 
2. Aspirin 81 mg PO DAILY 
3. BuPROPion (Sustained Release) 150 mg PO QAM 
4. Digoxin 0.125 mg PO 3X/WEEK (___) 
5. Ezetimibe 10 mg PO DAILY 
6. Febuxostat 40 mg PO DAILY 
7. Ferrous Sulfate 325 mg PO BID 
8. Fluticasone Propionate 110mcg 2 PUFF IH BID 
9. Levothyroxine Sodium 112 mcg PO DAILY 
10. Methylprednisolone 4 mg PO DAILY 
11. OxyCODONE (Immediate Release) 10 mg PO Q6H:PRN BREAKTHROUGH 
PAIN 
12. Warfarin 3.75 mg PO 5X/WEEK (___) 
13. Vitamin D ___ UNIT PO DAILY 
14. Warfarin 5 mg PO 2X/WEEK (___) 
15. Torsemide 60 mg PO BID 
16. Metolazone 2.5 mg PO DAILY 
17. Simethicone 40-80 mg PO QID:PRN bloating 
18. Prasugrel 10 mg PO DAILY 
19. nystatin 100,000 unit/gram topical ___ daily 
20. Miconazole Powder 2% 1 Appl TP BID 
21. Metoprolol Succinate XL 200 mg PO DAILY 
22. Spironolactone 12.5 mg PO DAILY 
23. Isosorbide Dinitrate 20 mg PO TID 
24. HydrALAZINE 20 mg PO Q8H 

 
Discharge Medications:
1.  Acetaminophen 650 mg PO Q8H  
2.  Bisacodyl ___AILY:PRN constipation  
3.  Docusate Sodium 100 mg PO BID constipation  
4.  FoLIC Acid 1 mg PO DAILY  
5.  Omeprazole 20 mg PO DAILY  
6.  Polyethylene Glycol 17 g PO DAILY constipation  
7.  Senna 8.6 mg PO BID:PRN constipation  
8.  Metolazone 2.5 mg PO PRN as directed by cardiologist  
9.  OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Severe 

RX *oxycodone 10 mg 1 tablet(s) by mouth q4-6h Disp #*18 Tablet 
Refills:*0 
10.  Albuterol Inhaler 2 PUFF IH Q4H:PRN sob  
11.  Aspirin 81 mg PO DAILY  
12.  BuPROPion (Sustained Release) 150 mg PO QAM  
13.  Digoxin 0.125 mg PO 3X/WEEK (___)  
14.  Ezetimibe 10 mg PO DAILY  
15.  Febuxostat 40 mg PO DAILY  
16.  Ferrous Sulfate 325 mg PO BID  
17.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
18.  HydrALAZINE 20 mg PO Q8H  
19.  Glargine 30 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin 
20.  Isosorbide Dinitrate 20 mg PO TID  
21.  Levothyroxine Sodium 112 mcg PO DAILY  
22.  Methylprednisolone 4 mg PO DAILY  
23.  Metoprolol Succinate XL 200 mg PO DAILY  
24.  Miconazole Powder 2% 1 Appl TP BID  
25.  nystatin 100,000 unit/gram topical ___ daily  
26.  Prasugrel 10 mg PO DAILY  
27.  Simethicone 40-80 mg PO QID:PRN bloating  
28.  Torsemide 60 mg PO BID  
29.  Vitamin D ___ UNIT PO DAILY  
30. HELD- Spironolactone 12.5 mg PO DAILY  This medication was 
held. Do not restart Spironolactone until your doctor tells you 
to restart
31. HELD- Warfarin 3.75 mg PO 5X/WEEK (___)  This 
medication was held. Do not restart Warfarin until your doctor 
tells you to restart
32. HELD- Warfarin 5 mg PO 2X/WEEK (___)  This medication was 
held. Do not restart Warfarin until your doctor tells you to 
restart

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
___ Diagnosis:
Hematochezia
Acute Blood Loss Anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - occasionally requires assistance 
or aid (walker or cane).

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the ___ for bleeding from your GI tract. 

What was done
==============
- Your blood thinning with Warfarin was reversed. You were not 
restarted on this medication. 
- Your bleeding stopped and your blood counts were stable.
- You received a B12 shot
- You had a Xray of your left foot that did not show a fracture

What to do next
================
- Please take all medications as prescribed. A list of your 
updated medications is attached. 
- You should discuss restarting Warfarin with your PCP. When 
your blood is not thinned, you are at risk of stroke. 
- Follow up with your PCP after discharge from rehab
- Tell your doctors ___ have further bleeding or worsening 
symptoms
- Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
- Try to keep your foot elevated to relieve swelling

We wish you the best of health moving forward

 
Followup Instructions:
___
","['02HV33Z' '30283B1' 'W20.8XXA' 'I27.2' 'N18.3' 'M10.9' 'F32.9' 'I13.0'
 'I34.0' 'D50.9' 'E78.5' 'I50.23' 'K57.91' 'R79.1' 'I25.10' 'E03.9'
 'E66.9' 'Z68.30' 'I48.91' 'Y92.239' 'D62.' 'E11.22' 'N17.9' 'I25.2'
 'D63.1' 'Z79.02' 'Z79.4' 'Z79.01' 'Z80.0' 'Z87.891' 'Z95.5']","['W20.8XXA' 'I27.2' 'N18.3' 'M10.9' 'F32.9' 'I13.0' 'I34.0' 'D50.9'
 'E78.5' 'I50.23' 'K57.91' 'R79.1' 'I25.10' 'E03.9' 'E66.9' 'Z68.30'
 'I48.91' 'Y92.239' 'D62.' 'E11.22' 'N17.9' 'I25.2' 'D63.1' 'Z79.02'
 'Z79.4' 'Z79.01' 'Z80.0' 'Z87.891' 'Z95.5']",['02HV33Z' '30283B1'],"['Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach'
 'Transfusion of Nonautologous 4-Factor Prothrombin Complex Concentrate into Vein, Percutaneous Approach'
 'Other cause of strike by thrown, projected or falling object, initial encounter'
 'Other secondary pulmonary hypertension'
 'Contusion of left foot, initial encounter'
 'Chronic kidney disease, stage 3 (moderate)' 'Gout, unspecified'
 'Major depressive disorder, single episode, unspecified'
 'Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease'
 'Nonrheumatic mitral (valve) insufficiency'
 'Iron deficiency anemia, unspecified' 'Hyperlipidemia, unspecified'
 'Acute on chronic systolic (congestive) heart failure'
 'Diverticulosis of intestine, part unspecified, without perforation or abscess with bleeding'
 'Abnormal coagulation profile'
 'Atherosclerotic heart disease of native coronary artery without angina pectoris'
 'Hypothyroidism, unspecified' 'Obesity, unspecified'
 'Body mass index (BMI) 30.0-30.9, adult'
 'Unspecified atrial fibrillation'
 'Unspecified place in hospital as the place of occurrence of the external cause'
 'Acute posthemorrhagic anemia'
 'Type 2 diabetes mellitus with diabetic chronic kidney disease'
 'Acute kidney failure, unspecified' 'Old myocardial infarction'
 'Anemia in chronic kidney disease'
 'Long term (current) use of antithrombotics/antiplatelets'
 'Long term (current) use of insulin'
 'Long term (current) use of anticoagulants'
 'Family history of malignant neoplasm of digestive organs'
 'Personal history of nicotine dependence'
 'Presence of coronary angioplasty implant and graft']",4,1842,31,2,,1,5,0
" 
Name:  ___            Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
TAVR 
 
Major Surgical or Invasive Procedure:
Transcatheter Aortic Valve Replacement ___
Pacemaker Placement ___

 
History of Present Illness:
___ y/o male with severe aortic stenosis (Mean pressure gradient 
49 mmHg, peak gradient 75 mmHg, and ___ 0.9 cm2), CAD s/p BMS 
stent to LAD in ___, HTN, HL, CKD who presents for TAVR.

The patient recently went on a trip to ___ with his wife in 
___ and was admitted to the hospital due to a CHF 
exacerbation. There, an echocardiogram obtained during that 
hospitalization showed an ___ 0.7 cms and a mean gradient 52 mm 
Hg. He was discharged when euvolemic and prescribed Lasix which 
he did not take. 28 days later the patient became extremely SOB, 
had significant peripheral edema and his weight was up 9lbs. He 
was placed on Lasix 40mg by his PCP and his symptoms improved 
and his Lasix was downtitrated to 20 mg daily.

When he returned home he was referred to Dr. ___ at ___ for 
surgical AVR, however, CT scan showed a calcified aorta and he 
was referred to ___ for TAVR evaluation.

Per patient and wife he had been having shortness of breath for 
several months, which improved after his hospitalization and 
diuresis as above. He is ___ Class III for symptoms.  He denies 
CP, palpitations, syncope, lightheadedness/dizziness. 

He denies recent illness, fever/chills, 
nausea/vomiting/diarrhea, blood in urine/stools, abdominal pain. 
Denies any prior history of stroke, TIA, deep venous thrombosis, 
pulmonary embolism.

 
Past Medical History:
1.  Hypercholesterolemia
2.  Hypertension, essential
3.  CAD s/p BMS stent to LAD in ___
 
Social History:
___
Family History:
Father: CVA x 2
 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
VS:  97.9| 144/54| 49| 16| 100% on RA 
Weight:  65.1 kg 
GEN:  Elderly man in NAD, AO x3
HEENT:  EOMI, PERRLA, MMM
NECK:  Neck supple, JVP mildly elevated
CV:  RRR, ___ systolic murmur w/ radiation into carotids. 
LUNGS:  CTAB, no wheezes or crackles
ABD:  Soft, BS+, non-distended, non-tender to palpation. 
EXT:  trace-1+ pitting edema of bilateral ankles. Lower 
extremities cool, b/l dorsal pulses palpable 
SKIN:  No skin lesions
NEURO:  CN ___ grossly intact, moves all extremities.

DISCHARGE PHYSICAL EXAMINATION:
VS: 98.3| 134-168/45-65| 63-77| 20| 96% on RA
I/O:  1170/650
Weight: 66.6 (67.4)  
GEN:  Elderly man in NAD, AO x3
HEENT: EOMI, MM dry 
CV: RRR, no murmurs rubs or gallops
Lungs: CTAB, decreased breath sounds diffusely 
EXT:  1+ pitting edema of bilateral ankles. 
SKIN:  No skin lesions
NEURO:  CN ___ grossly intact, moves all extremities.
 
Pertinent Results:
ADMISSION LABS: 
___ 05:05PM BLOOD WBC-4.6 RBC-3.51* Hgb-11.1* Hct-33.5* 
MCV-95 MCH-31.6 MCHC-33.1 RDW-13.2 RDWSD-44.9 Plt ___
___ 05:05PM BLOOD ___ PTT-32.7 ___
___ 05:05PM BLOOD Glucose-93 UreaN-77* Creat-2.8* Na-145 
K-3.8 Cl-105 HCO3-26 AnGap-18
___ 05:05PM BLOOD ALT-13 AST-12 CK(CPK)-55 AlkPhos-75 
TotBili-0.4

MICROBIOLOGY: 
___ Urine - negative
___ Staph aureus screen - negative 

IMAGING: 
CXR ___
Subtle opacity projecting over the left upper lobe which could 
represent 
pleural parenchymal scarring.  However, oblique views are 
recommended for 
further evaluation to exclude a pneumonia. 

ECHO ___
PreTAVR Deployment
 Study is quite limited given large hiatal hernia and poor echo 
views especially transgastric and deep transgastric.
 The left atrium is dilated. No spontaneous echo contrast is 
seen in the body of the left atrium. Regional left ventricular 
wall motion is normal. Overall left ventricular systolic 
function is normal (LVEF>55%). RV with normal free wall 
contractility. There are simple atheroma in the aortic root. 
There are simple atheroma in the ascending aorta. There are 
focal calcifications in the aortic arch. The number of aortic 
valve leaflets cannot be determined. The aortic valve leaflets 
are severely thickened/deformed. There is severe aortic valve 
stenosis (valve area <1.0cm2). No aortic regurgitation is seen. 
The mitral valve leaflets are severely thickened/deformed. 
Trivial mitral regurgitation is seen. There is a 
trivial/physiologic pericardial effusion. These findings were 
discussed with Drs. ___, and ___ at the time 
of exam.
PostTAVR Deployment
 There is a well-seated TAVR valve in place. Trace paravalvular 
regurgitation is noted. No new LV regional wall motion 
abnormalities are seen. Peak gradient is 9mmHg across the valve. 
The rest of exam is unchanged from prior. These findings were 
discussed with the procedural team at the time of exam in the 
operating room.  

ECHO ___
The left atrium is mildly dilated. Mild symmetric left 
ventricular hypertrophy with normal cavity size, and 
regional/global systolic function (biplane LVEF = 63 %). Doppler 
parameters are most consistent with Grade II (moderate) left 
ventricular diastolic dysfunction. Right ventricular chamber 
size and free wall motion are normal. There is abnormal septal 
motion/position consistent with right ventricular 
pressure/volume overload. The diameters of aorta at the sinus, 
ascending and arch levels are normal. An ___ aortic 
valve bioprosthesis is present. The transaortic gradient is 
normal for this prosthesis. A paravalvular aortic valve leak is 
probably present. The aortic valve VTI = 59 cm. Trace aortic 
regurgitation is seen. The mitral valve leaflets are mildly 
thickened. There is no mitral valve prolapse. Trivial mitral 
regurgitation is seen. There is moderate pulmonary artery 
systolic hypertension. There is a trivial/physiologic 
pericardial effusion. 

 IMPRESSION: A well seated aortic ___ valve is present with 
normal gradients and trace paravavluar aortic regurgitation. 
There appears to be varying PR interval - AV block cannot be 
exclude however echo is not a good modality to diagnose 
arrhythmia suggest obtaining an EKG to verify. Type II diastolic 
dysfunction with elevated LVEDP, moderate pulmonary hypertension 
and normal RV size and function.

 Compared with the prior study (images reviewed) of ___, 
there now is ___ aortic valve present. The rhythm appears 
to have changed.  

CXR ___
Opacity projecting over the left upper thorax is pleural plaque 
seen on prior chest CT. 

RENAL U/S ___
1.  Limited assessment of the renal vasculature.  No 
hydronephrosis or stones. 
2.  Innumerable bilateral renal cysts 

CXR ___
There has been placement of a new left-sided dual lead pacemaker 
with distal lead tips in right atrium and right ventricle.  
Valvular cage device is seen projecting over the heart.  There 
is mild prominence of the pulmonary interstitial markings 
without overt pulmonary edema.  There is a small left-sided 
pleural effusion.  There are no pneumothoraces. 

INTERVAL LABS: 
___ 06:00AM BLOOD Glucose-97 UreaN-74* Creat-3.6* Na-137 
K-4.0 Cl-98 HCO3-24 AnGap-19
___ 05:05PM BLOOD ___

DISCHARGE LABS: 
___ 06:40AM BLOOD WBC-5.3 RBC-2.84* Hgb-9.0* Hct-26.7* 
MCV-94 MCH-31.7 MCHC-33.7 RDW-13.0 RDWSD-44.5 Plt Ct-99*
___ 06:40AM BLOOD Glucose-93 UreaN-63* Creat-2.7* Na-141 
K-3.8 Cl-107 HCO3-25 AnGap-13
___ 06:40AM BLOOD Calcium-8.7 Phos-2.9 Mg-2.___ y/o male with severe aortic stenosis, CAD s/p BMS stent to 
LAD in ___, HTN, HL, CKD who presented for scheduled TAVR. TAVR 
completed successfully on ___. Course c/b ___ on CKID and 
development of high grade AV block, now s/p PPM 

CORONARIES: Stent in LAD. 30% stenosis in the proximal in stent 
in the LAD.  The RCA had a ___ proximal and mid stenosis. 
PUMP: 60% 
RHYTHM: Sinus 

ACUTE ISSUES
============
#) Severe AS: Pre-op with mean pressure gradient 49 mmHg, peak 
gradient 75 mmHg, and ___ 0.9 cm2. S/p transcatheter aortic 
valve replacement (TAVR) with ___ on ___, no complications. 
 Peak gradient of 9 mm Hg after procedure. Post TAVR echo with 
well seated valve with normal gradients and trace paravalvular 
aortic regurgitation, LVEF of 63%, varying PR interval. Placed 
on  AS 81, Plavix 75 mg ___. Post-op course c/b bradycardia to 
___, HD stable, found to have high grade AV block. EP was 
consulted and decision was made to place PPM, which occurred on 
___ without complications. 

#) High grade AV block: pt with new bradycardia to ___ on ___, 
found to have new conduction block consistent with high grade AV 
block. S/P PPM on ___. Treated with 3 day course of 
post-procedure Keflex ___ mg PO (last day ___. 

#) Acute on chronic diastolic heart failure: BNP of 20K on 
admission. EF Of 60% on TTE. Diuresed with IV Lasix 20 mg, 
increased to 40 mg. Discharged on home furosemide 20 mg ___ 
require further titration as outpatient. 

#) ___ on CKD: Unclear baseline, on admission with Cr of 2.8. 
Last Cr of 2.2 in ___. Reportedly 2.2 at baseline, per wife. 
___ be secondary to volume overload, unlikely contrast 
nephropathy given time course and Cr elevated at admission. 
Urine lytes suggestive of mixed picture. Renal ultrasound with 
innumerable b/l renal cysts. Renal was consulted, recommended 
holding diuresis with improvement of Cr. Diuresis held briefly 
with stabilization of Cr. Cr improved with re-initation of 
diuresis. Home lisinopril, bisoprolol-HCTZ, triamterene-HCTZ 
held in setting ___ and on discharge. Cr of  2.7 on 
discharge. Discharged on furosemide 20 mg ___

#) HTN: SBPs to 150s during admission. Started on isosorbide 
mononitrate ER 30 mg ___ for improved BP control. Home amlodipine 
increased to 10 mg ___. 

CHRONIC ISSUES
==============
#) CAD: s/p LAD stent in ___. Continued ASA and atorvastatin
#) GERD: continued omeprazole
#) BPH: continued home tamsulosin. 

TRANSITIONAL ISSUES
===================
-Please check CHEM 7 AND ACTIVELY TITRATE FUROSEMIDE IF NEEDED 
at appointment with Dr. ___ on ___.
-Renal U/S showed innumerable b/l renal cysts, which may be 
source for CKD
-Pt's Cr on DC was 2.7
-Pt's home HTN meds were changed:
---- Amlodipine was increased to 10 mg daily
---- Clopidogrel 75 daily for at least 3 months
---- He needs prophylactic cephalexin until ___ post PPM 
placement
---- Isosorbide mononitrate 30mg daily was started
---- Sevelamer Carbonate 800mg TID with meals
-Plan is for at least 3 months of Plavix 75mg daily, and 
continuation of ASA 81mg daily
-Pt was started on Keflex ___ q8h x3d s/p PPM placement for 
infxn prevention
-incidental finding: opacity on CXR projecting over the left 
upper lung persists is a calcified pleural plaque seen on CT 
chest from ___. 

# DRY WEIGHT: 66.6 kg 
# CODE: Full in setting of recent procedure and pacemaker 
placement
# CONTACT: ___ (Home/Wife), ___ (Son) 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amlodipine 5 mg PO DAILY 
2. Atorvastatin 40 mg PO QPM 
3. bisoprolol-hydrochlorothiazide 2.5-6.25 mg oral DAILY 
4. Lisinopril 20 mg PO TID 
5. Omeprazole 20 mg PO DAILY 
6. Tamsulosin 0.4 mg PO BID 
7. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Furosemide 20 mg PO DAILY 

 
Discharge Medications:
1. Amlodipine 10 mg PO DAILY 
RX *amlodipine 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
2. Aspirin 81 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. Omeprazole 20 mg PO DAILY 
5. Tamsulosin 0.4 mg PO BID 
6. Clopidogrel 75 mg PO DAILY 
RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*2
7. Furosemide 20 mg PO DAILY 
RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
8. Cephalexin 500 mg PO Q8H Duration: 3 Days 
Please take through ___. 
RX *cephalexin 500 mg 1 tablet(s) by mouth q 8 hours Disp #*4 
Tablet Refills:*0
9. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 
RX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY:
Severe Aortic Stenosis s/p TAVR
High Grade AV Block s/p PPM
Acute on Chronic Diastolic HF
___ on CKD
HTN

SECONDARY:
CAD
GERD
BPH

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to ___ for a scheduled TAVR, where your 
aortic valve in your heart was replaced. Your procedure was 
complicated by your developing of heart block, where your heart 
wasn't conducting electricity properly. You had a pacemaker 
placed to ensure your heart pumped appropriately. Your kidney 
function was also found to have worsened over this admission.

It is extremely important that you take your 81mg Aspirin and 
75mg Plavix every day for the next 3 months, when they will 
discuss whether or not to continue. 

Please follow up with your PCP, ___, and renal 
doctors.

___ was a pleasure taking care of you!

Your ___ CCU Team
 
Followup Instructions:
___
","['02H63JZ' '02HK3JZ' '02RF38Z' '0JH606Z' 'N17.9' 'I12.9' 'I97.89' 'I25.10'
 'N18.9' 'I50.33' 'Z95.5' 'K21.9' 'I44.2' 'Z00.6' 'N28.1' 'N40.0' 'I35.0'
 'Y83.8' 'Y92.230' 'Z87.891' 'E78.5' 'Z79.82']","['N17.9' 'I12.9' 'I97.89' 'I25.10' 'N18.9' 'I50.33' 'Z95.5' 'K21.9'
 'I44.2' 'Z00.6' 'N28.1' 'N40.0' 'I35.0' 'Y83.8' 'Y92.230' 'Z87.891'
 'E78.5' 'Z79.82']",['02H63JZ' '02HK3JZ' '02RF38Z' '0JH606Z'],"['Insertion of Pacemaker Lead into Right Atrium, Percutaneous Approach'
 'Insertion of Pacemaker Lead into Right Ventricle, Percutaneous Approach'
 'Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach'
 'Insertion of Pacemaker, Dual Chamber into Chest Subcutaneous Tissue and Fascia, Open Approach'
 'Acute kidney failure, unspecified'
 'Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease'
 'Other postprocedural complications and disorders of the circulatory system, not elsewhere classified'
 'Atherosclerotic heart disease of native coronary artery without angina pectoris'
 'Chronic kidney disease, unspecified'
 'Acute on chronic diastolic (congestive) heart failure'
 'Presence of coronary angioplasty implant and graft'
 'Gastro-esophageal reflux disease without esophagitis'
 'Atrioventricular block, complete'
 'Encounter for examination for normal comparison and control in clinical research program'
 'Cyst of kidney, acquired'
 'Benign prostatic hyperplasia without lower urinary tract symptoms'
 'Nonrheumatic aortic (valve) stenosis'
 'Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure'
 'Patient room in hospital as the place of occurrence of the external cause'
 'Personal history of nicotine dependence' 'Hyperlipidemia, unspecified'
 'Long term (current) use of aspirin']",5,2014,22,2,,1,5,0
" 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Ascites 
 
Major Surgical or Invasive Procedure:
paracentesis ___
pleurX placement ___

 
History of Present Illness:
___ hx T2DM on insulin, cirrhosis (suspect varices - on nadolol) 

c/b persistent ascites despite diuretics, HE, and suspected 
varices (on nadalol at home but receives liver care at ___), 
presenting with worsening SOB and abdominal distension.

The patient was admitted ___ for persistent ascites. She 
was
found to have ___ due to overdiuresis vs. HRS. Non response to
albumin and partial response to octreotide/midodrine suggested
presence of HRS. Renal was consulted. She was started on
outpatient midodrine prior to DC with Cr 1.9. She was also found
to have paracentesis growing strep viridans though PMNs did not
meet SBP criteria. She had no abdominal pain. ""After discussion
with ID we proceeded to treat with IV ceftriaxone x5 days and 
75g
albumin on day 1 and 3 and then resumed her home cipro
prophylaxis."" She was discharged for weekly paracentesis. Of
note, RUQUS here suggestive of clot and was not confirmed with
contrast imaging given her ___. Last para appears to be ___.

Changes:
- Started midodrine 
- Stopped lasix, spironolactone, nadolol due to ___
- stopped PPI and replaced with ranitidine due to possibility 
that it may make renal function worse 
- Held alendronate as use is not recommended when GFR <35, 
consider resuming if renal function improves

The patient subsequently started having worse abdominal swelling
and fullness without infectious symptoms, bleeding, or worsening
mental status. She went to follow-up at clinic and was referred
here for paracentesis due to dyspnea and abdominal fullness. At
the time of interview, she is comfortable. 

 
Past Medical History:
1. Cirrhosis (?___) followed at ___, esophageal varix noted in
___, c/b HE, recurrent ascites
2. Type 2 diabetes.
3. CKD stage 3
4. Osteoporosis.
5. Memory loss.

 
Social History:
___
Family History:
Father died in his ___ of an MI.  Mother died in her ___ of an 
MI.  She states that one of her brothers died during surgery. 
One of her daughters has a fatty liver and no history of 
diabetes in the family.
 
Physical Exam:
Admission Physical Exam:
========================
___ 0134 Temp: 97.9 PO BP: 104/51 R Lying HR: 73 RR: 20 O2
sat: 100% O2 delivery: @___ 
General: No apparent distress, comfortable
Pulmonary: Decreased breath sounds at the left lower lung fields
Cardiac: Soft systolic murmur throughout the precordium.  
Regular
rate and rhythm
Abdomen: Distended, nontender, soft, no rebound or guarding
Extremities: Warm well perfused, no lower extremity edema,
peripheral pulses intact bilaterally
Neuro: Knows her name and hospital, does not know the day of the
week.  However, she admits to some memory difficulties and is
able to say the days of the week backwards.  She knows why she 
is
in the hospital.

Discharge Physical Exam:
=========================
24 HR Data (last updated ___ @ ___
    RR: 16  
GENERAL: NAD, A&Ox3, lying in bed comfortably 
RESP: No accessory muscle usage
ABD: distended. 
Ext: Lower extremities warm without edema
SKIN: No jaundice

 
Pertinent Results:
Admission Labs:
===============
___ 09:51PM   ___ PO2-39* PCO2-29* PH-7.38 TOTAL 
CO2-18* BASE XS--6 INTUBATED-NOT INTUBA
___ 09:51PM   O2 SAT-68
___ 07:52PM   LACTATE-1.5
___ 07:49PM   GLUCOSE-258* UREA N-33* CREAT-1.7* 
SODIUM-129* POTASSIUM-5.3 CHLORIDE-100 TOTAL CO2-16* ANION 
GAP-13
___ 07:49PM   estGFR-Using this
___ 07:49PM   ALT(SGPT)-12 AST(SGOT)-37 LD(LDH)-176 ALK 
PHOS-114* TOT BILI-2.1*
___ 07:49PM   ALBUMIN-4.3
___ 07:49PM   WBC-3.7* RBC-2.88* HGB-8.6* HCT-27.2* MCV-94 
MCH-29.9 MCHC-31.6* RDW-16.8* RDWSD-58.2*
___ 07:49PM   NEUTS-68.1 LYMPHS-18.8* MONOS-10.1 EOS-1.9 
BASOS-0.8 IM ___ AbsNeut-2.51 AbsLymp-0.69* AbsMono-0.37 
AbsEos-0.07 AbsBaso-0.03
___ 07:49PM   PLT COUNT-117*
___ 07:49PM   ___ PTT-34.8 ___
___ 06:30PM ASCITES  TOT PROT-3.0 GLUCOSE-270
___ 06:30PM ASCITES  TNC-435* ___ POLYS-18* 
LYMPHS-58* ___ MACROPHAG-24*
___ 05:54PM URINE  HOURS-RANDOM UREA N-693
___ 05:54PM URINE  UHOLD-HOLD
___ 05:54PM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 05:54PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 
LEUK-TR*
___ 05:54PM URINE  RBC-<1 WBC-4 BACTERIA-NONE YEAST-NONE 
EPI-<1
___ 05:54PM URINE  HYALINE-18*
___ 05:54PM URINE  MUCOUS-RARE*

Pertinent Studies:
==================
___ Abd duplex u.s
Final Report 
EXAMINATION:  LIVER OR GALLBLADDER US (SINGLE ORGAN) 
  
INDICATION:  ___ with abdominal pain, h/o cirrhosis// eval for 
PVT 
  
TECHNIQUE:  Grey scale and color Doppler ultrasound images of 
the abdomen were 
obtained. 
  
COMPARISON:  Ultrasound done gallbladder in liver dated ___. 
  
FINDINGS:  
  
LIVER: The hepatic parenchyma appears within normal limits. The 
contour of the 
liver is smooth. There is no focal liver mass. Nonocclusive 
thrombus is  
demonstrated at the distal main portal vein.  The central 
branches of the 
portal vein remain patent.  There is large volume ascites. 
  
BILE DUCTS: There is no intrahepatic biliary dilation. 
  CHD: 3 mm 
  
GALLBLADDER: There is no evidence of stones or gallbladder wall 
thickening. 
  
PANCREAS: The imaged portion of the pancreas appears within 
normal limits, 
without masses or pancreatic ductal dilation, with portions of 
the pancreatic 
tail obscured by overlying bowel gas. 
  
SPLEEN:  Normal echogenicity. 
  Spleen length: 11.9 cm 
  
KIDNEYS:  Limited views of the kidneys show no hydronephrosis. 
  Right kidney: 9.2 cm 
  Left kidney: 10.3 cm 
  
RETROPERITONEUM:  The visualized portions of aorta and IVC are 
within normal 
limits. 
  
IMPRESSION: 
  
  
1. Nonocclusive thrombus is demonstrated in the distal main 
portal vein.  The 
central branches of the portal vein remain patent. 
2. Cirrhosis with large volume ascites. 
3. Cholelithiasis without evidence of acute cholecystitis. 

CXR ___
Final Report 
EXAMINATION:  Chest:  Frontal and lateral views 
  
INDICATION:   ___ with dyspnea// eval for pna 
  
TECHNIQUE:  Chest:  Frontal and Lateral 
  
COMPARISON:  Multiple prior chest radiographs, most recently on 
___ 
  
FINDINGS:  
  
Lung volumes are low with persistent left basilar opacity, 
likely representing 
a combination of atelectasis and pleural effusion.  Findings are 
similar to 
prior allowing for differences in technique.  No pneumothorax.  
Cardiomediastinal silhouette is stable. 
  
IMPRESSION:  
  
Small left pleural effusion with left basal atelectasis.  Low 
lung volumes 
limits assessment. 

TTE ___
Poor image quality. Normal left ventricular wall thickness and 
biventricular cavity
sizes and regional/global systolic function.

PleurX drainage catheter ___
Successful peritoneal PleurX catheter placement 

Pertinent Labs:
===============
___ 06:30PM ASCITES TNC-435* ___ Polys-18* 
Lymphs-58* ___ Macroph-24*
___ 06:30PM ASCITES TotPro-3.0 Glucose-270
___ 09:40AM URINE Hours-RANDOM UreaN-766 Creat-176 Na-<20 
K-28

(No discharge labs)

 
Brief Hospital Course:
Summary:
========
___ yo F PMHx T2DM on insulin, cirrhosis c/b persistent ascites 
despite diuretics, HE, and suspected varices (on nadolol at 
home) presented with decompensated NASH cirrhosis with 
hepatorenal syndrome. Given patient failed multiple lines of
therapy including a trial drug terlipressin, she was 
transitioned to hospice and transferred Season's in ___.

[ ] Code: DNR/DNI
[ ] CONTACT: ___, daughter, ___ 
[ ] LANGUAGE: ___ only 

Acute Issues:
=============
#Acute Kidney Injury 
#Concern for Hepatorenal syndrome 
The patient was discharged ___ from ___ on midodrine for 
management of acute kidney injury felt to possibly be secondary 
to hepatorenal syndrome. She was readmitted from clinic for 
increased ascites and need for a paracentesis. At that point, 
her Creatinine was lower than at her prior discharge (1.6 from 
1.9). She underwent a paracentesis ___. Creatinine then 
gradually increased. She was given IV albumin, octreotide and 
midodrine. Unfortunately her Creatinine continued to uptrend. 
She was then ruled in for the terlipressin trial on ___ and 
was enrolled into the study. However, her Creatinine did not 
improve while on the terlipressin trial. She was taken off of 
the study medication and restarted on midodrine and octreotide 
with ongoing worsening of her creatinine. Following several 
conversations with her family, decision was ultimately made to 
transition to CMO and she was discharged to a ___ facility. 
Her pain and comfort were treated aggressively.

#NASH Cirrhosis 
#Ascites
The patient was due for outpatient paracentesis on ___ 
however unfortunately had rapid reaccumulation of ascites and 
required a paracentesis sooner. She underwent a 6L paracentesis 
on ___ which significantly improved her symptoms. Diagnostic 
tap was negative for evidence of SBP. Due to her enrollment into 
the terlipressin trial, she was not tapped again until ___ 
when the trial was discontinued. She had another repeat 
paracentesis on ___ due to rapid reaccumulation. She was 
continued on ciprofloxacin prophylaxis while in the hospital. 
pleurX catheter was placed on ___ when she was transitioned to 
CMO. 

#Non-AGMA
Felt to be due to renal failure. She was started on oral 
bicarbonate but this was discontinued when she was made CMO.

CHRONIC ISSUES
==========================
#Diabetes. Home oral agents were held. She was placed on ISS but 
this was discontinued with transition to CMO
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Rifaximin 550 mg PO BID 
2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 
3. Ciprofloxacin HCl 500 mg PO Q24H 
4. Lactulose 15 mL PO DAILY 
5. Midodrine 15 mg PO TID 
6. Ranitidine 150 mg PO DAILY 
7. GlipiZIDE XL 5 mg PO DAILY 
8. Senna Plus (sennosides-docusate sodium) 8.6-50 mg oral BID 
9. Zaditor (ketotifen fumarate) 0.025 % (0.035 %) ophthalmic 
(eye) BID 
10. Glargine 24 Units Breakfast

 
Discharge Medications:
1.  Glycopyrrolate 0.1-0.2 mg IV Q4H:PRN excess secretions  
2.  HYDROmorphone (Dilaudid) 0.25-0.5 mg IV Q4H:PRN Pain - 
Severe 
RX *hydromorphone 0.5 mg/0.5 mL 0.25-0.5 mL every four (4) hours 
Disp #*10 Syringe Refills:*0 
3.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - 
Moderate 
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours 
Disp #*10 Tablet Refills:*0 
4.  Lactulose 15 mL PO DAILY  
5.  Midodrine 15 mg PO TID  
6.  Rifaximin 550 mg PO BID  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
===================
1) Refractory ascites from decompensated cirrhosis
2) Hepatorenal Syndrome 
3) Non-Anion Gap Metabolic Acidosis

Secondary Diagnosis:
====================
1) Diabetes Mellitus 

 
Discharge Condition:
Activity Status: Ambulatory - Independent.
Level of Consciousness: Lethargic but arousable.
Mental Status: Confused - sometimes.

 
Discharge Instructions:
Ingres a ___ con sntomas de lquido ___ abdomen. El 
lquido fue ___ insuficiencia renal. No 
respondio a muchos medicamentos y despues de muchas 
conversaciones con ___ familia, decidimos ___ 
___.

Fue un placer cuidarle!

Sinceramente,
___ de atencin ___.
 
Followup Instructions:
___
","['0W9G30Z' '0W9G3ZZ' 'E87.3' 'I50.30' 'E87.2' 'N18.3' 'R06.00' 'K76.7'
 'K72.00' 'N17.9' 'K75.81' 'R41.3' 'Z79.4' 'Z66.' 'Z51.5' 'M54.9' 'Z00.6'
 'K21.9' 'R18.8' 'E11.22']","['E87.3' 'I50.30' 'E87.2' 'N18.3' 'R06.00' 'K76.7' 'K72.00' 'N17.9'
 'K75.81' 'R41.3' 'Z79.4' 'Z66.' 'Z51.5' 'M54.9' 'Z00.6' 'K21.9' 'R18.8'
 'E11.22']",['0W9G30Z' '0W9G3ZZ'],"['Drainage of Peritoneal Cavity with Drainage Device, Percutaneous Approach'
 'Drainage of Peritoneal Cavity, Percutaneous Approach' 'Alkalosis'
 'Unspecified diastolic (congestive) heart failure' 'Acidosis'
 'Chronic kidney disease, stage 3 (moderate)' 'Dyspnea, unspecified'
 'Hepatorenal syndrome' 'Acute and subacute hepatic failure without coma'
 'Acute kidney failure, unspecified' 'Nonalcoholic steatohepatitis (NASH)'
 'Other amnesia' 'Long term (current) use of insulin' 'Do not resuscitate'
 'Encounter for palliative care' 'Dorsalgia, unspecified'
 'Encounter for examination for normal comparison and control in clinical research program'
 'Gastro-esophageal reflux disease without esophagitis' 'Other ascites'
 'Type 2 diabetes mellitus with diabetic chronic kidney disease']",6,1651,20,2,,1,5,0
" 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
possible rectal perforation
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Mr. ___ is an ___ with h/o CAD, COPD on home O2, UC on 
mesalamine, CKD, s/p screening EGD and colonoscopy c/b rectal 
perforation with contained RP air on imaging admitted for 
observation. Patient underwent routine screening colonoscopy 
yesterday that was difficult to perform to per colonoscopy 
report due to rectosiogmoid narrowing at 20cm with evidence of 
mucosal injury on imaging. He reportedly developed chills 
following colonoscopy and there was concern for colonic 
perforation given difficult exam, thus he reported to the ED 
where CT imaging demonstrated a notable amount of contained 
retroperitoneal air concerning for rectal perforation. Patient 
was subsequently admitted to ACS and Colorectal Surgery is now 
consulted for evaluation of potential surgical intervention in 
the setting of active colitis. Patient has continued to remain 
afebrile and hemodynamically stable throughout hospitalization 
without leukocytosis or lactic acidosis. He reports loose bowel 
movements and denies any abdominal pain or back pain, bloody or 
melenic stools, fevers/chills, CP/SOB, N/V.

 
Past Medical History:
PMHx: CAD, COPD on home O2 @ night, UC on mesalamine, CKD, HTN,
HLD, GERD, hx of CHF (but not on diuretics, last TTE seen in
chart ___ w/ normal LV EF ~55%)

PSHx: none
 
Social History:
___
Family History:
n/c
 
Physical Exam:
VS: VSS
GEN: WD, WN in NAD
HEENT: NCAT, EOMI, anicteric
CV: RRR, No JVD
PULM:  normal excursion, no respiratory distress
ABD: soft, NT, ND, no rebound or guarding
EXT: WWP, no CCE, 2+ B/L radial
NEURO: A&Ox3, no focal neurologic deficits
 
Pertinent Results:
See OMR for all lab and imaging results.
 
Brief Hospital Course:
Mr. ___ was admitted to the Colorectal Surgical Service from 
the ED at ___ for close observation and conservative 
management given concern for rectal perforation. During his 
stay, patient remained afebrile and hemodynamically stable 
without leukocytosis, lactic acidosis or evidence of peritonitis 
on abdominal exam and he continued to deny abdominal or back 
pain throughout admission.

Pt was maintained on NPO/IVF. He started on a 7-day course of 
antibiotics - IV cipro/flagyl which was transitioned to PO at 
time of discharge (end ___. Gastrografin enema was performed 
on ___ that showed no extraluminal contrast that would 
suggest leak.

On ___, the patient was discharged to home. At discharge, he 
was tolerating a regular diet, passing flatus, and ambulating 
independently. He will be discharged with a foley and plans to 
undergo a voiding trial with his urologist Dr. ___ week. He 
will also follow up with his GI Dr. ___ future 
mesalamine use. Last, he will follow-up in the ___ clinic in ___ 
weeks and with his PCP.  This information was communicated to 
the patient and his family directly prior to discharge.

 
Medications on Admission:
Active Medication list as of ___:
 
Medications - Prescription
umeclidinium-vilanterol (ANORO ELLIPTA) 62.5-25 mcg/actuation
Disk with Device, Inhale 1 puff daily
ipratropium-albuterol (DUO-NEB) 0.5 mg-3 mg(2.5 mg base)/3 mL
Solution for Nebulization
Use 3 mL in nebulizer every 4 hours as needed
ATENOLOL - atenolol 100 mg tablet. 1 tablet(s) by mouth once a
day -  (Prescribed by Other Provider)
ENALAPRIL MALEATE - enalapril maleate 20 mg tablet. 1 tablet(s)
by mouth once a day -  (Prescribed by Other Provider)
FOLIC ACID - folic acid 1 mg tablet. 1 tablet(s) by mouth once a
day -  (Prescribed by Other Provider)
MESALAMINE - mesalamine 800 mg tablet,delayed release. 2
tablet(s) by mouth three times a day -  (Prescribed by Other
Provider)
MESALAMINE [CANASA] - Canasa 1,000 mg rectal suppository. 1
suppository(s) rectally once a day -  (Prescribed by Other
Provider)
NITROGLYCERIN - nitroglycerin 0.4 mg sublingual tablet. 1
tablet(s) sublingually  as needed -  (Prescribed by Other
Provider)
NITROGLYCERIN - nitroglycerin 0.2 mg/hr transdermal 24 hour
patch. q 24 hrs  -  (Prescribed by Other Provider)
OMEPRAZOLE - omeprazole 20 mg capsule,delayed release. 1
capsule(s) by mouth twice a day before meals -  (Prescribed by
Other Provider)
OXYGEN - Dosage uncertain -  (Prescribed by Other Provider)
SIMVASTATIN - simvastatin 20 mg tablet. 1 tablet(s) by mouth 
once
a day -  (Prescribed by Other Provider)
TERAZOSIN - terazosin 5 mg capsule. 1 capsule(s) by mouth at
bedtime -  (Prescribed by Other Provider)
 
Medications - OTC
ASPIRIN [ADULT LOW DOSE ASPIRIN] - Adult Low Dose Aspirin 81 mg
tablet,delayed release. 1 tablet(s) by mouth once a day - 
(Prescribed by Other Provider)
CHOLECALCIFEROL (VITAMIN D3) - cholecalciferol (vitamin D3) 
1,000
unit capsule. ___ capsule(s) by mouth once a day -  (Prescribed
by Other Provider)
MULTIVITAMIN [DAILY MULTIPLE] - Daily Multiple tablet. 1
tablet(s) by mouth once a day -  (Prescribed by Other Provider)

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H  
2.  Ciprofloxacin HCl 500 mg PO Q12H 
RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth every 
12 hours Disp #*5 Tablet Refills:*0 
3.  MetroNIDAZOLE 500 mg PO Q8H 
RX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth every 
eight (8) hours Disp #*8 Tablet Refills:*0 
4.  Atenolol 100 mg PO DAILY  
5.  Enalapril Maleate 20 mg PO DAILY  
6.  Mesalamine ___ 1600 mg PO TID  
7.  Terazosin 5 mg PO QHS  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Possible rectal perforation

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Mr. ___, 

You were admitted for concern for rectal perforation. 
Gastrograffin enema was done and no contrast leak was seen. You 
were monitored closely and there was no sign of continued 
perforation. You were given IV fluids to maintain your volume 
and initially on no foods or liquids by mouth until you were 
deemed safe to do so. You were started on 2 antibiotics 
(ciprofloxacin, metronidazole) on ___ and you will be prescribed 
a full 7-day course that will end ___ (last dose on ___. 
Please follow up with your PCP and the ___ Clinic within 
the next ___ weeks. You will need to restart several home 
medications that were held while you were in the hospital. 
Please also follow up with your urologist Dr. ___ to remove the 
foley after undergoing a voiding trial. Finally, follow up with 
your GI doctor Dr. ___ this admission and the need to 
continue mesalamine.

 
Followup Instructions:
___
","['0DBL8ZX' '0DBN8ZX' '0DBM8ZX' '0DBH8ZX' '0DBP8ZX' '0DBK8ZX' 'Z87.891'
 'E78.5' 'N40.0' 'I25.2' 'I25.118' 'K21.9' 'K91.71' 'N18.3' 'K50.90'
 'Y65.8' 'Z99.81' 'Y92.9' 'I12.9' 'J43.9']","['Z87.891' 'E78.5' 'N40.0' 'I25.2' 'I25.118' 'K21.9' 'K91.71' 'N18.3'
 'K50.90' 'Y65.8' 'Z99.81' 'Y92.9' 'I12.9' 'J43.9']",['0DBL8ZX' '0DBN8ZX' '0DBM8ZX' '0DBH8ZX' '0DBP8ZX' '0DBK8ZX'],"['Excision of Transverse Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic'
 'Excision of Sigmoid Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic'
 'Excision of Descending Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic'
 'Excision of Cecum, Via Natural or Artificial Opening Endoscopic, Diagnostic'
 'Excision of Rectum, Via Natural or Artificial Opening Endoscopic, Diagnostic'
 'Excision of Ascending Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic'
 'Personal history of nicotine dependence' 'Hyperlipidemia, unspecified'
 'Benign prostatic hyperplasia without lower urinary tract symptoms'
 'Old myocardial infarction'
 'Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris'
 'Gastro-esophageal reflux disease without esophagitis'
 'Accidental puncture and laceration of a digestive system organ or structure during a digestive system procedure'
 'Chronic kidney disease, stage 3 (moderate)'
 ""Crohn's disease, unspecified, without complications""
 'Diagnostic and monitoring gastroenterology and urology devices associated with adverse incidents'
 'Other specified misadventures during surgical and medical care'
 'Dependence on supplemental oxygen' 'Unspecified place or not applicable'
 'Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease'
 'Emphysema, unspecified']",7,1063,20,2,,1,5,0
" 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
amoxicillin / azithromycin / amoxicillin
 
Attending: ___.
 
Chief Complaint:
CHIEF COMPLAINT: Chest pain 
 
Major Surgical or Invasive Procedure:
___ Coronary angiography and left heart catheterization 
with right radial access

 
History of Present Illness:
Mr. ___ is a ___ year old man with a prior history of 
borderline hypertension and recurrent strep pharyngitis who 
presents with sore throat, fevers, chills, nausea and vomiting 
in addition to chest pressure. 

He was in his usual state of health until ___ when he 
worked all day inside of a very hot ___. He felt suddenly 
lethargic, diaphoretic and tremulous, and subsequently had some 
episodes of emesis and a headache. He had intenseThe following 
day he felt slightly improved, but developed sore throat 
consistent with prior strep pharyngitis infections. On ___ he 
was still feeling tired and somewhat weak with a sore throat. 
Around midnight on the morning of admission, he developed 
substernal chest pain. This lasted an hour, but then returned an 
hour lated and lasted until admission. He denied pleuritic or 
positional pain. 

He describes the sensation mostly as an irritation with some 
heaviness and no radiation. Notably the pain was worse with deep 
inspiration but was not positional. Given concern for inability 
to eat or drink well and the heaviness in his chest, he 
presented to the ED. 

He has not had any sick contacts, recent travel, tick exposure, 
new medications, illicit drugs. He has had knee pain related to 
a meniscal tear and has been taking 600mg ibuprofen three times 
daily. 

EMERGENCY DEPARTMENT COURSE
In the ED initial vitals were:  
- T: 97.0, HR: 74, BP: 124/83, O2: 100% RA

Exam notable for:  
- Exam: +tonsillar exudates. +cervical adenopathy ttp. CV/Lung
exam wnl. Abd benign. wwp. 

Images notable for:  
- CXR with no acute intrathoracic process 

EKG: 
- ST Depression V1 and V3 with J point elevation in lateral
leads, nonspecific but could represent ischemia
- Posterior EKG with 1mm ST elevation in V7 and V8

Patient was given:  
___ ___
___ 07:03IVKetorolac 15 mg
___ 07:03IVDexamethasone 10 mg
___ 07:47PO/NGSulfameth/Trimethoprim DS 1 TAB
___ 07:47PO/NGCephalexin 500 mg
___ 08:37PO/NGAspirin 324 mg
___ 08:41SLNitroglycerin SL .4 mg
___ 08:51IVFNS 1000 mLStopped (2h ___
___ 09:26PO/NGAtorvastatin 80 mg
___ 09:32IVHeparin 4000 UNIT
___ 09:32IVHeparinStarted 1000 units/hr
___ 09:40IV DRIPNitroglycerin (0.35-3.5 mcg/kg/min
ordered)Started 0.35 mcg/kg/min
___ 09:51IV DRIPNitroglycerinChanged to 0.5 mcg/kg/min
___ 10:03IV DRIPNitroglycerin Changed to 1 mcg/kg/min
___ 10:17IV DRIPNitroglycerinChanged to 1.5 mcg/kg/min
___ 10:34IV DRIPNitroglycerinChanged to 2 mcg/kg/min

Vitals on transfer to cath lab :  
HR: 92, BP: 110/65, RR: 16, RR: 97% RA

On the floor
- Complete resolution of chest pain/pressure
- No dyspnea 

 
Past Medical History:
- Recurrent infectious pharyngitis including two paratonsillar
abscesses requiring drainage 
- Borderline hypertension without prior treatment
- Right arm cellulitis requiring hospitalization
- Microscopic hematuria 

 
Social History:
___
Family History:
Mother: ___ disorder
Father: HTN, HLD
Brother: ___ use disorder
No family history of cardiomyopathy or sudden cardiac death 
 
Physical Exam:
PHYSICAL EXAM ON ADMISSION 
==========================
VS:  T:98.0 BP:101/65, HR:73, RR:18: O2:95, RA
GENERAL:  Tired appearing man speaking to us in no apparent
distress
HEENT: Pupils equal and reactive, no scleral icterus or
injection. Enlarged tonsils with bilateral tonsillar exudates.
Submandibular and cervical tenderness and mild swelling without
asymmetry or overt lymphadenopathy. Moist mucous membranes. 
NECK: JVP ___ with some hepatojugular reflex. 
CARDIAC: S1/S2 regular without murmurs, rubs or S3/S4. No rub in
forward leaning position. 
LUNGS: Clear bilaterally. 
ABDOMEN: Soft, non-tender, non-distended. 
EXTREMITIES:  Warm extremities without edema. R arm with radial
bandage. Good pulse and warm fingers with normal sensation and
movement. 
PULSES: Strong pedal pulses. 

PHYSICAL EXAM ON DISCHARGE 
===========================
GENERAL: well appearing man in NAD, sitting up in bed 
HEENT: Pupils equal and reactive, no scleral icterus or
injection. Enlarged erythemic tonsils with bilateral tonsillar 
exudates R >L
Submandibular and cervical tenderness, though no notable 
cervical or clavicular lymphadenopathy. MMM 
NECK: JVP ___ with mild hepatojugular reflex. 
CARDIAC: S1/S2 regular without murmurs, rubs or S3/S4.No rub 
appreciated while sitting forward  
LUNGS: Clear bilaterally, no crackles or wheezing noted  
ABDOMEN: Soft, non-tender, non-distended, +BS
EXTREMITIES:  Warm extremities without edema. R arm with intact 
radial
bandage. Good pulse and warm fingers with normal sensation and
movement. 
PULSES: Strong pedal pulses.
SKIN: Dry and intact 
 
Pertinent Results:
ADMISSION LABS 
=============
___ 06:09AM BLOOD WBC-13.5* RBC-4.79 Hgb-13.6* Hct-39.4* 
MCV-82 MCH-28.4 MCHC-34.5 RDW-13.7 RDWSD-40.7 Plt ___
___ 06:09AM BLOOD Neuts-84.7* Lymphs-5.3* Monos-8.5 
Eos-0.1* Baso-0.4 Im ___ AbsNeut-11.46* AbsLymp-0.72* 
AbsMono-1.15* AbsEos-0.01* AbsBaso-0.05
___ 07:36PM BLOOD ___ PTT-25.7 ___
___ 06:09AM BLOOD Plt ___
___ 06:09AM BLOOD Glucose-121* UreaN-17 Creat-0.8 Na-137 
K-3.6 Cl-100 HCO3-21* AnGap-16
___ 06:09AM BLOOD CK(CPK)-539*
___ 06:09AM BLOOD CK-MB-41* MB Indx-7.6* cTropnT-0.73*
___ 07:36PM BLOOD CK-MB-39* MB Indx-9.0* cTropnT-0.57*
___ 07:36PM BLOOD Calcium-9.3 Phos-2.5* Mg-2.0
___ 07:36PM BLOOD TSH-0.33

DISCHARGE LABS 
=============
___ 07:45AM BLOOD WBC-13.5* RBC-4.77 Hgb-13.5* Hct-39.9* 
MCV-84 MCH-28.3 MCHC-33.8 RDW-13.7 RDWSD-42.1 Plt ___
___ 07:45AM BLOOD Plt ___
___ 07:45AM BLOOD Glucose-106* UreaN-17 Creat-0.7 Na-142 
K-3.9 Cl-105 HCO3-22 AnGap-15
___ 07:45AM BLOOD ALT-43* AST-53* LD(LDH)-346* AlkPhos-83 
TotBili-0.4
___ 07:45AM BLOOD Calcium-9.6 Phos-3.3 Mg-2.0

MICROBIOLOGY
============
___ Blood Culture = Pending
___ Strep and viral throat swabs = Pending

REPORTS AND IMAGING STUDIES
=========================

___ TRANSTHORACIC ECHOCARDIOGRAM 
The left atrium is mildly dilated. The right atrium is mildly 
enlarged. There is no evidence for an atrial septal defect by 
2D/color Doppler. The estimated right atrial pressure is ___ 
mmHg. There is normal left ventricular wall thickness with a 
mildly increased/dilated cavity. There is mild global left 
ventricular hypokinesis. No thrombus or mass is seen in the left 
ventricle. Quantitative biplane left ventricular ejection 
fraction is 42 %. Due to severity of mitral regurgitation, 
intrinsic left ventricular systolic function may be lower. There 
is no resting left ventricular outflow tract gradient. Tissue 
Doppler suggests a normal left ventricular filling pressure 
(PCWP less than 12mmHg). There is normal diastolic function. 
Normal right ventricular cavity size with uninterpretable free 
wall motion assessment. The aortic valve leaflets (3) appear 
structurally normal. There is no aortic valve stenosis. There is 
no aortic regurgitation. The mitral valve leaflets appear 
structurally normal with no mitral valve prolapse. There is mild 
[1+] mitral regurgitation. The tricuspid valve leaflets appear 
structurally normal. There is mild [1+] tricuspid regurgitation. 
The estimated pulmonary artery systolic pressure is normal. 
There is a trivial pericardial effusion.

IMPRESSION: Normal left ventricular wall thickness with mild 
cavity dilation and mild global systolic dysfunction c/w a 
nonischemic cardiomyopathy or myocarditis. Mild mitral 
regurgitation. Mild tricuspid regurgitation.

Compared with the prior TTE (images reviewed) of ___ , 
the findings are similar. Left ventricular cavity size was 
underestimated on the prior study.

___ TRANSTHORACIC ECHOCARDIOGRAM 
The left atrial volume index is mildly increased. The right 
atrium is mildly enlarged. There is mild symmetric left 
ventricular hypertrophy with a normal cavity size. There is 
normal regional and global left ventricular systolic function. 
Quantitative biplane left ventricular ejection fraction is 42 %. 
There is no resting left ventricular outflow tract gradient. 
Normal right ventricular cavity size with normal free wall 
motion. The aortic sinus diameter is normal for gender with 
normal ascending aorta diameter for gender. The aortic arch 
diameter is normal. The aortic valve leaflets (3) appear 
structurally normal.
There is no aortic valve stenosis. There is no aortic 
regurgitation. The mitral valve leaflets appear structurally 
normal with no mitral valve prolapse. There is mild [1+] mitral 
regurgitation. The tricuspid valve leaflets appear structurally 
normal. There is mild [1+] tricuspid regurgitation. The 
estimated pulmonary artery systolic pressure is normal. There is 
no pericardial effusion.

IMPRESSION: Mild global left ventricular systolic dysfunction. 
MIld mitral regurgitation.

___ LEFT HEART CATHETERIZATION AND CORONARY ANGIOGRAPHY
LV Systolic = 101 
LVEDP = 21 
HR = 109

AO Systolic 93
AO Diastolic 73
AO Mean 76
HR 86

Angiography report pending, preliminary is no significant 
disease
 
Brief Hospital Course:
=================
SUMMARY STATEMENT
=================
Mr. ___ is a ___ year old man with a prior history of 
borderline hypertension and recurrent strep pharyngitis who 
presents with pharyngitis and chest pain and was found to have 
ECG changes and troponin elevation consistent with 
myopericarditis. A TTE revealed depressed LVEF of 40%. He did 
not show evidence of hemodynamic compromise, heart failure 
decompensation, conduction abnormality, or arrhythmia. His 
troponins started downtrending within 12 hours of admission. He 
was discharged on treatment for presumed bacterial pharyngitis 
and pericarditis. 

# CORONARIES: ___: NO CAD
# PUMP: LVEF 42%, global LV systolic dysfunction, mild MR
# RHYTHM: Sinus

==================
TRANSITIONAL ISSUES
==================
Discharge Weight: (___) 94.8kg (209lb) 
Discharge Diuretic: None (written for lasix, but should only use 
if directed)
Discharge Creatinine: 0.7

[ ] If he has symptoms of recurrent chest pain, it would be 
reasonable to treat with colchicine in addition to ibuprofen. 
Would avoid steroids until absolutely necessary. 
[ ] Would consider elective tonsillectomy given recurrent strep 
pharyngitis
[ ] LFTs elevated, possibly in the setting of acute viral 
infection, but would repeat within 2 weeks as an outpatient 
[ ] Patient was provided with furosemide 20mg tablets, but 
should only take if instructed by a physician 
[ ] Will have repeat TTE in heart failure clinic to re-evaluate 
for improving systolic function 

New Medications: 
- Cephalexin 500mg twice daily through ___
- Ibuprofen 800mg three times daily x 7d, followed by 
- Ibuprofen 400mg three times daily x 7d
- Ibuprofen 400mg PRN after this 
- Torsemide 20mg PO, only to be taken if directed by physician 

___: None
Discontinued Medications: None

====================
ACUTE MEDICAL ISSUES
====================
#Myopericarditis with global LV dysfunction (LVEF 40%) 
Mr. ___ presented with clinical signs of pericarditis 
(pleuritic chest pain) and ECG evidence of pericaridits as well. 
Troponins were elevated confirming concomittant myocarditis. A 
coronary angiography did not show coronary disease. Left heart 
catheterization did show elevated LVEDP of 21, and a TTE showed 
global LV dysfunction with LVEF 40%. He did not show signs of 
hemodynamic compromise, heart failure decompensation, conduction 
abnormality, or arrhythmia, despite evidence of elevated filling 
pressures. 

Etiology very likely to be related to recent pharyngitis 
infection, especially given concurrent pericarditis. There is 
case-report evidence of strep pharyngitis-associated myocarditis 
and pericarditis. He received IV toradol and steroids, and was 
started on a nitroglycerin and heparin gtt in the ED and his 
chest pain resolved. He did not have recurrent chest pain. 

Utox negative, few eosinophils on peripheral smear. Mild 
presentation not consistent with giant cell myocarditis. No 
other evidence of endocarditis. His cardiac biomarkers, 
including CK-MB and troponin T, were downtrending during his 
admission. Limited repeat TTE on the day of discharge showed 
stable mild LV dysfunction. Review of his telemetry revealed on 
occasional premature atrial depolarizations without any 
sustained supraventricular or ventricular arrhythmias and no 
evidence of heart block. For treatment of his pharyngitis and 
myopericarditis:  

- Keflex ___ PO twice daily through ___ 
- Ibuprofen 800mg three times daily x 7d
- Ibuprofen 400mg three times daily x 7d
- Ibuprofen 400mg PRN after this 
- Strep culture and viral culture pending at discharge, but will 
treat with 7d course of keflex for presumptive strep pharyngitis 
given strong history of this
- Follow-up in heart failure clinic to be arranged after 
discharge
- Low threshold to restart colchicine if recurrent pericarditis 
symptoms 

#Pharyngitis
Extended history of bacterial pharyngitis including two episodes 
of peritonsillar abscess requiring drainage. Clear evidence of 
pharyngitis on exam without evidence of abscess. Culture taken, 
but after antibiotics already started. Will treat empirically 
for bacterial infection with 7d course of keflex ___ twice 
daily.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Ibuprofen 600 mg PO Q8H:PRN Pain - Moderate 

 
Discharge Medications:
1.  Cephalexin 500 mg PO Q12H 
RX *cephalexin 500 mg 1 capsule(s) by mouth twice daily Disp 
#*11 Capsule Refills:*0 
2.  Furosemide 20 mg PO DAILY 
Do not take unless instructed by doctor.  
RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*10 Tablet 
Refills:*0 
3.  Ibuprofen 800 mg PO Q8H Duration: 7 Days 
RX *ibuprofen 800 mg 1 tablet(s) by mouth three times daily Disp 
#*21 Tablet Refills:*0 
4.  Ibuprofen 400 mg PO Q8H Duration: 7 Days 
start after completing course of 800mg three times daily 
RX *ibuprofen 400 mg 1 tablet(s) by mouth three times daily Disp 
#*21 Tablet Refills:*0 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
================
PRIMARY DIAGNOSIS
================
Myopericarditis

===================
SECONDARY DIAGNOSES
===================
Acute heart failure with reduced ejection fraction, not 
decompensated 
Pharyngitis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___, 

It was a pleasure caring for you while you were admitted to ___ 
___. 

WHY WERE YOU ADMITTED TO THE HOSPITAL?
- You were having throat pain and chest pain. 

WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?
- We found that you have inflammation of the heart muscle, and 
of the sack the surrounds the heart: this is called myocarditis 
and pericarditis. 
- Because your symptoms can be consistent with a heart attack, 
we did a procedure to look at the vessels in the heart (coronary 
angiography). This did not show any blockages or narrowing. 

WHAT SHOULD YOU DO WHEN YOU GO HOME?
- You are still at risk for cardiac complications. If you have 
difficult breathing, swelling in your legs, worsening fatigue, 
feeling lightheaded, call a doctor right away. You need to call 
___ or go to an emergency department if it feels like your heart 
is beating strangely or too fast, or if you pass out at any 
time. 
- Do not do any exercise until you see a doctor who tells you 
this is ok. Normal household activities are fine to do. 
- Buy a scale and take your weight every morning after getting 
up. If your weight goes up 3 pounds in a day or 5 pounds in a 
week, call your doctor right away. Your weight when you left the 
hospital was  209 pounds (94.8 kilograms). 
- Carefully review the attached medication list. 

Sincerely, 
Your ___ Care Team 
 
Followup Instructions:
___
",['4A023N7' 'B211YZZ' 'I50.21' 'Z88.1' 'I34.0' 'I30.1' 'J02.0' 'F14.90'],['I50.21' 'Z88.1' 'I34.0' 'I30.1' 'J02.0' 'F14.90'],['4A023N7' 'B211YZZ'],"['Measurement of Cardiac Sampling and Pressure, Left Heart, Percutaneous Approach'
 'Fluoroscopy of Multiple Coronary Arteries using Other Contrast'
 'Acute systolic (congestive) heart failure'
 'Allergy status to other antibiotic agents status'
 'Nonrheumatic mitral (valve) insufficiency' 'Infective pericarditis'
 'Nonrheumatic tricuspid (valve) stenosis' 'Streptococcal pharyngitis'
 'Cocaine use, unspecified, uncomplicated']",8,2339,8,2,,1,5,0
" 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Scheduled Chemotherapy 
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ PMH CNS lymphoma c/b IPH and encephalopathy with relapse who
was admitted for his ___ re-induction HD-MTX.

During last cycle, patient had fecal incontinence which was
worked up with MRI/LP which did not show e/o explanatory
pathology. Given intermittent nature, team wondered whether or
not encephalopathy was contributing. Sphincter tone was noted to
be intact. As per discussion with patient and family,
incontinence has been intermittent at home, lasting a few days 
at
a time, then spontaneously resolving with asymptomatic periods 
in
between. Patient is a poor historian but noted that urge to
defecate comes on quick and doesn't have time to get to the
bathroom. Denied any abdominal pain, nausea, vomiting, fevers. 

Patient noted that he was otherwise feeling well and denied any
other complaints. Noted that he is trying to eat healthy, and
denied weight change. Reported that his family was doing well so
he was in good spirits. 
 

 
Past Medical History:
PAST ONCOLOGIC HISTORY:  
As per last d/c summary:
1) the patient was brought to ___ on ___
by EMS because of confusion and confabulation,
(2) head CT and MRI on ___ both showed enhancement in the
left medial temporal lobe and the right splenium of the corpus
callosum,
(3) admission to the general neurology service at ___ on ___,
(4) a lumbar puncture on ___ showed over 240 white blood
cells, 90% lymphocytes, protein level of 116, and an elevated
glucose to 148,
(5) discharged home on ___, 
(6) evaluation at ___ emergency department 
on
___,
(7) transferred to the ___ neurology service at ___
on ___,
(6) EEG on ___ showed slowing but no epileptiform activity,
(7) EEG on ___ showed slowing but no epileptiform activity,
(8) stereotaxic brain biopsy on ___ by Dr. ___
showed CNS lymphoma based on the cytogenetics, 
(9) transferred to ___ Service on ___, 
(10) placement of PICC line on ___,
(11) received C1 induction high-dose methotrexate on ___ at
a dose of 8 grams/m2,
(12) received C2 induction high-dose methotrexate on ___ at
a dose of 8 grams/m2,
(13) non-contrast head CT on ___ showed resolution of
post-biopsy blood in the left temporal lobe and decreased
cerebral edema,
(14) discontinued antibiotics on ___,
(15) discontinued levetiracetam on ___,
(16) Portacath placement on ___,
(17) received C3 induction high-dose methotrexate on ___ at
a dose of 8 grams/m2,
(18) gadolinium-enhanced head MRI performed on ___ showed
near complete response,
(19) received C4 induction high-dose methotrexate on ___ at
a dose of 8 grams/m2, 
(20) discharged from ___ Service on ___,
(21) re-admission to ___ 11 for C5 induction high-dose
methotrexate on ___ at a dose of 8 grams/m2,
(22) discharged from ___ Service on ___,
(23) re-started metformin 25 mg BID on ___,
(24) admission to ___ 11 for C6 induction high-dose
methotrexate on ___ at a dose of 8 grams/m2, and
(25) admission to ___ 11 for C7 induction high-dose
methotrexate on ___ at a dose of 8 grams/m2.
(26) admission to ___ 11 for C8  induction high-dose
methotrexate on ___ at dose of 8 gram/m2.
(27) admission to ___ 11 for C9 induction high-dose
methotrexate on ___ for C9 
(28) induction C1W1 rituximab on ___.
(29) admission to ___ for re-induction C1 (C10) high-dose
methotrexate on ___ at dose of 8 gram/m2.
(30) induction C1W2 rituximab on ___.
(31) induction C1W3 rituximab on ___.
(32) admission to ___ for re-induction C2 (C11) high-dose
methotrexate on ___ at dose of 8 gram/m2.
(33) induction C1W4 rituximab on ___.
(34) C2 rituximab on ___.
(35) admission to ___ for re-induction C3 (C12) high-dose
methotrexate on ___ at dose of 8 gram/m2.
(36) gadolinium-enhanced head MRI from ___ showed shrinkage
of his CNS lymphomas.
(37) gadolinium-enhanced head MRI on ___ showed partial
response.
(38) C3 rituximab on ___.
(39) admission to ___ for re-induction C4 (C13) high-dose
methotrexate on ___ at dose of 8 gram/m2.
(40) C4 rituximab on ___.
(41) admission to ___ for re-induction C5 (C14) high-dose
methotrexate on ___ at dose of 8 gram/m2.
(42) C5 rituximab on ___.
(43) admission to ___ for re-induction C6 (C15) high-dose
methotrexate on ___ at dose of 8 gram/m2.
(44) C6 rituximab on ___.                   
(45) admission to ___ for re-induction C7 (C16) high-dose
methotrexate on ___ at dose of 8 gram/m2.
(46) C7 rituximab on ___
(47) Re Induction C8 (c17) HD MTX on ___
(48) C8 rituximab ___
 
PAST MEDICAL HISTORY:  
1. Hypertension
2. Diabetes mellitus (a1c 7.0 ___
3. Hyperlipidemia
4. Obesity
5. ___
6. Cholecystitis
7. CNS Lymphoma
8. History of pseudomonal bacteremia (___)
9. History of C. Diff colitis (___)
 
Pertinent Results:
Hemoglobin a1c 6.2%

MTX: 
___ 06:30AM BLOOD mthotrx-9.9*
___ 06:24AM BLOOD mthotrx-1.0*
___ 06:00AM BLOOD mthotrx-0.20
___ 06:30AM BLOOD mthotrx-0.___ is a ___ with CNS lymphoma c/b intraparenchymal 
hemorrhage and encephalopathy with relapse who was admitted for 
C9 of re-induction HD-MTX (C18 overall). 

#CNS Lymphoma
#Hypomagnesemia
Here for ___ cycle re-induction HD-MTX. He tolerated 
chemotherapy well and cleared on day 5. He will return on ___ 
for C9 rituximab and in 2 weeks for next cycle HD-MTX. Discussed 
possibility of MRI brain prior to next admission with Dr 
___ recommended holding off for now. 

#Diarrhea/Fecal Incontinence
#T2DM
During last cycle, patient had fecal incontinence worked up via 
MRI/LP with no e/o explanatory pathology. No infectious signs. 
Given intermittent nature with normal stools in between likely 
to be dietary related (perhaps from artificial sweeteners given 
patient's diabetic diet) or medication side effects (perhaps 
combination of methotrexate + metformin).

He was not observed to have episodes of fecal incontinence in 
the hospital. 

His a1c was rechecked and was 6.2%. Downtitration of his 
metformin ___ be considered if symptoms recur. 

# ? Cerumen impaction
He reported a sensation of ""plugged ears"" and was trialed on 
debrox x 4 days with improvement in symptoms. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever 
2. Divalproex (EXTended Release) 1000 mg PO QAM 
3. Divalproex (EXTended Release) 1250 mg PO QPM 
4. Docusate Sodium 100 mg PO BID:PRN constipation 
5. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
6. Senna 8.6 mg PO BID:PRN constipation 
7. Sodium Bicarbonate 1300 mg PO FOUR TIMES PER DAY FOR 2 DAYS 
PRIOR TO CHEMOTHERAPY 
8. Steglatro (ertugliflozin) 5 mg oral DAILY 
9. Aspirin 81 mg PO DAILY 
10. melatonin 10 mg oral QHS 
11. MetFORMIN (Glucophage) 1000 mg PO BID 
12. Omeprazole 20 mg PO DAILY 
13. Pravastatin 40 mg PO QPM 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever  
2.  Aspirin 81 mg PO DAILY  
3.  Divalproex (EXTended Release) 1000 mg PO QAM  
4.  Divalproex (EXTended Release) 1250 mg PO QPM  
5.  Docusate Sodium 100 mg PO BID:PRN constipation  
6.  melatonin 10 mg oral QHS  
7.  MetFORMIN (Glucophage) 1000 mg PO BID  
8.  Omeprazole 20 mg PO DAILY  
9.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  
10.  Pravastatin 40 mg PO QPM  
11.  Senna 8.6 mg PO BID:PRN constipation  
12.  Sodium Bicarbonate 1300 mg PO FOUR TIMES PER DAY FOR 2 DAYS 
PRIOR TO CHEMOTHERAPY  
13.  Steglatro (ertugliflozin) 5 mg oral DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
CNS Lymphoma
Encounter for chemotherapy

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
                             ___ MD ___
 
Completed by: ___
","['3E03305' 'E78.5' 'Z51.11' 'R19.7' 'I10.' 'C85.88' 'H61.20' 'E11.9'
 'R15.9' 'E83.42']","['E78.5' 'Z51.11' 'R19.7' 'I10.' 'C85.88' 'H61.20' 'E11.9' 'R15.9'
 'E83.42']",['3E03305'],"['Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach'
 'Hyperlipidemia, unspecified' 'Encounter for antineoplastic chemotherapy'
 'Diarrhea, unspecified' 'Essential (primary) hypertension'
 'Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites'
 'Impacted cerumen, unspecified ear'
 'Type 2 diabetes mellitus without complications'
 'Full incontinence of feces' 'Hypomagnesemia']",9,1264,10,2,,1,5,0
" 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Iodine-Iodine Containing / Duragesic / Chlorine / perphenazine / 
Depakote
 
Attending: ___.
 
Chief Complaint:
cough
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old male with PMHx of HIV (last CD4 ___, h/o 
STEMI, afib on apixaban, DVT, depression, back pain on chronic 
opioids presenting with chief complaint of cough and lethargy. 
He endorses feeling sick over the past week with progressive 
cough and lethargy at his nursing home. Noted to be around sick 
contacts with several members coughing. He denies difficulty 
breathing. PO intake has been decreased over the last week.

Was tachycardic and hypotensive at ___. Rapid 
aflutter in rate of 140s. He was hypotensive and received 10mg 
of Dilt. He became more hypotensive and required on Levophed. 
Got Vanc/Zosyn. 3L of fluids. Also got Lasix and steroids.

Workup from OSH
-cbc: 6.5 > 11.5/35 < 287
-chem: 129 4.6 91 22 49/4.5 151
-lactate 1.3
-abg 7.40/39/45
-CT chest: multifocal pna with tree in ___ opacities 
-vanc zosyn, 3L IVF
-thought to have AFL -> given 10 dilt -> hypotensive ___ -> 
started on NE
-oxygen requirement increased from NC to NRB -> Lasix IV -> 700 
cc opt
-prednisone 40 po given

___ ED Course notable for:  
- Narrow complex tachycardia to 150s
- adenosine 6mg, then adenosine 12mg, looked like aflutter
- started on norepi
- given fent and etomidate, DCCV with 125 J ofr HD unstable 
aflutter, converted to sinus
- azithromycin 500mg
- Placement of right femoral CVL
- Point of care ultrasound showing hyperdynamic LV (before LV), 
no respirophasic variation

On arrival to the MICU, he endorses the story above.

 
Past Medical History:
1. HIV diagnosed in year ___ and has been on AZT, 3TC and 
nevirapine since ___ with no other regimens and has 
been virologically suppressed for years. Risk factor MSM, nadir 
CD4 122. Otherwise include eosinophilic folliculitis in ___.  
2. Chronic low back pain, on chronic opiates.  
3. Depression and anxiety followed by Dr. ___ in Psychiatry.  
4. Anal condylomata, follows with ___.  
5. Hypertension.  
6. Thyroid nodule status post hemithyroidectomy in ___  

with benign pathology.  
7. NSTEMI II  
8. B/L DVT (___)  

 
Social History:
___
Family History:
Noncontributory  
 
Physical Exam:
ADMISSION EXAM
===========================
VITALS: Reviewed in metavision  
GENERAL: Alert, oriented, cachexic, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear  
NECK: supple, JVP not elevated, no LAD  
LUNGS: Clear to auscultation bilaterally anteriorly, no wheezes, 
rales, rhonchi  
CV: Tachycardic, regular rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding, no organomegaly  
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
SKIN:  Cool legs and arms, no rashes or lesions noted. Tattoo 
over chest.
NEURO: Lethargic, slow to respond  

DISCHARGE EXAM
===========================
97.8 PO 141 / 86 100 17 95 RA   
GENERAL: NAD, laying flat in bed with no issue
HEENT: AT/NC
HEART: RRR
LUNGS: bronchial breath sounds at right base, inspiratory
adventitious breath sounds diffusely
ABDOMEN: nondistended, nontender in all quadrants, no
rebound/guarding
EXTREMITIES: no edema, moving all 4 extremities with purpose  
NEURO: moving all 4 extr spontaneously
SKIN: warm and well perfused, no excoriations or lesions, no
rashes  
 
Pertinent Results:
ADMISSION LABS
========================
___ 02:00AM BLOOD WBC-7.1 RBC-3.46* Hgb-10.5* Hct-32.4* 
MCV-94 MCH-30.3 MCHC-32.4 RDW-14.0 RDWSD-47.9* Plt ___
___ 02:00AM BLOOD Neuts-87* Bands-2 Lymphs-8* Monos-2* 
Eos-1 Baso-0 ___ Myelos-0 AbsNeut-6.32* 
AbsLymp-0.57* AbsMono-0.14* AbsEos-0.07 AbsBaso-0.00*
___ 02:00AM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-NORMAL Macrocy-1+* Microcy-NORMAL Polychr-NORMAL
___ 02:00AM BLOOD ___ PTT-25.9 ___
___ 02:00AM BLOOD Glucose-226* UreaN-39* Creat-2.2*# Na-135 
K-4.4 Cl-100 HCO3-18* AnGap-17
___ 02:00AM BLOOD ALT-17 AST-22 LD(LDH)-266* AlkPhos-95 
TotBili-0.7
___ 02:00AM BLOOD cTropnT-<0.01 proBNP-2438*
___ 02:00AM BLOOD Albumin-3.1* Calcium-7.9* Phos-4.0 Mg-2.2
___ 04:05PM BLOOD IgG-1356 IgA-62* IgM-70
___ 02:10AM BLOOD Lactate-1.1

RELEVANT STUDIES
=======================
___ TTE:
The left atrial volume index is normal. The right atrium is 
mildly enlarged. There is no evidence for an atrial septal 
defect by 2D/color Doppler. The estimated right atrial pressure 
is ___ mmHg. There is mild symmetric left ventricular 
hypertrophy with a normal cavity size. There is normal regional 
and global left ventricular systolic function. Quantitative 
biplane left ventricular ejection fraction is 66 %. Left 
ventricular cardiac index is high (>4.0 L/min/m2). There is no 
resting left ventricular outflow tract gradient. Tissue Doppler 
suggests a normal left ventricular filling pressure (PCWP less 
than 12mmHg). Mildly dilated right ventricular cavity with mild 
global free wall hypokinesis. Tricuspid annular plane systolic 
excursion (TAPSE) is depressed. The aortic sinus is mildly 
dilated with mildly dilated ascending aorta. The aortic arch 
diameter is normal. The aortic valve leaflets (3) are mildly 
thickened. There is no aortic valve stenosis. There is no aortic 
regurgitation.
The mitral valve leaflets appear structurally normal with no 
mitral valve prolapse. There is trivial mitral regurgitation. 
The tricuspid valve leaflets appear structurally normal. There 
is mild [1+] tricuspid
regurgitation. There is mild pulmonary artery systolic 
hypertension. There is no pericardial effusion.

IMPRESSION: Mildly dilated right ventricle with mild free wall 
hypokinesis and mild pulmonary hypertension. Mild symmetric left 
ventricular hypertrophy with normal cavity size and regional/ 
global systolic function.

MICROBIOLOGY
=========================

___ 2:08 pm MRSA SCREEN      Source: Nasal swab. 

                            **FINAL REPORT ___

   MRSA SCREEN (Final ___:    No MRSA isolated.

 
 
___ 4:04 am URINE      Source: Catheter. 

                            **FINAL REPORT ___

   Legionella Urinary Antigen  (Final ___: Negative

___ 11:46 am SPUTUM      Source: Expectorated. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      >25 PMNs and <10 epithelial cells/100X field. 
      3+  ___ per 1000X FIELD):   BUDDING YEAST. 
      1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S). 

   RESPIRATORY CULTURE (Final ___: 
      SPARSE GROWTH Commensal Respiratory Flora. 
      YEAST.    MODERATE GROWTH. 

DISCHARGE LABS
=========================
___ 05:02AM BLOOD WBC-10.5* RBC-3.20* Hgb-9.9* Hct-29.6* 
MCV-93 MCH-30.9 MCHC-33.4 RDW-14.3 RDWSD-47.2* Plt ___
___ 05:02AM BLOOD Glucose-156* UreaN-8 Creat-0.8 Na-142 
K-4.0 Cl-103 HCO3-26 AnGap-13
___ 05:02AM BLOOD Calcium-8.4 Phos-3.3 Mg-1.___ w/ HIV (CD4 ___, CAD (h/o STEMI), AF on apixaban, 
h/o DVT, depression, LBP p/w cough and lethargy found to have 
multifocal PNA and SVT, initially required pressors in MICU, 
subsequently stabilized and called out to floor.

#Septic shock:
#Pneumonia:
#Bronchiectasis
Pt was initially admitted to MICU, as he was hypotensive and 
tachycardic on arrival. Required Levophed and aggressive IVF. CT 
w/ multifocal PNA, although has GGOs in same pattern as prior, 
and has a consolidation in LLL that may just be lobar PNA. PJP 
unlikely as patient had normal ___. Has now had multiple 
similar presentations over past ___ years. Sputum cx growing 
yeast, commensal flora. Was initialy treated with 
vanc/ceftaz/azithromycin, narrowed to augmentin/cipro once he 
was stable on the floor. Will plan for 14 day course (last day 
___, and should have pulmonary followup given GGOs on imaging 
and recurrent PNA. 

#Afib/aflutter with rapid ventricular rates: 
Likely driven by infection as above. Underwent DCCV with 125J in 
the ED. He had a hospitalization in ___ that noted AF w/ RVR 
that resolved with metop. Unclear if this was true AF or SVT. 
Continued home apixaban 5mg BID and metoprolol 25mg q6h once he 
was no longer hypotensive/septic.

___: 
baseline 0.7-1.0, 2.2 on admission. Was initially 4.5 at OSH, 
responded well to IVF and now normalized. Likely secondary to 
hypovolemia/septic shock. Creatinine on discharge 0.8.

#Anemia: 
chronic, though he had normal counts in ___. Likely block in
iron utilization ___ infection as above vs anemia of chronic
disease iso HIV. Hemoglobin on discharge 9.9.

#CAD
#H/o STEMI: 
EF 66% w/o RV hypokinesis and RV free WMA. Continued ASA and 
atorva 80, initially held ACE, restarted once stable.

#HIV: Continued descovy and dolutegravir.

#Chronic pain: Once no longer septic, continued on home regimen 
with bowel meds.

TRANSITIONAL ISSUES
===================
- Antibiotics = Augmentin/Cipro, 14 day course (last day ___
- Please ensure pulmonary followup (scheduled on day of 
discharge) given GGOs on imaging and recurrent PNA. 

#CODE: Full code
#CONTACT: HCP ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Atorvastatin 80 mg PO QPM 
3. Cyanocobalamin 1000 mcg PO DAILY 
4. Fetzima (levomilnacipran) 120 mg oral DAILY 
5. Gabapentin 300 mg PO TID 
6. Metoprolol Succinate XL 100 mg PO DAILY 
7. Morphine SR (MS ___ 45 mg PO Q12H 
8. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO BID 
9. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 
10. Diazepam 5 mg PO TID:PRN anxiety 
11. Docusate Sodium 100 mg PO BID 
12. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN congestion 
13. Multivitamins W/minerals 1 TAB PO DAILY 
14. Senna 8.6 mg PO BID:PRN constipation 
15. OLANZapine 25 mg PO QHS 
16. Lisinopril 5 mg PO DAILY 
17. Atovaquone Suspension 750 mg PO DAILY 
18. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB 
PO QHS 
19. Dolutegravir 50 mg PO QHS 
20. Apixaban 5 mg PO BID 

 
Discharge Medications:
1.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H  
2.  Benzonatate 100 mg PO TID:PRN cough  
3.  Ciprofloxacin HCl 500 mg PO Q12H  
4.  GuaiFENesin ___ mL PO Q6H:PRN cough  
5.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  
6.  Apixaban 5 mg PO BID  
7.  Aspirin 81 mg PO DAILY  
8.  Atorvastatin 80 mg PO QPM  
9.  Atovaquone Suspension 750 mg PO DAILY  
10.  Cyanocobalamin 1000 mcg PO DAILY  
11.  Diazepam 5 mg PO TID:PRN anxiety  
12.  Docusate Sodium 100 mg PO BID  
13.  Dolutegravir 50 mg PO QHS  
14.  Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB 
PO QHS  
15.  Fetzima (levomilnacipran) 120 mg oral DAILY  
16.  Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN congestion 
 
17.  Gabapentin 300 mg PO TID  
18.  Lisinopril 5 mg PO DAILY  
19.  Metoprolol Succinate XL 100 mg PO DAILY  
20.  Morphine SR (MS ___ 45 mg PO Q12H  
21.  Multivitamins W/minerals 1 TAB PO DAILY  
22.  OLANZapine 25 mg PO QHS  
23.  OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO BID  
24.  Senna 8.6 mg PO BID:PRN constipation  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Pneumonia
Supraventricular Tachycardia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,  

It was a pleasure caring for you at ___.  

WHY WAS I IN THE HOSPITAL?  
- You had a cough

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- We found that you had a pneumonia, which we treated with 
antibiotics. You also had a fast heart rate that required us to 
shock you with electricity.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
- Continue to take all your medicines and keep your 
appointments.  
- We would like you to follow up with a lung doctor

___ wish you the best!  

Sincerely,  
Your ___ Team  
 
Followup Instructions:
___
","['06HY33Z' '5A2204Z' 'A41.9' 'Z86.718' 'I48.91' 'Z79.01' 'I25.2' 'F32.9'
 'G89.29' 'Z21.' 'J47.0' 'I25.10' 'I10.' 'N17.9' 'D64.9' 'F17.210'
 'I48.92' 'R65.21' 'J18.9']","['A41.9' 'Z86.718' 'I48.91' 'Z79.01' 'I25.2' 'F32.9' 'G89.29' 'Z21.'
 'J47.0' 'I25.10' 'I10.' 'N17.9' 'D64.9' 'F17.210' 'I48.92' 'R65.21'
 'J18.9']",['06HY33Z' '5A2204Z'],"['Insertion of Infusion Device into Lower Vein, Percutaneous Approach'
 'Restoration of Cardiac Rhythm, Single' 'Sepsis, unspecified organism'
 'Personal history of other venous thrombosis and embolism'
 'Unspecified atrial fibrillation'
 'Long term (current) use of anticoagulants' 'Old myocardial infarction'
 'Major depressive disorder, single episode, unspecified'
 'Other chronic pain'
 'Asymptomatic human immunodeficiency virus [HIV] infection status'
 'Bronchiectasis with acute lower respiratory infection'
 'Atherosclerotic heart disease of native coronary artery without angina pectoris'
 'Essential (primary) hypertension' 'Acute kidney failure, unspecified'
 'Anemia, unspecified' 'Nicotine dependence, cigarettes, uncomplicated'
 'Unspecified atrial flutter' 'Severe sepsis with septic shock'
 'Pneumonia, unspecified organism']",10,1767,19,2,,1,5,0
" 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cephalosporins / Vancomycin / Codeine
 
Attending: ___
 
Chief Complaint:
buttock pain/bladder spasm
 
Major Surgical or Invasive Procedure:
Left buttock skin abscess I&D ___

 
History of Present Illness:
___ with PMHx cervical CA s/p hysterectomy, XRT, radiation 
cystitis with chronic indwelling foley with recurrent UTIs now 
s/p Rt nephrectomy, radiation enteritis s/p 
colectomy/end-ileostomy and short gut syndrome now on chronic 
TPN, chronic pain presents with Lt gluteal abscess.  
 Patient noticed pain over Lt buttock since ___, has been 
worsening. No fevers/chills. Saw PCP today who thought likely 
infected and referred to ED. She also has chronic indwelling 
Foley and feels she has UTI given significant burning and 
abdominal pain c/w prior UTIs. No flank pain.  
 
 In the ED, initial vitals were:  
 - Exam notable for: RRR with II/VI systolic murmur at LUSB  
 abdomen benign with ileostomy in place, opaque so unable to 
visualize stoma, no CVAT, large indurated fluctuant erythematous 
tender area over L buttock, foley in place with clear urine  
 I&D of L buttock abscess: mucousy sanguinous drainage, packing 
in place. Foley exchanged in ED.  
 - Labs notable for: WBC 10.5 (88.5% PMN), H/H 9.5/28.2% (above 
recent baseline ___, Na 127, Cr 1.0 (at baseline), CO2 20, UNa 
44, UOsm 206, U/A ___, +Nit, 32 WBC, 0 Epi, few bact, Mod Bld, 
7 RBC, Lactate 1.4  
 - Imaging: Left Hip/Pelvis XR: No acute fracture or dislocation 
seen  
 - IV Vanc 1gm, IV CTX 1gm, IV fentanyl 100mcg, PO Oxycodone 
10mg, 1L NS was given.  
 Upon arrival to the floor, patient reports she has been having 
fevers (highest 99.9) and chills all week with burning on 
urination. She has bladder spasms since her Foley was changed in 
ED.  
 Denies cough, SOB, DOE, chest pain, abd pain, N/V/D, black or 
bloody stools, falls.  

 
Past Medical History:
1. Cervical CA s/p TAH BSO (___), XRT with recurrence in ___  
2. Radiation cystitis & urinary Retention - currently with  
chronic indwelling foley  
4. R ureteral stricture  
----> c/b recurrent infections  
----> s/p right nephrectomy (___)  
5. Recurrent UTIs:  
----> Klebsiella (amp resistant)  
----> Enterococcus (Levo resistant)
----> Serratia (Nitro resistant)
----> Alpha Hemolytic Strep
----> ___
----> Psudomonas (pansensitive, ___
6. Radiation enteritis s/p colostomy (___) with resultant short 
gut syndrome  
----> TPN x ___ years via indwelling central line (___)  
----> Multiple prior ___ line / ___ infections  
7. Osteoporosis  
8. Hypothyroidism  
9. Migraine HA  
10. Depression  
11. Fibromyalgia  
12. Chronic abdominal pain syndrome  
13. DVT / thrombophlebitis from indwelling central access  
14. Lumbar radiculopathy  
15. SBO followed by surgery  
___. STEMI ___ Takotsubo CMP (clean coronaries on cath ___  
17. Hyponatremia: previously attributed to HCTZ use  
19. Suspected TRALI ___  
20. Chronic pain from back/neck osteoarthritis  
21. Hx hip fracture  

 
Social History:
___
Family History:
Per OMR:
- Mother: brain cancer
- Father: EtOH abuse, CAD  
- 2 brothers with CAD, one with renal cell ca 
- 3 children, all healthy 

 
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
VITAL SIGNS - 98.4 164/82 80 18 97% RA  
 GENERAL - ___ woman, uncomfortable, laying in bed  
 HEENT - anicteric, PERRL, EOMI, MOM, OP clear  
 NECK - supple, no LAD, no elevated JVD  
 CARDIAC - RRR, normal S1S2, no M/R/G  
 CHEST - Lt ___ c/d/I, no tenderness, erythema, warmth  
 LUNGS - NLB on RA, CTAB  
 ABDOMEN - soft, NT, ND, right sided ileostomy non-tender, NABS  

 GU - no CVAT, foley draining clear yellow urine (in tube)  
 EXTREMITIES - WWP, LLE chronically plantar flexed, b/l 
sensation intact  
 NEUROLOGIC - A&O, face symmetric, SILT, MAE, RLE dorsiflexion 
impaired, gait not assessed  
 SKIN - warm, dry, pink, left gluteal abscess site dressed and 
packed with serosanguenous drainage  
 

DISCHARGE PYHSICAL EXAM
=======================
VITALS:  97.8  170/70  80  20  98Ra 
GENERAL - ___ woman, uncomfortable, lying in bed    
CARDIAC - RRR, normal S1S2, no M/R/G   
LUNGS - NLB on RA, CTAB  
ABDOMEN - soft, NT, ND, right sided ileostomy non-tender, NABS  
GU - no CVAT, foley draining clear yellow urine  
EXTREMITIES - WWP, LLE chronically plantar flexed, b/l sensation 
intact  
SKIN - warm, dry, pink, left gluteal abscess approx. 3cm 
incision, wound packed with gauze tape, some bleeding with 
removal of tape, no frank purulence. Mild surrounding erythema 
and induration.

 
Pertinent Results:
ADMISSION LABS
==============
___ 05:10PM BLOOD WBC-10.5* RBC-3.41* Hgb-9.5*# Hct-28.2* 
MCV-83 MCH-27.9 MCHC-33.7# RDW-16.3* RDWSD-49.4* Plt ___
___ 05:10PM BLOOD Neuts-88.8* Lymphs-5.8* Monos-3.4* 
Eos-1.1 Baso-0.3 Im ___ AbsNeut-9.28* AbsLymp-0.61* 
AbsMono-0.36 AbsEos-0.11 AbsBaso-0.03
___ 05:10PM BLOOD Glucose-98 UreaN-21* Creat-1.0 Na-127* 
K-4.6 Cl-93* HCO3-20* AnGap-19
___ 05:10PM BLOOD Iron-27*
___ 05:10PM BLOOD calTIBC-322 Ferritn-172* TRF-248
___ 05:10PM BLOOD 25VitD-34
___ 05:24PM BLOOD Lactate-1.4
___ 04:48PM URINE Color-Straw Appear-Hazy Sp ___
___ 04:48PM URINE Blood-MOD Nitrite-POS Protein-30 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-LG
___ 04:48PM URINE RBC-7* WBC-32* Bacteri-FEW Yeast-NONE 
Epi-0
___ 04:48PM URINE AmorphX-RARE
___ 04:48PM URINE Mucous-RARE
___ 04:48PM URINE Hours-RANDOM Na-44
___ 04:48PM URINE Osmolal-206

DISCHARGE LABS
==============
___ 04:34AM BLOOD WBC-5.6 RBC-3.26* Hgb-8.8* Hct-27.7* 
MCV-85 MCH-27.0 MCHC-31.8* RDW-15.9* RDWSD-50.2* Plt ___
___ 04:34AM BLOOD Glucose-99 UreaN-20 Creat-0.9 Na-132* 
K-3.8 Cl-99 HCO3-22 AnGap-15
___ 04:34AM BLOOD Calcium-9.2 Phos-3.6 Mg-2.4

REPORTS
=======
Hip XR ___
IMPRESSION:  
No acute fracture or dislocation seen.  Stable chronic 
appearance of the left superior and inferior pubic rami.  
Diffuse osteopenia. 

MICROBIOLOGY
============
___ 4:48 pm URINE      Source: Unknown. 
   URINE CULTURE (Preliminary): 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 
      ID AND SUSCEPTIBILITES REQUESTED BY ___. ___ (___) 
ON ___. 
      GRAM NEGATIVE ROD(S).    >100,000 CFU/mL. 
      GRAM NEGATIVE ROD #2.    10,000-100,000 CFU/mL. 

___ Blood cultures x2 NGTD

 
Brief Hospital Course:
___ with PMHx cervical CA s/p hysterectomy, XRT, radiation 
cystitis with chronic indwelling foley with recurrent UTIs now 
s/p Rt nephrectomy, radiation enteritis s/p 
colectomy/end-ileostomy and short gut syndrome now on chronic 
TPN, chronic pain presents with Lt gluteal abscess.  

# Left buttock abscess  
S/P I&D and packing in ED, no evidence of surrounding cellulitis 
or systemic illness. No evidence of undrained abscess. Wound 
packing and dressing were changed daily. There was minimal blood 
and no purulence from the wound. Skin was healing well and pain 
improving at the time of discharge. 
  
# UTI  
# Radiation cystitis & urinary Retention - Chronic indwelling 
foley. History of resistant Enterobacter, most recent Urine 
culture ___ with CTX sensitive Klebsiella, MSSA and 
vancomycin sensitive, amp resistant enterococcus. She was 
treated with vancomycin and ceftriaxone initially, but with 
clinical improvement and polymicrobial urine culture consistent 
with multiple GNR colonies, vancomycin was discontinued and she 
was discharged on ceftriaxone with a plan to complete a 1 week 
course.   
 
# Hyponatremia, mild, asymptomatic  
Likely due to decreased PO intake. Mild and stable.

Chronic Issues  
# Continue home ASA  
 
# Lumbar radiculopathy  
- Continued home Lidocaine 5% Patch 1 PTCH TD QAM  
- Continued home Pregabalin 150 mg PO BID  

# HTN  
- Continued home Lisinopril 10 mg QD  

# Depression: Continued home FLUoxetine 40 mg PO QD, alprazolam 
0.5 mg PO QHS:PRN insomnia/anxiety  

# Hypothyroidism: last TSH ___ 8.0 
- Continued home Levothyroxine 50mcg QD   

Core Measures  
# FEN: TPN, regular diet  
# PPX: Subcutaneous heparin, Senna/Colace, analgesics prn  
# ACCESS: PIVs  
# CODE: Full code  
# CONTACT: HCP/husband ___ ___ (home), 
___ (cell)  
# DISPO: Medicine, pending above  

TRANSITIONAL ISSUES:
#Her foley catheter was changed in the emergency room. 
#Urine gram stain shows multiple GNRs with one colony>100k not 
yet speciated. Pt improved with CTX, so we felt comfortable 
continuing this at home. Please follow up urine culture for 
possible resistence
#TPN was continued in house, no changes were made to her home 
regimen
#Her wound is packed with iodoform and covered with dry gauze. 
___ will change packing and dressing daily. Please re-assess 
wound and ongoing wound care needs. 
#Obtain repeat TSH as outpatient 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 1000 mg PO Q8H 
2. Cyanocobalamin 1000 mcg IM/SC ONCE PER MONTH 
3. Vitamin D ___ UNIT PO 1X/WEEK (MO) 
4. FLUoxetine 40 mg PO DAILY 
5. Ethanol 70% Catheter DWELL (Tunneled Access Line) 2 mL DWELL 
DAILY 
6. Levothyroxine Sodium 50 mcg PO DAILY 
7. Lidocaine 5% Patch 1 PTCH TD QAM 
8. Lisinopril 10 mg PO DAILY 
9. Miconazole Powder 2% 1 Appl TP QID:PRN fungal rash 
10. Omeprazole 20 mg PO DAILY 
11. Oxybutynin 5 mg PO DAILY:PRN bladder spasm 
12. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - 
Moderate 
13. Pregabalin 150 mg PO BID 
14. ALPRAZolam 0.5 mg PO QHS:PRN insomnia/anxiety 
15. Vivelle-Dot (estradiol) 0.05 mg/24 hr transdermal 1X/WEEK 
16. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line 
flush 
17. Sarna Lotion 1 Appl TP TID:PRN rash 
18. Sodium Chloride 0.9%  Flush 10 mL IV DAILY and PRN, line 
flush 
19. Aspirin 81 mg PO DAILY 
20. diclofenac sodium 1 % topical BID:PRN 
21. Acetaminophen-Caff-Butalbital 1 TAB PO Q6H:PRN Headache 
22. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 

 
Discharge Medications:
1.  CefTRIAXone 1 gm IV Q24H 
RX *ceftriaxone in dextrose,iso-os 1 gram/50 mL 1 g IV once a 
day Disp #*3 Intravenous Bag Refills:*0 
2.  FLUoxetine 40 mg PO DAILY  
3.  Acetaminophen-Caff-Butalbital 1 TAB PO Q6H:PRN Headache  
4.  Acetaminophen 1000 mg PO Q8H  
5.  ALPRAZolam 0.5 mg PO QHS:PRN insomnia/anxiety  
6.  Artificial Tears ___ DROP BOTH EYES PRN dry eyes  
7.  Aspirin 81 mg PO DAILY  
8.  Cyanocobalamin 1000 mcg IM/SC ONCE PER MONTH  
9.  diclofenac sodium 1 percent topical BID:PRN pain  
10.  Ethanol 70% Catheter DWELL (Tunneled Access Line) 2 mL 
DWELL DAILY 
RX *ethanol (ethyl alcohol) 98 % 2 mL Tunneled line dwell once a 
day Disp #*30 Ampule Refills:*0 
11.  Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line 
flush  
12.  Levothyroxine Sodium 50 mcg PO DAILY  
13.  Lidocaine 5% Patch 1 PTCH TD QAM  
14.  Lisinopril 10 mg PO DAILY  
15.  Miconazole Powder 2% 1 Appl TP QID:PRN fungal rash  
16.  Omeprazole 20 mg PO DAILY  
17.  Oxybutynin 5 mg PO DAILY:PRN bladder spasm  
18.  OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - 
Moderate  
19.  Pregabalin 150 mg PO BID  
20.  Sarna Lotion 1 Appl TP TID:PRN rash  
21.  Sodium Chloride 0.9%  Flush 10 mL IV DAILY and PRN, line 
flush  
22.  Vitamin D ___ UNIT PO 1X/WEEK (MO)  
23.  Vivelle-Dot (estradiol) 0.05 mg/24 hr transdermal 1X/WEEK 
(___)  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___ Diagnosis:
Skin abscess
UTI

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You came to the hospital because of an abscess on your buttock 
and symptoms of a UTI. Your abscess was drained in the ER and 
you were given antibiotics for your UTI, which improved your 
symptoms. We continued your TPN. You are going home on IV 
antibiotics for your UTI for 3 more days. Your home infusion 
company will arrange for the antibiotics. Your visiting nurse 
___ come daily to change your dressing until you follow up with 
your PCP. 

Best wishes,
Your ___ Care Team
 
Followup Instructions:
___
","['0H98XZZ' '3E0436Z' 'E03.9' 'F32.9' 'M47.892' 'I25.10' 'I25.2' 'E55.9'
 'Y92.9' 'R33.9' 'I42.9' 'K91.2' 'L02.31' 'N30.40' 'M81.0' 'Z93.2' 'D50.9'
 'G43.909' 'N39.0' 'M47.816' 'Y84.2' 'Z85.41' 'Z86.718' 'N32.89' 'Z90.5']","['E03.9' 'F32.9' 'M47.892' 'I25.10' 'I25.2' 'E55.9' 'Y92.9' 'R33.9'
 'I42.9' 'K91.2' 'L02.31' 'N30.40' 'M81.0' 'Z93.2' 'D50.9' 'G43.909'
 'N39.0' 'M47.816' 'Y84.2' 'Z85.41' 'Z86.718' 'N32.89' 'Z90.5']",['0H98XZZ' '3E0436Z'],"['Drainage of Buttock Skin, External Approach'
 'Introduction of Nutritional Substance into Central Vein, Percutaneous Approach'
 'Hypothyroidism, unspecified'
 'Major depressive disorder, single episode, unspecified'
 'Other spondylosis, cervical region'
 'Atherosclerotic heart disease of native coronary artery without angina pectoris'
 'Old myocardial infarction' 'Vitamin D deficiency, unspecified'
 'Unspecified place or not applicable' 'Retention of urine, unspecified'
 'Cardiomyopathy, unspecified'
 'Postsurgical malabsorption, not elsewhere classified'
 'Cutaneous abscess of buttock' 'Irradiation cystitis without hematuria'
 'Age-related osteoporosis without current pathological fracture'
 'Ileostomy status' 'Iron deficiency anemia, unspecified'
 'Migraine, unspecified, not intractable, without status migrainosus'
 'Urinary tract infection, site not specified'
 'Spondylosis without myelopathy or radiculopathy, lumbar region'
 'Radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure'
 'Personal history of malignant neoplasm of cervix uteri'
 'Personal history of other venous thrombosis and embolism'
 'Other specified disorders of bladder' 'Acquired absence of kidney']",11,1832,25,2,,1,5,0
" 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Abd Pain, Abnormal Labs, Tachycardia
 
Major Surgical or Invasive Procedure:
ERCP ___

 
History of Present Illness:
Ms. ___ is a ___ year-old female with past medical history
significant for autoimmune hepatitis s/p liver transplant ___,
___ on tacrolimus, DM2 on insulin, DVT, and ulcerative 
colitis
on mesalamine presenting to ___ with acute onset RUQ pain
and vomiting. The patient was in her usual state of health until
the day of admission. The patient works at a daycare and was
playing outside when she presented with acute onset RUQ and R
flank pain. After eating lunch, she subsequently had 3 episodes
of emesis. She denied any diarrhea, hematochezia, melena, 
dysuria
or hematuria. 

She has been taking her antirejection medications. No fevers or
chills. No chest pain or shortness of breath. No cough.

GI consult
___ years old female PMH of liver transplant ___ years ago due to
AIH? on TAC/prednisone, presenting with RUQ. In the ___ hypoxic
hypotensive (received MO in OSH) eleavted WBC neturophilia,
elevated ALT AST ALKP ___ times upper limit of normal. US and
chest x ray unrevelaing. Team in ___ noted RLQ rales. 

In the ___, 
- Initial vitals: 
T 99.4 HR 127 BP 129/36 RR 16 SPO2 94% RA  

- Exam notable for: 
No ascites on U/S
 
- Labs notable for:  
CBC: WBC 14.3 Hb 13.7 Plt 300
BMP: K 2.9 BUN/Cr ___ Mg: 1.0 P: 2.3
K: 2.7
Lactate: 3.0 -> 1.4
LFTS: ALT 252 AST 417 AP 336 T bili 3.4 Alb 3.0
INR: 2.5

FluAPCR: Neg
FluBPCR: Neg

Blood Cx X2: Pending

- Imaging was notable for: 
+CXR:
No acute cardiopulmonary process. 

+RUQUS: 
Patent hepatic vasculature with appropriate waveforms. Left and
right hepatic artery resistive indices are at the lower limit of
normal (0.46-0.54), however this result should be interpreted
with caution given the limited nature of the exam.

- Patient was given:  
3L NS
IV Piperacillin-Tazobactam  
PO Potassium Chloride 20 mEq 
PO Potassium Chloride 40 mEq 
IV Vancomycin  
IV MethylPREDNISolone Sodium Succ 100 mg 

-Vitals on Transfer: 
HR 126 BP 79/56 RR 26 SPO2 96% 3L NC 
 
Upon arrival to the ICU, patient confirms above history. 
 
Past Medical History:
AIH s/p Liver Transplant ___ at ___
Ulcerative Colitis
DM2
Hypertension
 
Social History:
___
Family History:
No family history of liver disease.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VITALS: Temp 97.9F BP 129/77 HR 112 95% on RA
GENERAL: NAD, resting comfortably
HEENT: PERRLA, EOMI, MMM, OP clear
CARDIAC: tachycardic, no murmurs, rubs, gallops
PULMONARY: CTAB, no wheezes, rales, rhonchi 
ABDOMEN: soft, NTND, +BS
EXTREMITIES: no ___ edema
SKIN: no rashes
NEURO: AAOx3, no focal deficits

DISCHARGE PHYSICAL EXAM:
========================
24 HR Data (last updated ___ @ 729)
    Temp: 98 (Tm 98.0), BP: 137/88 (107-141/76-95), HR: 94
(84-109), RR: 18 (___), O2 sat: 92% (92-95), O2 delivery: RA,
Wt: 210.4 lb/95.44 kg       
General: Well developed, well nourished, alert and cooperative,
and appears to be in no acute distress.
HEENT: Normocephalic, atraumatic. PERRLA EOMI. 
Neck: Neck supple, non-tender without lymphadenopathy, masses or
thyromegaly.
Cardiac: Tachycardic. Normal S1 and S2. No S3, S4 or murmurs.
Rhythm is regular.
Pulmonary: Clear to auscultation without rales, rhonchi, 
wheezing
or diminished breath sounds.
Abdomen: Obese. Normoactive bowel sounds.  Soft, nondistended,
nontender.  No guarding or rebound.  No masses. Occasional
purpura. 
Extremities: ROM intact in spine and extremities. No joint
erythema or tenderness. Muscle bulk and tone appropriate for age
and habitus. There is 1+ edema of b/l lower extremities L>R. 
Neuro: Alert and oriented x3. No gross focal deficits. 

 
Pertinent Results:
ADMISSION LABS:
================
___ 08:20PM BLOOD WBC-14.3* RBC-5.07 Hgb-13.7 Hct-42.8 
MCV-84 MCH-27.0 MCHC-32.0 RDW-14.2 RDWSD-42.3 Plt ___
___ 08:20PM BLOOD Neuts-93.0* Lymphs-3.6* Monos-2.7* 
Eos-0.0* Baso-0.3 Im ___ AbsNeut-13.29* AbsLymp-0.52* 
AbsMono-0.39 AbsEos-0.00* AbsBaso-0.04
___ 08:20PM BLOOD Glucose-276* UreaN-12 Creat-0.7 Na-143 
K-2.9* Cl-105 HCO3-21* AnGap-17
___ 08:20PM BLOOD ALT-252* AST-417* AlkPhos-336* 
TotBili-3.4*
___ 08:20PM BLOOD Albumin-3.0* Calcium-8.8 Phos-2.3* 
Mg-1.0*

PERTINENT LABS/MICRO:
=====================
___ 05:54AM BLOOD WBC-19.1* RBC-4.73 Hgb-12.9 Hct-40.5 
MCV-86 MCH-27.3 MCHC-31.9* RDW-14.3 RDWSD-43.8 Plt ___
___ 08:20PM BLOOD ALT-252* AST-417* AlkPhos-336* 
TotBili-3.4*
___ 05:54AM BLOOD ALT-388* AST-388* AlkPhos-305* 
TotBili-5.2* DirBili-5.1* IndBili-0.1
___ 10:53AM BLOOD IgG-794 IgA-664* IgM-88
___ 10:53AM BLOOD HIV Ab-NEG
___ 10:53AM BLOOD HCV Ab-NEG

DISCHARGE LABS:
================
___ 05:23AM BLOOD WBC-6.7 RBC-4.48 Hgb-12.2 Hct-38.9 MCV-87 
MCH-27.2 MCHC-31.4* RDW-14.6 RDWSD-45.2 Plt ___
___ 05:25AM BLOOD Neuts-50.9 ___ Monos-11.7 Eos-1.6 
Baso-1.0 Im ___ AbsNeut-3.14 AbsLymp-2.03 AbsMono-0.72 
AbsEos-0.10 AbsBaso-0.06
___ 05:23AM BLOOD ___ PTT-26.1 ___
___ 05:23AM BLOOD Glucose-152* UreaN-6 Creat-0.5 Na-143 
K-3.4* Cl-104 HCO3-24 AnGap-15
___ 05:23AM BLOOD ALT-33 AST-25 AlkPhos-287* TotBili-0.6
___ 05:23AM BLOOD Albumin-3.0* Calcium-8.8 Phos-4.1 Mg-1.4*
___ 05:23AM BLOOD tacroFK-7.0

PERTINENT IMAGING:
==================
___ CXR:
No acute cardiopulmonary process.

___ RUQ Ultrasound w/ doppler:
Patent hepatic vasculature with appropriate waveforms.  Left and 
right hepatic artery resistive indices are at the lower limit of 
normal (0.46-0.54), however this result should be interpreted 
with caution given the limited nature of the exam. 

 
Brief Hospital Course:
PATIENT SUMMARY:
================
Ms. ___ is a ___ year-old female with past medical history 
significant for autoimmune hepatitis s/p liver transplant ___, 
___ on tacrolimus and prednisone, recurrent DVTs on warfarin, 
and ulcerative colitis on mesalamine who presented to ___ 
with acute onset RUQ and epigastric pain and nonbloody vomiting 
on ___ found to have GPC bacteremia and imaging concerning for 
cholangitis. She underwent ERCP which showed a right 
intrahepatic stricture with upstream biliary scalloping and 
atypical cells on brushings. She received IV ceftriaxone/flagyl 
(D1 = ___, which were continued at discharge. 

ACUTE ISSUES ADDRESSED:
======================
#Cholangitis 
#Transaminitis
#Strep anginosus blood stream infection
MRCP concerning for cholangitis and patient now with 2 blood 
culture bottles positive for GPCs now speciated as strep 
angiosus (___ group). Likely cholangitis with bacterial 
translocation. Clinically stabilized with antibiotics. She 
underwent ERCP ___ which showed R intrahepatic stricture with 
upstream biliary scalloping suggestive of cholangiopathy. Ddx 
includes ischemic stricture with secondary cholangiopathy, PCS 
and malignancy. Hepatitis serologies obtained, she is hep A and 
B non-immune and should have vaccinations, EBV negative and CMV 
VL non detectable. ___, AMA, ___ obtained and all negative. 
Cytology of brushings showed atypical cells, possibly consistent 
with PCS infection vs malignancy. She will require repeat 
brushings with her next ERCP 1 month after the first one. IgG 
subclasses obtained and IgG subclass 2 low. ___ consulted for 
drainage of bilomas seen on MRCP and deemed no intervention 
necessary at this time s/p ERCP. She was continued on 
ceftriaxone/flagyl (___), with plan for duration likely ___ 
weeks to be determined by ___ clinic follow up. She will 
require repeat ERCP in 4 weeks from ___.

#Autoimmune hepatitis s/p liver transplant ___: 
Patient with history of AIH s/p liver transplant in ___ at 
___. Tacro levels have been elevated to >15. The dose was 
downtitrated given goal trough this far out from transplant is 
usually ___, however further management deferred to outpatient 
hepatologist. She additionally has continued on budesonide for 
years, which was discontinued as it was unclear if patient had 
ongoing UC. She has also been on prednisone 10mg daily (recently 
downtitrated to 5mg daily in setting of recent dx DM). For 
immune suppression, lowered tacro to 1 mg BID from 1.5 mg BID at 
home given high levels. She was continued on pred 5mg daily. 
Contacted her transplant clinic (Dr. ___, at ___ 
___. Follow up appointment was made and informed 
patient of need for repeat ERCP. If ___ unable to follow up 
she will need f/u ERCP at ___ in four weeks. Transitionally, 
she should get repeat hep B vaccination (has had difficulty 
serocoverting in past); she should also get the hep A vaccine. 

#Tachycardia
Sinus tachycardia. Initially concerning for sepsis though 
patient is well appearing and adequately fluid resuscitated. 
Also component of rebound tachycardia from holding home 
metoprolol. She was given IVF and resumed on home metoprolol. 

#Electrolyte Abnormalities 
#Hypomagnesemia
#Hypokalemia
#Hypophosphatemia
Mg was 1.0 on arrival. Continued to waste Mg and K throughout. 
Hypomagnesemia is common in patients who have received solid 
organ transplants on tacrolimus Her 24 h urine collection was 
difficult to interpret in setting of repletion, but per renal 
likely represents increased urinary wasting in setting of 
hypokalemia and hypomagnesemia. Omeprazole may also play role in 
electrolyte disturbance, now switched to ranitidine. She is 
being discharged on BID magnesium supplementation and daily 
potassium supplementation. 

#DM2: Diagnosed 1.5 weeks prior to admission with ___, no hx of 
previous prediabetes. A1c 12%. She was restart glargine given 
hyperglycemia, recent DKA and 5 units Humalog TID w/ meals with 
insulin sliding scale. 

CHRONIC ISSUES:
================
#HTN: 
Once stabilized, resumed home amlodipine 10mg and home 
metoprolol tartrate 75mg BID.

#Ulcerative Colitis: Resumed home Mesalamine 800mg TID. Held 
home budesonide given uncertainty of diagnosis.

#CAD: pravastatin 40mg daily 
#Recurrent DVT: resumed warfarin 72 hr s/p ERCP without a 
bridge. US study negative for DVT. 

TRANSITIONAL ISSUES:
=====================
#Cholangitis 
#Atypical brushings
Cytology brushings were abnormal from right intrahepatic biliary
branches: ""Atypical ductal epithelial cells and bile pigment.""
Differential includes ischemic stricture with secondary
cholangiopathy, PCS, and malignancy. 
[] Repeat ERCP 4 weeks from ___ to reassess/remove stent. 
Needs to be coordinated with home ___ 
___
[] Will need repeat biopsies on repeat ERCP to follow up 
atypical cells found on first set of brushings. Per Dr. ___, 
___ need
repeat biopsies of this area at next ERCP in ___. 

#Electrolyte disturbances
[] Monitor hypokalemia, hypomagnesemia, consider pursuing 
further workup outpatient.
[] Should follow up CMP one week of discharge while on repletion 
of K, Mg (please obtain on ___. 
[] Discharging on 800mg Magnesium Oxide BID and 20mEq K daily. 

#DVTs
[] INR to be followed up by PCP ___. MD). Pt 
has received 7.5mg of Warfarin for the last 4 days of her 
hospitalization. Last INR was 1.5.

#Diabetes:
[] Blood sugars should be closely monitored with titration of 
insulin as needed. 

#S/p liver transplant
[] Tacrolimus dose has been reduced to 1mg BID. Levels should be 
monitored closely and dosage adjusted as needed. Goal Tacro 
trough ___.

#Possible Ulcerative Colitis:
[] Budesonide for ulcerative colitis was stopped as patient 
already on significant immunosuppression with prednisone and 
tacro.
[] Patient should undergo colonoscopy as outpatient to determine 
activity of UC.
[] Patient should have repeat hepatitis B vaccine, hepatitis A 
vaccine.

#CODE STATUS: Full (confirmed) 
#CONTACT: ___ (sister) ___, HCP is mother
 
___ on ___:
The Preadmission Medication list is accurate and complete.
1. Glargine 15 Units Breakfast
Humalog 5 Units Breakfast
Humalog 5 Units Lunch
Humalog 5 Units Dinner
2. amLODIPine 10 mg PO DAILY 
3. PredniSONE 5 mg PO DAILY 
4. Tacrolimus 1.5 mg PO Q12H 
5. Mesalamine ___ 800 mg PO TID 
6. Metoprolol Tartrate 75 mg PO BID 
7. Uceris (budesonide) 9 mg oral DAILY 
8. Warfarin 7.5 mg PO 5X/WEEK (___) 
9. Warfarin 10 mg PO 2X/WEEK (MO,FR) 
10. Pravastatin 40 mg PO QPM 
11. Omeprazole 20 mg PO DAILY 

 
Discharge Medications:
1.  CefTRIAXone 2 gm IV Q 24H 
RX *ceftriaxone in dextrose,iso-os 2 gram/50 mL 2 g IV daily 
Disp #*30 Intravenous Bag Refills:*0 
2.  Magnesium Oxide 800 mg PO BID 
RX *magnesium oxide 400 mg 2 tablet(s) by mouth twice a day Disp 
#*120 Tablet Refills:*0 
3.  MetroNIDAZOLE 500 mg PO Q8H 
RX *metronidazole 500 mg 1 tablet(s) by mouth every 8 hours Disp 
#*90 Tablet Refills:*0 
4.  Potassium Chloride 20 mEq PO DAILY 
RX *potassium chloride 20 mEq 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0 
5.  Ranitidine 150 mg PO BID 
RX *ranitidine HCl 150 mg 1 tablet(s) by mouth every 12 hours 
Disp #*60 Tablet Refills:*0 
6.  Tacrolimus 1 mg PO Q12H 
RX *tacrolimus 1 mg 1 capsule(s) by mouth every 12 hours Disp 
#*60 Capsule Refills:*0 
7.  amLODIPine 10 mg PO DAILY  
8.  Glargine 15 Units Breakfast
Humalog 5 Units Breakfast
Humalog 5 Units Lunch
Humalog 5 Units Dinner 
9.  Mesalamine ___ 800 mg PO TID  
10.  Metoprolol Tartrate 75 mg PO BID  
11.  Pravastatin 40 mg PO QPM  
12.  PredniSONE 5 mg PO DAILY  
13.  Warfarin 7.5 mg PO 5X/WEEK (___)  
14.  Warfarin 10 mg PO 2X/WEEK (MO,FR)  
15. HELD- Uceris (budesonide) 9 mg oral DAILY  This medication 
was held. Do not restart Uceris until you see your 
gastroenterologist 
16.Outpatient Lab Work
ALL LAB RESULTS SHOULD BE SENT TO:
ATTN: ___ CLINIC - FAX: ___
CEFTRIAXONE: WEEKLY: CBC with differential, BUN, Cr, AST, ALT, 
Total Bili, ALK PHOS, CRP
ICD-9 Code: 276.9 (Electrolyte and fluid disorders)

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY:
Cholangitis
Blood infection
Autoimmune hepatitis s/p liver transplant

SECONDARY:
Hypokalemia
Hypomagnesemia
IDDM 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,  
 
WHY WERE YOU ADMITTED TO THE HOSPITAL?
- You were admitted to the hospital because you were having 
abdominal pain and you were found to have cholangitis and a 
blood stream infection. 

WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?  
- You were found to have an infection of your bile ducts called 
cholangitis. This infection was also in your bloodstream.
- You had a procedure to clear the infection in your bile ducts 
called an ERCP. 
- Your immunosuppression was found to be elevated and was 
adjusted. 
- Your insulin regimen was adjusted. 
- Your electrolyte levels were low and were repleted. 
- You improved and were ready to leave the hospital.  

WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?  
- Please take all of your medications as prescribed and go to 
your follow up appointments with your doctors ___ below)   
- Weigh yourself every morning, before you eat or take your 
medications. Call your doctor if your weight increases by more 
than 3 pounds  
- Please maintain a low salt diet and monitor your fluid intake  

- Seek medical attention if you have new or concerning symptoms 
or you develop.

It was a pleasure participating in your care. We wish you the 
best!
 
 - Your ___ Care Team  

 
Followup Instructions:
___
","['02HV33Z' '0F758DZ' 'A40.8' 'Z86.718' 'K83.8' 'Y92.9' 'I10.' 'Z79.4'
 'I25.10' 'R65.20' 'Z79.01' 'R79.1' 'R00.0' 'K83.1' 'T47.1X5A' 'K51.90'
 'Z94.4' 'K83.09' 'E11.9' 'E83.42' 'E87.6' 'E83.39']","['A40.8' 'Z86.718' 'K83.8' 'Y92.9' 'I10.' 'Z79.4' 'I25.10' 'R65.20'
 'Z79.01' 'R79.1' 'R00.0' 'K83.1' 'T47.1X5A' 'K51.90' 'Z94.4' 'K83.09'
 'E11.9' 'E83.42' 'E87.6' 'E83.39']",['02HV33Z' '0F758DZ'],"['Extraction of Right Hepatic Duct, Via Natural or Artificial Opening Endoscopic, Diagnostic'
 'Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach'
 'Dilation of Right Hepatic Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic'
 'Other streptococcal sepsis'
 'Personal history of other venous thrombosis and embolism'
 'Other specified diseases of biliary tract'
 'Unspecified place or not applicable' 'Essential (primary) hypertension'
 'Long term (current) use of insulin'
 'Atherosclerotic heart disease of native coronary artery without angina pectoris'
 'Severe sepsis without septic shock'
 'Long term (current) use of anticoagulants'
 'Abnormal coagulation profile' 'Tachycardia, unspecified'
 'Obstruction of bile duct'
 'Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter'
 'Ulcerative colitis, unspecified, without complications'
 'Liver transplant status' 'Other cholangitis'
 'Type 2 diabetes mellitus without complications' 'Hypomagnesemia'
 'Hypokalemia' 'Other disorders of phosphorus metabolism']",12,2340,22,2,,1,5,0
" 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: OBSTETRICS/GYNECOLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Contractions
 
Major Surgical or Invasive Procedure:
Vaginal delivery
D&C post partum

 
History of Present Illness:
___ G1P0 at ___ with contractions. +ctx, -VB, -LOF. +FM. Had 
outpatient Ob visit today and was 1.5cm dilated and 60% effaced. 
After SVE, she had increased crampy pain. At home, at ___, she 
noticed some mucus with small amount of blood in toilet. No LOF 
or VB before or after that. 

 
Past Medical History:
PNC: 
- ___ ___ by LMP
- Labs A-neg/Rh- s/p rhogam/Abs -/Rub immnue/RPR NR/HBsAg 
neg/HIV
neg/GBS neg
- Screening NIPT LR
- FFS normal
- GLT 84
- Issues
     *hypothyroidism on levothyroxine
     *anxiety on citalopram
 
OBHx:
- G1
 
GynHx:
- Denies history of STIs
 
PMH: 
- hypothyroidism during pregnancy
- anxiety
- migraines
- syncope
- acne

PSH: 
- R bunionectomy
 
Social History:
___
Family History:
Non-contributory 
 
Physical Exam:
Exam on Day of Discharge
AVSS
CV: AOx3, NAD
Resp: CTAB
Abd: Soft, non-distended, no rebound or guarding
Ext: non-tender
 
Pertinent Results:
___ 08:10PM   ___ PTT-32.6 ___
___ 08:10PM   ___ 05:25PM   CALCIUM-7.0* PHOSPHATE-2.8 MAGNESIUM-1.4*
___ 05:25PM   WBC-22.1* RBC-2.39* HGB-7.1* HCT-20.4* MCV-85 
MCH-29.7 MCHC-34.8 RDW-13.2 RDWSD-41.0
___ 05:25PM   PLT SMR-VERY LOW PLT COUNT-65*
___ 12:40PM   GLUCOSE-63* UREA N-13 CREAT-1.4* SODIUM-133 
POTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-19* ANION GAP-14
___ 12:40PM   CALCIUM-6.8* PHOSPHATE-2.1* MAGNESIUM-1.3*
___ 11:29AM   WBC-17.8* RBC-2.64*# HGB-7.7*# HCT-23.4*# 
MCV-89 MCH-29.2 MCHC-32.9 RDW-12.5 RDWSD-40.1
___ 11:29AM   PLT COUNT-125*
___ 11:29AM   ___ PTT-37.9* ___
___ 11:29AM   ___ 12:09AM   WBC-13.3*# RBC-3.78* HGB-11.0* HCT-33.0* 
MCV-87# MCH-29.1 MCHC-33.3 RDW-12.2 RDWSD-38.6
___ 12:09AM   PLT COUNT-159
 
Brief Hospital Course:
Ms. ___ is a ___, G1, P1, who had a spontaneous 
vaginal delivery on the morning of ___. Over the course 
of her labor, she had developed chorioamnionitis and was being 
treated with ampicillin and gentamicin. Following her delivery, 
she initially had a small amount of blood loss. However, she was 
then noted to have persistent vaginal bleeding.  Manual 
evacuation was performed initially at the bedside.  However, the 
patient continued to have significant vaginal bleeding due to 
uterine atony and there was a question of possible retained 
placenta and the decision was made to proceed to the operating 
room. She was found to have lower uterine atony and no evidence 
of retained placenta. She had a D&C and a bakri balloon placed 
with subsequently improved bleeding. She also received cytotec, 
Pitocin, hemabate, and methergine. Total blood loss in the labor 
and delivery room was estimated to be 1000 cc. She received 2 
units of packed RBCs with a subsequent hematocrit of 21.4. 

Post-partum she developed ___ likely due to hypovolemia which 
steadily improved. She had her bakri removed with stable 
bleeding. She completed 24 hours of ampicillin, gentamicin, and 
clindamycin.  

On ___ patient was discharged home in stable condition with 
appropriate follow-up scheduled. 
 
Medications on Admission:
- PNV
- levothyroxine 
- citalopram 10mg daily
 
Discharge Medications:
1. Escitalopram Oxalate 10 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Vaginal bleeding
Post partum hemorrhage

 
Discharge Condition:
Good

 
Discharge Instructions:
Rest. no heavy lifting, exercise, baths for 4 weeks
 
Followup Instructions:
___
","['10D17ZZ' '10E0XZZ' '0KQM0ZZ' '0W3R7ZZ' 'E03.9' 'O99.344' 'E86.1' 'O90.4'
 'O70.1' 'O72.1' 'Z3A.39' 'O99.284' 'F41.9' 'Z37.0' 'O41.1230']","['E03.9' 'O99.344' 'E86.1' 'O90.4' 'O70.1' 'O72.1' 'Z3A.39' 'O99.284'
 'F41.9' 'Z37.0' 'O41.1230']",['10D17ZZ' '10E0XZZ' '0KQM0ZZ' '0W3R7ZZ'],"['Extraction of Products of Conception, Retained, Via Natural or Artificial Opening'
 'Delivery of Products of Conception, External Approach'
 'Repair Perineum Muscle, Open Approach'
 'Control Bleeding in Genitourinary Tract, Via Natural or Artificial Opening'
 'Hypothyroidism, unspecified'
 'Other mental disorders complicating childbirth' 'Hypovolemia'
 'Maternal care for other rhesus isoimmunization, third trimester, not applicable or unspecified'
 'Postpartum acute kidney failure'
 'Second degree perineal laceration during delivery'
 'Other immediate postpartum hemorrhage' '39 weeks gestation of pregnancy'
 'Endocrine, nutritional and metabolic diseases complicating childbirth'
 'Anxiety disorder, unspecified' 'Single live birth'
 'Chorioamnionitis, third trimester, not applicable or unspecified']",13,530,15,2,,1,5,0
" 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics) / Penicillins
 
Attending: ___.
 
Chief Complaint:
Shortness of Breath
 
Major Surgical or Invasive Procedure:
___: Transcatheter Aortic Valve Replacement via bilateral 
groin access 

 
History of Present Illness:
Mr. ___ is a pleasant ___ year old man with a history of 
aortic stenosis, carotid artery stenosis, chronic obstructive 
pulmonary disease, hyperlipidemia, and hypertension. He was 
evaluated by the cardiac surgery service in ___ after he 
presented to the hospital with worsening dyspnea and chest pain. 
A CTA of the chest was negative for pulmonary embolism. An 
echocardiogram revealed aortic stenosis with an aortic valve 
area of 1 cm2 and ___ aortic insufficiency. Cardiac 
catheterization was significant for no obstructive coronary 
artery disease. At that time, he did not meet indication for 
surgical intervention. He has been closely followed by 
cardiology since that time. A
repeat echocardiogram in ___ of this year demonstrated 
progression of his aortic stenosis to severe. The aortic valve 
area was 0.7 cm2 with peak and mean gradients of 75 mmHg and 43 
mmHg, respectively. There was 2+ aortic insufficiency and 2+ 
tricuspid regurgitation.  He was seen by cardiac surgery and 
deemed High risk for conventional surgical AVR due to 
comorbidities. He reports symptoms continue with increase in 
fatigue. Referred for TAVR on ___.

___ Class: III

 
Past Medical History:
Alcohol Abuse
Anxiety
Aortic Stenosis
Benign Prostatic Hyperplasia
Carotid Artery Stenosis ___ left 50-69%, right <50%)
Chronic Obstructive Pulmonary Disease 
Esophageal Stricture s/p dilatation > ___ ago
Hearing Loss
Hyperlipidemia
Hypertension
Hyponatremia (baseline 134-136)
Pulmonary Nodules
Skin Cancer with XRT to top of head & chronic wound
Mohs surgery for skin ca
Bilat cataracts and detached retina repairs
Last esophageal dilation ___ ago  

 
Social History:
___
Family History:
There was no family history of stroke, diabetes, hypertension, 
___ disease.   His mother died at ___ of old age. 
His father died in his ___ of cancer. 

 
Physical Exam:
ADMISSION EXAM:
====================
VS: afebrile, 157/62, HR 68, RR 18, 02 at 98% 3L NC 
EKG: SB 50's
Tele:  SB 50's  
Gen: Lying on bed in PACU, alert, in NAD
Neuro: Awake alert and oriented x4.  Speech clear and 
appropriate
comprehensible.  Tongue midline.  Smile symmetric.  MAE equal 
and
strong bilaterally. PERRL @ 3mm.
HEENT: Neck supple, no lymphadenopathy appreciated.
CV: Regular rate and rhythm
Chest: LS clear to auscultate anteriorly.  Non-labored.  No use
of accessory muscles noted.
ABD: Round, soft, nontender positive BS x4.
Extr: Warm and well-perfused.  +1 palpable pedal pulses 
confirmed
by Doppler.
Skin: Intact, no rashes.
Access sites: ___ femoral access: left with small ooze noted post
procedure, right with bleeding post procedure requiring manual
pressure by ___, NP. Small amount of ecchymosis noted,
soft, no further bleeding; no bruit noted. 

DISCHARGE EXAM: 
======================
VS: Temp: 97.8 PO BP: 155/79 HR: 102 RR: 17 O2 sat: 93% RA 
Weight: 73.0 kg / 160.9 lbs. 

General: Alert, no acute distress 
Cardiovascular: Regular rate/rhythm 
Respiratory: Breathing non-labored, mild left sided expiratory
wheeze, otherwise clear to auscultation 
Abdomen: Soft, Non-tender, +BS 
Extremities: BLE warm/well-perfused, ___ pulses, no ___ edema 
Skin: Warm, dry and intact 
Neuro: Alert, oriented x 3, appropriate 
Access site: Bilateral groin access sites stable, soft and
non-tender to palpation. Minimal bruising to L groin, Moderate 
to
large area of bruising to right groin with no evidence of
hematoma and no active bleeding. 

 
Pertinent Results:
Labs:
====================
___ 10:24AM BLOOD WBC-8.8 RBC-3.10* Hgb-10.2* Hct-29.9* 
MCV-97 MCH-32.9* MCHC-34.1 RDW-13.6 RDWSD-48.0* Plt ___
___ 07:40AM BLOOD WBC-10.0 RBC-3.17* Hgb-10.6* Hct-31.1* 
MCV-98 MCH-33.4* MCHC-34.1 RDW-13.6 RDWSD-48.9* Plt ___
___ 07:30AM BLOOD WBC-9.5 RBC-3.26* Hgb-10.6* Hct-32.2* 
MCV-99* MCH-32.5* MCHC-32.9 RDW-13.6 RDWSD-48.9* Plt ___

___ 10:24AM BLOOD Glucose-122* UreaN-14 Creat-0.9 Na-135 
K-4.0 Cl-97 HCO3-25 AnGap-13
___ 07:40AM BLOOD Glucose-107* UreaN-12 Creat-0.8 Na-135 
K-4.1 Cl-95* HCO3-26 AnGap-14
___ 07:30AM BLOOD Glucose-106* UreaN-12 Creat-0.8 Na-137 
K-4.0 Cl-97 HCO3-26 AnGap-14 Calcium-9.1 Phos-3.5 Mg-2.1

--------------
ECHO ___:
--------------
LVEF  64%. 
The left atrial volume index is normal. 
The estimated right atrial pressure is ___ mmHg. 
Mild symmetric left ventricular hypertrophy with normal cavity 
size. 
There is normal regional left ventricular systolic function. 
Left ventricular cardiac index is normal (>2.5 L/min/m2). 
There is no resting left ventricular outflow tract gradient. 
Normal right ventricular cavity size with normal free wall 
motion. 
The aortic sinus diameter is normal for gender with normal 
ascending aorta diameter for gender. 
A ___ 3 aortic valve bioprosthesis is present. The prosthesis 
is well seated with normal leaflet motion and gradient. There is 
no aortic valve stenosis. The effective orifice area index is 
moderately reduced (0.65-0.90 cm2/m2). There is no aortic 
regurgitation. 
The mitral valve leaflets are mildly thickened with no mitral 
valve prolapse. There is trivial mitral regurgitation. 
The tricuspid valve leaflets appear structurally normal. There 
is mild [1+] tricuspid regurgitation. 
There is mild-moderate pulmonary artery systolic hypertension. 
There is no pericardial effusion.

IMPRESSION: Well seated, normal functioning ___ 3 TAVR with 
normal gradient and no aortic regurgitation. Mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global biventricular systolic function. Mild-moderate 
pulmonary artery systolic hypertension.

 
Brief Hospital Course:
 
 # Aortic Stenosis: s/p TAVR #26 ___ ___  
{HTN post-procedure controlled with Hydralazine. Right groin 
bleeding post procedure controlled by manual pressure without 
recurrent bleeding.} 
 - Anticoagulation plan: Aspirin and Plavix
 - Post-TAVR Echo showed well seated, normal functioning valve 
with Peak/Mean gradients ___ (improved from 75/43) and ___ 1.5 
(improved from 0.7) 
 - Continue home dose Lasix 60mg daily 
 - SBE Prophylaxis with Clindamycin x 6 months post procedure 
 - Outpatient f/u with PCP and ___ 

 # Hypertension: Elevated today at 156/71
 - Metoprolol Tartrate increased to 50mg TID today and 
tolerating well so on d/c can go back on home dose 150 XL daily 

 # COPD: Stable on home inhalers and O2 2L at night as per home 
regimen. 
 - Incentive spirometer 10x/hour while awake
 - Continue inhalers per home regimen

Follow Up: ___, ___ at ___ office ___ @ 2PM 
 Structural ___ Team will contact patient for follow up 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB 
2. Atorvastatin 60 mg PO DAILY 
3. budesonide-formoterol 160-4.5 mcg/actuation inhalation BID 
4. Furosemide 60 mg PO DAILY 
5. Metoprolol Succinate XL 150 mg PO DAILY 
6. Tamsulosin 0.4 mg PO QHS 
7. Tiotropium Bromide 2 CAP IH DAILY 
8. Aspirin 81 mg PO DAILY 
9. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Clindamycin 600 mg PO ONCE Duration: 1 Dose 
Take 600mg once, one hour prior to procedure   
2.  Clopidogrel 75 mg PO DAILY  
3.  Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB  
4.  Aspirin 81 mg PO DAILY  
5.  Atorvastatin 60 mg PO DAILY  
6.  budesonide-formoterol 160-4.5 mcg/actuation inhalation BID  
7.  Furosemide 60 mg PO DAILY  
8.  Metoprolol Succinate XL 150 mg PO DAILY  
9.  Tamsulosin 0.4 mg PO QHS  
10.  Tiotropium Bromide 2 CAP IH DAILY  
11.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Aortic Stenosis s/p TAVR ___

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted for a trans catheter aortic valve repair 
(TAVR) to treat your aortic valve stenosis which was done on 
___. 

 It is very important to take all of your ___ healthy 
medications. In particular, you are now taking aspirin and 
Plavix (Prescription sent electronically to your pharmacy). 
These medications help to prevent blood clots from forming on 
the new valve. If you stop these medications or miss ___ dose, you 
risk causing a blood clot forming on your new valve. This could 
cause it to malfunction and it may be life threatening. Please 
do not stop taking aspirin or Plavix without taking to your 
___ doctor, even if another doctor tells you to stop the 
medications.  

 You will need prophylactic antibiotics prior to any dental 
procedure. Please inform your dentist about your recent cardiac 
procedure. One hour prior to your dental procedure take 
Clindamycin 600mg once. (Printed prescription provided that can 
be filled if needed). 

 Please weigh yourself every day in the morning after you go to 
the bathroom and before you get dressed. If your weight goes up 
by more than 3 lbs in 1 day or more than 5 lbs in 3 days, please 
call your ___ doctor or your primary care doctor and alert 
them to this change. Your weight at discharge is 160.9 lbs.
 
 If you have any urgent questions that are related to your 
recovery from your procedure or are experiencing any symptoms 
that are concerning to you and you think you may need to return 
to the hospital, please call the ___ HeartLine at ___ 
to speak to a cardiologist or cardiac nurse practitioner.  
 It has been a pleasure to have participated in your care and we 
wish you the best with your health.

 
Followup Instructions:
___
","['X2RF332' 'E78.5' 'J44.9' 'H91.90' 'F41.9' 'I35.0' 'I10.' 'Z00.6'
 'Z85.828' 'Z87.891']","['E78.5' 'J44.9' 'H91.90' 'F41.9' 'I35.0' 'I10.' 'Z00.6' 'Z85.828'
 'Z87.891']",['X2RF332'],"['Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Approach, New Technology Group 2'
 'Hyperlipidemia, unspecified'
 'Chronic obstructive pulmonary disease, unspecified'
 'Unspecified hearing loss, unspecified ear'
 'Anxiety disorder, unspecified' 'Nonrheumatic aortic (valve) stenosis'
 'Essential (primary) hypertension'
 'Encounter for examination for normal comparison and control in clinical research program'
 'Personal history of other malignant neoplasm of skin'
 'Personal history of nicotine dependence']",14,1481,10,2,,1,5,0
" 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
codeine / latex
 
Attending: ___.
 
Chief Complaint:
Chest pain
 
Major Surgical or Invasive Procedure:
Cardiac cath with DES x3 ___

 
History of Present Illness:
___ yo man with history of HCV cirrhosis s/p transplant ___,
CAD s/p MI with PCI (___), PVD, COPD/emphysema who
presents for chest pain. 

Patient was in his USOH until about 10 days prior to admission
when he had chest pain that woke him from sleep. This was a
burning chest pain in the ___ his chest. He was not sure 
if
it was acid reflux or cardiac in origin. He sat up and took his
SL nitro which relieved the pain. This continued, worse at 
night,
almost every day for the last 10 days. Each time he had the 
chest
pain, he took nitro which relieved the pain. He called his
cardiologist and was planned for cath on ___. However,
since he was not sure if this was cardiac or dyspepsia, he felt
it was not necessary. However, on the day of presentation, the
pain started to occur more frequently and was more severe. He 
was
in the shower and the pain would not go away until he finished
the shower and could get to the nitro SL. He took a total of 4
tabs SL nitro. Given this, he called EMS and was brought to ___,
where he received 162 mg aspirin (had already taken 162 aspirin
at home). He was started on heparin gtt with bolus and
transferred to ___ given that he receives all his care here.

He describes the pain as a ___ burning chest pain in the ___ his chest, nonradiating, not associated with diaphoresis,
nausea, or SOB. Pain is similar in quality to his MI in ___ but
not as severe; that was a ___. Currently, it has been coming 
on
every 30 minutes or so and lasts about ___ seconds then
resolves spontaneously or with nitro. He has not had nitro since
presenting to medical care as the chest pain has not recurred 
for
longer than 30 seconds

In the ED, initial VS were:  97.2 87 123/73 18 95% RA 
 
Exam notable for:  none reported in ED
Labs showed:  Cr 1.5, trops neg
Imaging showed: 
CXR: No evidence of an acute cardiopulmonary abnormality. 

 
Past Medical History:
- Child ___ Class A Cirrhosis due to  hepatitis C genome 1 
status post 3 months SVR (tx/simprevir and sofosbuvir) in ___. 
Decompensated with HCC.
- EGD in ___ with no esophageal varices
- HCC: on ___ lesion in segment VIII, which met OPTN 5B criteria 
and underwent radiofrequency ablation on ___. Also has 
small subcentimeter nodules, which need follow up imagin in 
___.
- COPD/emphysema. Uses inhalers and is not on oxygen. Recent 
PFTs done at ___ in ___.
- CKD grade II
- s/p CVA s/o residual focal weakness
- ?seizure not recurrent
- Drug dependence. ___ years history of incarceration in 
Federal Prison until ___. He had negative annual PPDs at 
prison
- Peripheral vascular disease. Aorta and iliac arteries. Given 
claudication as well as positive noninvasive tests at ___, no 
leg ulcers or chronic edema
- Hypertension
- Dyslipidemia
- Compression fractures in T9, T12 on his chest CT in ___ s/p 
biopsy, not on chronic pain medications
- CAD s/p MI and s/p 2x stent (LAD, RCA ___ ___, 2x stents 
(LAD, RCA) in ___ in ___ and 3 DES (mid RCA, mid and 
apical LAD, ___
- Neuropathy
- Upper GI bleed while incarcerated

PAST SURGICAL HISTORY
- left ACL repair
- removal of a benign tumor near his clavicle in ___, which 
resulted in nerve damage. done at ___. Then 
underwent a nerve transplant in his right arm in ___ at the 
___. He has had varying success in 
reinnervation of his biceps.
 
Social History:
___
Family History:
Per OMR, Negative for liver cancer or liver disease. His mother 
had colon cancer at age ___. His father and grandfather both had 
prostate cancer.
 
Physical Exam:
ADMISSION EXAM
==============
VS:  97.8 165/87 77 16 95 RA 
GENERAL: NAD, well appearing middle aged man
HEENT: AT/NC, PERRL, anicteric sclera, pink conjunctiva, MMM  
NECK: supple, no LAD, no JVD  
HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles. L chest wall port c/d/i
ABDOMEN: nondistended, nontender in all quadrants 
EXTREMITIES: no edema  
PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: warm and well perfused, no excoriations or lesions, no
rashes  

DISCHARGE EXAM
==============
VS:  ___ 0809 Temp: 99.2 PO BP: 128/74 R Lying HR: 69 RR: 
18
O2 sat: 96% O2 delivery: Ra 
GENERAL: NAD, well appearing middle aged man
HEENT: AT/NC, PERRL, anicteric sclera, pink conjunctiva, MMM  
NECK: supple, no JVD  
HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles. L chest wall port c/d/i
ABDOMEN: nondistended, nontender in all quadrants 
EXTREMITIES: no ___ edema. L femoral cath site c/d/i
PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  

 
Pertinent Results:
ADMISSION LABS
==============
___ 10:45PM BLOOD WBC-12.6* RBC-5.08 Hgb-13.9 Hct-41.9 
MCV-83 MCH-27.4 MCHC-33.2 RDW-13.8 RDWSD-40.5 Plt ___
___ 10:45PM BLOOD Glucose-121* UreaN-30* Creat-1.5* Na-142 
K-4.3 Cl-105 HCO3-23 AnGap-14
___ 10:45PM BLOOD cTropnT-<0.01
___ 05:16AM BLOOD CK-MB-1 cTropnT-<0.01
___ 10:45PM BLOOD Calcium-9.5 Phos-2.9 Mg-1.9

STUDIES
=======

CARDIAC CATH REPORT ___
Pending

___
TTE: The left atrium and right atrium are normal in cavity size.
The estimated right atrial pressure is ___ mmHg. Left 
ventricular
wall thickness, cavity size, and global systolic function are
normal (LVEF>55%). Doppler parameters are most consistent with
Grade I (mild) left ventricular diastolic dysfunction. Right
ventricular chamber size and free wall motion are normal. The
aortic valve leaflets (3) are mildly thickened but aortic
stenosis is not present. Mild (1+) aortic regurgitation is seen.
The mitral valve leaflets are mildly thickened. Trivial mitral
regurgitation is seen. There is a trivial/physiologic 
pericardial
effusion. 

Compared with the prior study (images reviewed) of ___,
there is no significant change. There was concern for apical
hypokinesis on the prior study, however the image quality was
poor on that study.  

___ CXR
No evidence of an acute cardiopulmonary abnormality. 

DISCHAGE LABS
=============

___ 05:22AM BLOOD WBC-9.5 RBC-4.58* Hgb-12.6* Hct-38.0* 
MCV-83 MCH-27.5 MCHC-33.2 RDW-13.9 RDWSD-41.7 Plt ___
___ 05:22AM BLOOD Glucose-127* UreaN-23* Creat-1.2 Na-142 
K-4.0 Cl-107 HCO3-22 AnGap-13
___ 05:22AM BLOOD Calcium-8.4 Phos-2.7 Mg-1.___ yo man with history of HCV cirrhosis s/p liver transplant 
___, CAD s/p ___ ___, RCA ISR s/p DES ___, and p/m 
RCA ___ to transplant surgery, hx PVD, who presented with 
unstable angina. He reported several days of worsening chest 
discomfort reminiscent of prior MI, without EKG changes or 
troponin elevation. He was taken to cath on ___ showing RCA ISR 
s/p DES and LAD ISR s/p DES and new DES to apical LAD. He was 
treated with heparin gtt, ASA, intraprocedural cangelor, Plavix 
load and maintence, metoprolol. He did well postprocedurally. 

#PUMP: EF 50-55%; grade I LV diastolic dysfunction, 1+ AR, no MR
#CORONARIES: CAD s/p LAD/RCA PCI ___, LAD ISR s/p DES ___ RCA 
ISR s/p DES ___ and ___ s/p ___ ___ preop liver. Type II 
NSTEMI post xplant 16 from dLAD
#RHYTHM: NSR

Other chronic issues: 
___ on CKD: Mild ___ on admission resolved without 
intervention, likely mild prerenal due to poor PO intake. His 
CKD is felt to be due to metabolic syndrome and CNI toxicity. 

#HCV cirrhosis c/b HCC, s/p transplant ___. Transplant team was 
aware of his admission. He continued his home tacrolimus 1.5mg 
daily with target level ___ mycophenolate sodium ___ 360 BID. 

#HTN: Home Metoprolol and imdur. 
#Insomnia: Home TraZODone 100mg; HydrOXYzine 50 mg PRN
#PVD: Aspirin, plavix, and atorvastatin as above. 
#Diarrhea: chronic and known to be ___ cellcept. Continued 
loperamide. 
#COPD: Home tioptropium. Advair instead of symbicort in house. 
#Neuropathy: Home gabapentin 300 mg PO BID 
#Osteoporosis: home Ca2+/vitamin D combo is NF; On denosumab as 
well as oupt (next due ___
#H/o HCV: genome ___ s/p simprevir and sofosbuvir x3 months with 
SVR

Transitional issues: 
[] Antiplatelet agent: ASA 81mg and Plavix 75mg 
[] Please perform groin cath side check (R femoral) at PCP 
appointment on ___, assess for hematoma, femoral/distal pulses
[] f/u Chem 10 at next appointment to ensure Cr has remained 
stable. 1.2 at time of discharge. 
[] Resume regular follow up with hepatology for management of 
immunosuppression
[] Outpatient workup of mild anemia, HgB 12.6 in house, has been 
intermittently ___ range since transplant 
[] f/u pending blood cultures from ED though there was no real 
suspicion of infection this admission. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Terazosin 10 mg PO QHS 
2. Gabapentin 300 mg PO BID 
3. LOPERamide 2 mg PO DAILY 
4. Tiotropium Bromide 1 CAP IH DAILY 
5. HydrOXYzine 50 mg PO QHS 
6. Metoprolol Succinate XL 50 mg PO QAM 
7. Denosumab (Prolia) 60 mg SC Q6M 
8. Atorvastatin 80 mg PO QPM 
9. Mycophenolate Sodium ___ 360 mg PO BID 
10. Tacrolimus 1.5 mg PO Q12H 
11. Multivitamins 1 TAB PO DAILY 
12. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 
13. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN as needed for chest 
pain  
14. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 
15. Sodium Polystyrene Sulfonate 30 gm PO ASDIR 
16. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600-125 
mg-unit oral DAILY 
17. Aspirin 81 mg PO DAILY 
18. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN 
19. TraZODone 100 mg PO QHS:PRN insomnia 
20. Metoprolol Succinate XL 100 mg PO QHS 

 
Discharge Medications:
1.  Clopidogrel 75 mg PO DAILY to prevent stent thrombosis 
RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*90 
Tablet Refills:*0 
2.  albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN  
3.  Aspirin 81 mg PO DAILY  
4.  Atorvastatin 80 mg PO QPM  
5.  budesonide-formoterol 80-4.5 mcg/actuation inhalation BID  
6.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600-125 
mg-unit oral DAILY  
7.  Denosumab (Prolia) 60 mg SC Q6M  
8.  Gabapentin 300 mg PO BID  
9.  HydrOXYzine 50 mg PO QHS  
10.  Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY  
11.  LOPERamide 2 mg PO DAILY  
12.  Metoprolol Succinate XL 50 mg PO DAILY  
13.  Metoprolol Succinate XL 100 mg PO QHS  
14.  Multivitamins 1 TAB PO DAILY  
15.  Mycophenolate Sodium ___ 360 mg PO BID  
16.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN as needed for chest 
pain   
17.  Sodium Polystyrene Sulfonate 30 gm PO ASDIR  
18.  Tacrolimus 1.5 mg PO Q12H  
19.  Terazosin 10 mg PO QHS  
20.  Tiotropium Bromide 1 CAP IH DAILY  
21.  TraZODone 100 mg PO QHS:PRN insomnia  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Unstable Angina, status post drug eluting stents x3 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___, 

It was a pleasure caring for you here at ___. 

Why you were here: 
- You were having chest pain that was reminiscent of your prior 
heart attacks. 

What we did: 
- We did a cardiac catheterization and found that 2 of your 
stents had become blocked off. These were opened up with new 
stents in the RCA and LAD. We also placed a third stent at the 
apex of the heart.

What to do when you go home: 
- It is important to take both aspirin and Plavix every day 
without missing any doses. If you miss any doses your stent 
could clot off and cause another heart attack. 
- Follow up with Dr. ___ your primary care doctor. 
- Please weigh yourself every day and call your doctor if you 
gain more than 3 lbs. 
- Return to the ER or call your doctor if you notice recurrent 
chest pain, palpitations, lightheadedness, leg swelling, or any 
other symptoms that concern you.  

We wish you the best! 

Sincerely, 
Your Care Team 
 
Followup Instructions:
___
","['027036Z' 'Z94.4' 'M81.0' 'I70.219' 'T45.1X5A' 'Y83.1' 'T82.855A' 'K52.1'
 'J43.9' 'G62.9' 'E78.5' 'N18.2' 'I25.110' 'N17.9' 'G47.00' 'Z87.891'
 'I25.2' 'Z80.0' 'Z80.42' 'Z85.05' 'Z86.19' 'I12.9' 'Y92.009']","['Z94.4' 'M81.0' 'I70.219' 'T45.1X5A' 'Y83.1' 'T82.855A' 'K52.1' 'J43.9'
 'G62.9' 'E78.5' 'N18.2' 'I25.110' 'N17.9' 'G47.00' 'Z87.891' 'I25.2'
 'Z80.0' 'Z80.42' 'Z85.05' 'Z86.19' 'I12.9' 'Y92.009']",['027036Z'],"['Dilation of Coronary Artery, One Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach'
 'Liver transplant status'
 'Age-related osteoporosis without current pathological fracture'
 'Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity'
 'Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter'
 'Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure'
 'Stenosis of coronary artery stent, initial encounter'
 'Toxic gastroenteritis and colitis' 'Emphysema, unspecified'
 'Polyneuropathy, unspecified' 'Hyperlipidemia, unspecified'
 'Chronic kidney disease, stage 2 (mild)'
 'Atherosclerotic heart disease of native coronary artery with unstable angina pectoris'
 'Acute kidney failure, unspecified' 'Insomnia, unspecified'
 'Personal history of nicotine dependence' 'Old myocardial infarction'
 'Family history of malignant neoplasm of digestive organs'
 'Family history of malignant neoplasm of prostate'
 'Personal history of malignant neoplasm of liver'
 'Personal history of other infectious and parasitic diseases'
 'Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease'
 'Unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause']",15,2011,23,2,,1,5,0
" 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Iodinated Contrast Media - IV Dye
 
Attending: ___.
 
Chief Complaint:
___/___
 
Major Surgical or Invasive Procedure:
___  Deceased donor liver transplant, back table
preparation of deceased donor liver allograft, back table
preparation of donor arterial conduit, supraceliac
aortic conduit.
.
___: Bilateral chest tube placement (both removed prior to 
discharge)

 
History of Present Illness:
___ who presents to the hospital for a possible
deceased donor liver transplant. He has a history of liver
cirrhosis and HCC with a lab MELD score of 7 but exception score
of 32.  

He is asymptomatic and has no liver decompensation. He has no
hematemesis or melena he has had no significant abdominal
swelling or ankle swelling.  He has had no jaundice
pill stools or dark urine.  His past medical history is notable
for potential hematuria with kidney stones.  He has never been
hospitalized for any medical illness.

Today he reports feeling well overall. He is understandably
nervous given the possible upcoming surgery.  

 
Past Medical History:
Past Medical History:
Cirrhosis
Hepatocellular carcinoma
Portal Hypertension
Esophageal varices grade 1 varices
Nephrolithiasis and recurrent UTI
.                                      
                       
Past Surgical History:
___: RFA ablation
___:  Cystourethroscopy, dilation and urethrotomy of
urethral strictures, catheter insertion(complex).    
 
Social History:
___
Family History:
No family history of colon cancer, liver cancer or other GI or
liver diseases.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vitals:
97.9F,BP 128/78,HR 96,RR 16, 96% RA
GEN: A&O, NAD
HEENT: No scleral icterus, mucus membranes moist
CV: RRR
PULM: Clear to auscultation b/l
ABD: Soft, nondistended, nontender, no rebound or guarding, no
palpable masses
Ext: No ___ edema, ___ warm and well perfused

DISCHARGE PHYSICAL EXAM:
24 HR Data (last updated ___ @ 328)
    Temp: 97.8 (Tm 98.2), BP: 125/71 (115-129/66-74), HR: 77
(73-99), RR: 18, O2 sat: 97% (94-98), O2 delivery: RA, Wt: 207.5
lb/94.12 kg

Fluid Balance (last updated ___ @ 2226)
  Last 8 hours  Total cumulative -280ml
    IN: Total 120ml, PO Amt 120ml
    OUT:  Total 400ml, Urine Amt 400ml
  Last 24 hours  Total cumulative -720ml
    IN: Total 1240ml, PO Amt 1240ml
    OUT:  Total 1960ml, Urine Amt 1900ml, Chest Tube (R) 60ml

GENERAL: [x]NAD [x]A/O x 3 
CARDIAC: [x]RRR 
LUNGS: [x]no respiratory distress [x] previous CT site w/o
leakage
ABDOMEN: [x]NBS  [x]soft  [x]Nontender [x]nondistended  [x]no
rebound/guarding 
WOUND: [x]CD&I  [x]no erythema/induration 
EXTREMITIES: [x]no CCE  [x]Pulse 2+ ___ bilateral 
 
Pertinent Results:
Labs on Admission: ___ 
WBC-8.4 RBC-4.56* Hgb-13.4* Hct-40.1 MCV-88 MCH-29.4 MCHC-33.4 
RDW-13.5 RDWSD-43.3 Plt ___ PTT-29.3 ___
Glucose-87 UreaN-14 Creat-0.6 Na-138 K-3.7 Cl-103 HCO3-26 
AnGap-9*
ALT-37 AST-50* AlkPhos-115 TotBili-0.4
Albumin-4.0 Calcium-8.9 Phos-3.0 Mg-1.9
HBsAg-NEG HBsAb-NEG HBcAb-NEG IgM HBc-NEG
HIV Ab-NEG
HCV Ab-NEG
HBV VL-NOT DETECT HCV VL-NOT DETECT
.
Labs at Discharge: ___
WBC-12.8* RBC-2.87* Hgb-8.9* Hct-28.1* MCV-98 MCH-31.0 
MCHC-31.7* RDW-20.4* RDWSD-69.8* Plt ___ PTT-27.6 ___
Glucose-92 UreaN-17 Creat-0.9 Na-136 K-5.3 Cl-103 HCO3-22 
AnGap-11
ALT-68* AST-31 AlkPhos-241* TotBili-0.5
Calcium-8.0* Phos-4.3 Mg-1.7
tacroFK-11.6

___ Liver Duplex:
IMPRESSION: 
 
Patent hepatic vasculature with appropriate waveforms.

___ CTA Chest:
IMPRESSION:

1. No evidence of pulmonary embolism or acute aortic 
abnormality.
2. Moderate volume left-sided pleural effusion with relaxation 
atelectasis and collapse of the left lower lobe.
3. Intercostal approach right pigtail drainage catheter is 
entirely fissural,
starting in the minor, ending in the major.  Right pleural 
effusion is
minimal.  No pneumothorax
4. Multifocal opacities, some of which demonstrate ground-glass 
attenuation
are present throughout both lungs.  Possible etiologies include 
multifocal
pneumonia, aspiration or less likely pulmonary hemorrhage.

___ TTE:
IMPRESSION: Poor image quality. Normal left ventricular wall 
thickness, cavity size, and global systolic function. 

___ CXR:
IMPRESSION: 
 
In comparison with the study of ___, there is little 
interval change. 
Bilateral chest tubes are in place with no evidence of 
pneumothorax.  An
continued low lung volumes with the cardiac silhouette within 
normal limits. 
No vascular congestion or pleural effusion.  Streaks of 
atelectasis are seen at both bases

 
Brief Hospital Course:
Deceased donor liver transplant with supraceliac aortic arterial 
conduit and repair of right diaphragm, ___.  Surgeons were 
Dr. ___ Dr. ___ with an intraoperative consult to Dr. 
___.  Intraoperative fluids: Cell Saver 160 cc, crystalloid 3 
L, Plasma-Lyte 1 L, albumin 1 L.  Post-operative chest x-ray 
revealed PA in right main pulm artery, NG tube in stomach, ETT 
in between clavicle and carina. Left lung field minor 
atelectasis. No pleural effusion or PTX. Post op liver U/S: 
Patent hepatic vasculature with appropriate waveforms.  The 
patient was resuscitated appropriately in the SICU. Antibiotics 
were discontinued after 24 hour course, his ___ was exchanged 
for a triple lumen CVL, and he was called out to the floor on 
POD#2.  At this time his arterial line and foley catheter were 
also discontinued.
.
The patient received routine induction immunosuppression to 
include Mycophenolate 1 gram pre-op and continued at 1 gram BID 
with good GI tolerance. Intra-op he received 500 mg Solumedrol, 
and started the solumedrol to prednisone taper per pathway, 
however the prednisone taper rate of decrease was dropped to 
every 5 days (instead of every 7) due to anxiety and possible 
steroid role.
Tacro was started on the evening of POD 1 with daily levels and 
dose adjusted per level. Discharge level was 11.6 and he is 
discharged on 2 mg BID.
.
On POD#3 he was offered a regular diet.  His foley catheter was 
replaced after he failed to void, and he was diuresed with 
intravenous Lasix.  

On POD#4 he was found to have a new oxygen supplementation 
requirement, first 3L NC and progressing to 10 L. After being 
placed on a non-rebreather, he was transferred to the ICU for 
high flow nasal cannula.  CXR revealed opacification of the left 
hemithorax concerning for pleural effusion, and a pigtail chest 
tube was placed.  A CTA of the chest was negative for PE, and he 
was intubated due to persistent hypoxia.  A right sided pigtail 
chest tube was also placed.  A dobhoff feeding tube was placed, 
and tube feeds were initiated.  He underwent bronchoscopic 
evaluation, revealing thick yellow secretions  A BAL was sent 
and empiric vanc/cefepime for possible pneumonia was initiated.  


On POD#5 he was extubated and weaned down on high flow nasal 
cannula.  He tolerated a clear liquid diet. 

On POD#6 he was advanced to a regular diet.  His chest x-ray was 
improved from prior.  His foley catheter was still in place for 
accurate urine monitoring.

On POD#7, ___, he tolerated a regular diet plus tube feeds, his 
urine output was satisfactory, and he had no further ICU needs.  
His lateral JP drain was removed, and his left pigtail chest 
tube was removed.  His foley catheter was removed after a dose 
of IV Lasix.  He was called out to the floor in good condition.

On POD#8, He was tolerating a regular diet. ___ was 
monitoring his blood sugars and adjusting his insulin as needed. 


On POD#9, His LFTs were slightly increased and he underwent 
ultrasound of the liver which demonstrated patent vasculature 
and good waveforms. A CXR demonstrated small pleural effusions 
and he was give Lasix to help reduce his volume overload.

On POD#10, ___, his other JP drain was removed and his dobhoff 
tube was removed with cessation of supplemental feeding. He 
continued to require insulin and he completed a 7 day coruse of 
cefepime for possible pneumonia. 

ON POD#___, ___, his WBC continued to be elevated. He remained 
afebrile and there was never purulent material coming from his 
drains. He underwent CT Torso with IV/PO contrast, which 
demonstrated small left pneumothorax, heterogenous fluid on the 
right base, and right subcutaneous emphysema. From ___, he 
was monitored with continued large amount of serous drainage 
from his chest tube. However, the amount was slowly down over 
these days and by ___ it put out less than 200cc over 24 hours. 
His chest tube was removed and his post pull was without 
pneumothorax. During this time period, his insulin regimen 
continued to be adjusted for improved blood sugars. On ___, he 
was deemed appropriate for discharge after the appropriate 
insulin management teaching, pharmacy teaching, and general care 
teaching. He understands that if he has any questions or 
concerns to give the transplant office a call. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever 
2. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN congestion 

 
Discharge Medications:
1.  Docusate Sodium 100 mg PO BID 
Stop using if having loose BMs or more than 2 BMs daily  
2.  Fluconazole 400 mg PO Q24H  
3.  NPH 9 Units Breakfast
Insulin SC Sliding Scale using HUM Insulin 
4.  Mycophenolate Mofetil 1000 mg PO BID  
5.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - 
Moderate 
No driving if taking this medication. Taper as tolerated  
6.  Pantoprazole 40 mg PO Q24H  
7.  PredniSONE 15 mg PO DAILY Duration: 4 Days 
Continue taper as directed  
8.  Propranolol 10 mg PO BID  
9.  Senna 8.6 mg PO QHS 
___ discontinue use if having loose BMs or more than 2 BMs daily 
 
10.  Sodium Polystyrene Sulfonate 15 gm PO DAILY:PRN elevated 
potassium 
take only when instructed by the transplant coordinator  
11.  Sulfameth/Trimethoprim SS 1 TAB PO DAILY  
12.  Tacrolimus 2 mg PO Q12H  
13.  TraZODone 50 mg PO QHS:PRN insomnia  
14.  ValGANCIclovir 900 mg PO DAILY  
15.  Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever 
Maximum 4 of the 500 mg tablets daily  
16.  Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN congestion 
 
17.Glucometer kit
supply one kit as covered by patient's insurance
test glucose up to 4 times a day
refill: none
ICD 10 EO9.65
18.Glucometer Test Strips
test glucose up to 4 times per day
Supply: one box of 100
Refill: 2
ICD 10 EO9.65
19.Lancets
test blood glucose up to 4 times daily
Supply: one box of 100
Refill: 2    ICD10: EO9.65
20.Insulin Pen Needles
use to inject insulin 4 times daily, # 100, Refills: 2
32G, ___ nano)
ICD 10:EO9.65

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
___/___ now s/p deceased donor liver transplant
Respiratory distress
Right and left pleural effusion
Pneumonia
malnutrition
Hyperglycemia

 
Discharge Condition:
activity as tolerated
no heavy lifting more than 10 pounds for 6 weeks after surgery/ 
no straining
may shower, but no tub baths

 
Discharge Instructions:
___ arranged to follow you at home
.
Please call the transplant clinic at ___ for fever of 
101 or higher, chills, nausea, vomiting, diarrhea, constipation, 
inability to tolerate food, fluids or medications, yellowing of 
skin or eyes, increased abdominal pain, incisional redness, 
drainage or bleeding, dizziness or weakness, decreased urine 
output or dark, cloudy urine, swelling of abdomen or ankles, or 
any other concerning symptoms.
.
Bring your pill box and list of current medications to every 
clinic visit.
.
You will need to have labwork drawn every ___ and ___ as 
arranged by the transplant clinic, with results to the 
transplant clinic (Fax ___ . CBC, Chem 10, AST, ALT, 
Alk Phos, T Bili, Trough Tacro level.
.
*** On the days you have your labs drawn, do not take your 
Tacrolimus until your labs are drawn. Bring your Tacrolimus with 
you so you may take your medication as soon as your labwork has 
been drawn.
.
Follow your medication card, keep it updated with any dosage 
changes, and always bring your card with you to any clinic or 
hospital visits.
.
You may shower. Allow the water to run over your incision and 
pat area dry. No rubbing, no lotions or powder near the 
incision. You may leave the incision open to the air. The 
staples are removed approximately 3 weeks following your 
transplant.
.
No tub baths or swimming
.
No driving if taking narcotic pain medications
.
Avoid direct sun exposure. Wear protective clothing and a hat, 
and always wear sunscreen with SPF 30 or higher when you go 
outdoors.
.
Drink enough fluids (but not plain water) to keep your urine 
light in color. Your appetite will return with time. Eat small 
frequent meals, and you may supplement with things like 
carnation instant breakfast or Glucerna.
.
Check your blood sugars at home and treat with insulin as you 
have been directed. Report values above 200 or less than 80 to 
the transplant clinic.
.
Check blood pressure at home. Report consistently elevated 
values above 160 systolic to the transplant clinic
.
Do not increase, decrease, stop or start medications without 
consultation with the transplant clinic at ___. There 
are significant drug interactions with anti-rejection 
medications which must be considered in medication management 
following transplant.
.
Consult transplant binder, and there is always someone on call 
at the transplant clinic with any questions that may arise
.
___ recommendations for managing Prednisone taper:
PREDNISONE & NPH tapered dosing as follows: 
15mg = 9 units 
12.5mg = 6 units
10mg = 6 units
7.5mg = 4 units
5mg = 4 units
2.5mg = 0 units (discontinue NPH) 
**Do not administer NPH insulin if you are not taking Prednisone
- both medications should be administered at the same time**

Humalog Sliding Scale - administer dose based on pre-meal
fingerstick blood glucose level (at B, L, D).  
71-150mg/dL = 0 units
151-200mg/dL = 2 units
201-250mg/dL = 3 units 
251-300mg/dL = 4 units 
> 300mg/dL = 5 units 
**Do not administer Humalog if you are not eating.**
 
Please call your provider (transplant team or primary care
physician) if you have frequent blood glucoses less than 70mg/dL
or frequent glucoses greater than 250mg/dL for possible
medication adjustments. Follow the Rule of 15 to treat
hypoglycemia (i.e. a blood glucose < 70mg/dL). Always carry
glucose tablets with you to treat a sudden low blood sugar. 

 
Followup Instructions:
___
","['0W9B30Z' '0BJ08ZZ' '02HV33Z' '0W9930Z' '0FY00Z0' '3E0G76Z' 'R09.02'
 'N17.9' 'D62.' 'K74.69' 'Z76.82' 'N12.' 'J18.9' 'E87.6' 'Z78.1' 'R73.9'
 'E83.39' 'J98.09' 'Z68.34' 'Y92.230' 'K76.6' 'C22.0' 'K75.81' 'J90.'
 'G47.33' 'I77.79' 'E66.9' 'T38.0X5A']","['R09.02' 'N17.9' 'D62.' 'K74.69' 'Z76.82' 'N12.' 'J18.9' 'E87.6' 'Z78.1'
 'R73.9' 'E83.39' 'J98.09' 'Z68.34' 'Y92.230' 'K76.6' 'C22.0' 'K75.81'
 'J90.' 'G47.33' 'I77.79' 'E66.9' 'T38.0X5A']",['0W9B30Z' '0BJ08ZZ' '02HV33Z' '0W9930Z' '0FY00Z0' '3E0G76Z'],"['Drainage of Left Pleural Cavity with Drainage Device, Percutaneous Approach'
 'Bypass Abdominal Aorta to Lower Artery with Nonautologous Tissue Substitute, Open Approach'
 'Inspection of Tracheobronchial Tree, Via Natural or Artificial Opening Endoscopic'
 'Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach'
 'Drainage of Right Pleural Cavity with Drainage Device, Percutaneous Approach'
 'Transplantation of Liver, Allogeneic, Open Approach'
 'Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening'
 'Hypoxemia' 'Acute kidney failure, unspecified'
 'Acute posthemorrhagic anemia' 'Other cirrhosis of liver'
 'Awaiting organ transplant status'
 'Tubulo-interstitial nephritis, not specified as acute or chronic'
 'Pneumonia, unspecified organism' 'Hypokalemia'
 'Physical restraint status' 'Hyperglycemia, unspecified'
 'Other disorders of phosphorus metabolism'
 'Other diseases of bronchus, not elsewhere classified'
 'Body mass index (BMI) 34.0-34.9, adult'
 'Patient room in hospital as the place of occurrence of the external cause'
 'Portal hypertension' 'Liver cell carcinoma'
 'Nonalcoholic steatohepatitis (NASH)'
 'Pleural effusion, not elsewhere classified'
 'Obstructive sleep apnea (adult) (pediatric)'
 'Dissection of other specified artery' 'Obesity, unspecified'
 'Adverse effect of glucocorticoids and synthetic analogues, initial encounter']",16,2259,28,2,,1,5,0
" 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Omnipaque / oxaliplatin / Iodinated Contrast Media
 
Attending: ___
 
Chief Complaint:
fevers
 
Major Surgical or Invasive Procedure:
___: 14 ___ Right Chest Tube Insertion 
___: Uncomplicated 18-gauge targeted liver biopsy x 3, with 
specimens sent to pathology and microbiology.
 
History of Present Illness:
================================================================ 


Oncology Hospitalist Admission

Date: ___

================================================================

PCP: ___
PRIMARY ONCOLOGIST: ___., MD
PRIMARY DIAGNOSIS: Pancreatic Cancer
TREATMENT REGIMEN: FOLFOX with Oxaliplatin Desensitization

CHIEF COMPLAINT: Fever

HISTORY OF PRESENT ILLNESS:

Mr. ___ is a pleasant ___ years old Male who presents to
___ ED for the further evaluation of fever at home (tmax of
101). He has a complicated oncological history after undergoing
multiple chemo regimens and multiple Whipple attempts with prior
hepatic abscess drained by ___ and history of cholangitis that 
was
treated. He has required multiple GI interventions via MRCP for
micro abscesses on the liver and he has been on prophylactic
Augmentin for the past three weeks. Temperatures at home have
been slowly climbing up, 99.4 last night but reached 101 this 
AM.
His wife called her oncologist who recommended he come in for
further medical care. Pt also endorse back pain secondary to an
L5 bulging disc, for which he recently underwent a plexus block
on ___. He otherwise feels well and reports no other
constitutional symptoms. He denies any chills, chest pain,
shortness of breath, nausea, vomiting, diarrhea, abdominal pain,
recent prolonged traveling, or known exposure to sick contacts.
Of note, last session of chemo was in ___ of this year.

In the ED, initial vitals: 101.5 92 128/74 16 94% RA
 
Past Medical History:
PAST ONCOLOGIC HISTORY: 

Pancreatic cancer stage IIA (T3N0M0)
- ___ Developed loose stool. 
- ___ Developed weight loss following TKR surgery despite
eating regularly. He reported increased frequency of his stools
for which he avoided lactose. 
- ___ He was seen by Dr. ___ who felt he had a
malabsorption from CF gene and f/u for this was started,
including an abdominal U/S to look at the pancreas. This
unfortunately revealed a 3.2 x 3.1 x 2.8 cm pancreatic head 
mass with PD dilatation worrisome for malignancy. Two
indeterminate hepatic masses were seen. 
- ___ He underwent EUS which revealed an ill-defined
pancreatic head mass w/o vascular involvement, which confirmed
moderately-differentiated pancreatic ductal adenocarcinoma. CA
___ found to be elevated to 492. 
- ___ CTA torso showed an ill-defined, infiltrative
hypoattenuating mass in the head of the pancreas, consistent 
with
adenocarcinoma, resulting in pancreaticobiliary ductal
obstruction, and with stranding extending to superior 
mesenteric and splenic veins. Hyperenhancing lesion in the dome
of the liver may represent hemangioma, however is incompletely
characterized on this split bolus examination. 
- ___ Underwent attempted Whipple resection.
Intra-operatively, he was found to have a large, inflammatory
carcinoma measuring 7-8 cm occupying the entire pancreas into 
the
uncinate and down to the root of the mesentery (and 
down by the superior mesenteric vessels). Due to the severity of
the inflammatory pancreatitis and the size of the tumor were
prohibitive to proceed with an attempt at safe
pancreaticoduodenectomy resection. As such, it was 
determined to be locally invasive and open CCY and double bypass
performed, fiducials placed. Of note, the liver was also
inspected intra-operatively and the possible hemangioma seen in
the dome on imaging was not seen or palpable and the liver 
looked
healthy overall. Uncomplicated post-op course. 
- ___ C1D1 FOLFIRINOX
- ___ C1D1 DF/HCC ___ CAT-IQ trial
- ___ C2D1 FOLFIRINOX + Neulasta
- ___ CTA torso showed stable disease, new line 
associated
clot. Holding isoquercetin and switch to enoxaparin. 
Chemotherapy
hold for toxicity
- ___ C3D1 FOLFOX6 (holding IRI from FOLFIRINOX)
- ___ - ___ Admitted with fever, found to have Ecoli
bacteremia. 
- ___ C3D15 FOLFIRNOX (IRI reduced by 50% to 90 mg/m2)
- ___ SBRT to tumor
- ___ held FOLFIRINOX given stomach pain, fatigue, LFTs up
- ___ FOLFOX, found to have UGT1A1 polymorphism
- ___ CTA torso showed decrease in the pancreatic mass 
and
no metastatic disease. Felt to represent resectable disease
- ___ Taken to the OR for curative attempt with a 
Whipple.
Liver lesions noted during the procedure. Biopsies were taken 
and
fresh sections read as adenocarcinoma, so Whipple was aborted.
Final pathology showed biliary hamartomas however. 
- ___ MR abdomen showed 2.9 x 2.7 cm pancreatic head mass
contacting the SMV less than 90 degrees with associated distal
pancreas atrophy. No definite metastases in the abdomen,
including liver.
- ___ Third attempt at Whipple found inoperable vascular
involvement at the SMV root
- ___ CT torso showed stable locally advanced disease, no
metastatic disease
- ___ CTA showed continued gradual decrease in size of
pancreatic mass, no metastatic disease
- ___ CT torso showed stable disease, no metastatic
disease
- ___ CT torso showed stable disease, no metastatic
disease
- ___ CT torso showed stable disease, no metastatic
disease
- ___ CT torso showed stable disease, no metastatic
disease
- ___ CT torso showed stable disease, no metastatic
disease
- ___ CT torso showed stable disease, no metastatic
disease
- ___ EUS with path showing adenocarcinoma, ERCP unable 
to
be performed due to anatomy
- ___ CT torso showed stable disease, no metastatic
disease, small, nonocclusive thrombus of the portal vein.
- ___ CT torso showed stable disease
- ___ CT chest showed 7 tiny (<5mm) lung nodules
- ___ PET with 3.5 x 2.5 cm pancreatic head mass; No 
other
areas of abnormal FDG uptake noted.
- ___ - ___ Admitted for slowed speech, found to have
epileptiform discharges and started on keppra. brain MRI neg 
- ___ CT chest ___. MR abdomen progressive disease of
pancreatic head
- ___ FOLFOX C1D1
- ___ FOLFOX C1D15 held due to oxaliplatin reaction
- ___ MRCP with slightly improved cholangitis, stable
disease
- ___ FOLFOX C2D1 with inpatient oxaliplatin
desensitization
- ___ FOLFOX C2D15 with inpatient oxaliplatin
desensitization
- ___: admitted with fevers, found to have liver
abscesses
- ___: MRI with improved cholangitis, stable panc head mass
- ___: FOLFOX C3D1 with inpatient oxaliplatin
desensitization
- ___: FOLFOX C3D15 with inpatient oxaliplatin
desensitizaton
- ___: EGD with banding of two grade II-III varices
- ___ CT chest and MR abdomen showed persistent evidence
of cholangitis but resolved abscess, stable disease
- ___ C4D1 mFOLFOX with oxali densensitization (LV 200
mg/m2 ci5FU 960 mg/m2/day) + Neulasta
- ___ CT chest and MR abdomen show stable chronic
cholangitis and stable disease
- ___ MRCP with stable chronic cholangitis, stable
pancreatic head mass, and subcentimeter lesions in segment 4A 
and
8 consistent with either microabscesses or metastatic lesions

PAST MEDICAL HISTORY:  

- Pancreatic Cancer, as above
- Portal Vein Thrombus
- Opioid Use Disorder on Suboxone
- s/p total knee replacement
- s/p appendectomy
- L5 Disc herniation

 
Social History:
___
Family History:
 1.  Mother died of cholangiocarcinoma.
 2.  Father was unknown to him, but died in his ___.
 3.  No other family history of malignancy.

 
Physical Exam:
VITAL SIGNS: ___ ___ Temp: 98.0 PO BP: 130/78 HR: 85 RR: 
16 O2 sat: 97% O2 delivery: RA 
General:  NAD
HEENT:  MMM 
CV:  RR, NL S1S2 no S3S4, no MRG
PULM:  CTAB, respirations unlabored, improved aeration at the R 
base
ABD:  BS+ SNT/ND has RLQ TTP that is chronic and unchanged from 
baseline
LIMBS:  No ___, WWP
SKIN:  No rashes on extremities
NEURO:  Speech fluent, strength grossly intact
PSYCH: thought process logical, linear, future oriented
ACCESS: chest port site intact w/o erythema, dressing C/D/I
 
Pertinent Results:
___ 05:02AM BLOOD WBC-13.7* RBC-3.60* Hgb-8.6* Hct-27.3* 
MCV-76* MCH-23.9* MCHC-31.5* RDW-19.5* RDWSD-53.5* Plt ___
___ 05:55AM BLOOD Glucose-178* UreaN-10 Creat-0.5 Na-135 
K-4.3 Cl-99 HCO3-22 AnGap-14
___ 05:02AM BLOOD ALT-28 AST-34 AlkPhos-479* TotBili-0.4
___ 05:02AM BLOOD Iron-14*
___ 05:55AM BLOOD Calcium-8.2* Phos-2.4* Mg-1.9
___ 05:02AM BLOOD calTIBC-198* Ferritn-147 TRF-152*
___ 01:14PM BLOOD CEA-84.0*
___ 01:14PM BLOOD CA ___ -PND
___ 10:15AM PLEURAL TNC-2200* ___ Polys-55* 
Lymphs-5* Monos-1* Baso-1* Macro-38* Other-0
___ 10:15AM PLEURAL TotProt-4.0 Glucose-104 LD(LDH)-368 
Albumin-2.1 Cholest-62 proBNP-___ w/ locally advanced, non-resectable pancreatic cancer s/p
chemo and SBRT, on FOLFOX w/ desens, whose course has been c/b
recurrent bouts of cholangitis and hepatic abscess, p/w sepsis 
on
___ after having a plexus block on ___.

# Sepsis, resolving

Patient presented with fever, tachycardia, leukocytosis, despite
taking augmentin. Suspect most likely source is biliary with
elevated lfts and absence of any localizing symptoms. He quickly
improved with IV Zosyn. Imaging (MRCP, CT-torso) c/w metastatic 
disease rather
than cholangitis or abscesses. ID consulted and advised holding
abx, but ok to resume home prophylactic abx. Imaging and case
reviewed at tumor board today and noted that his findings are 
not
entirely clear w/ progression and recommended biopsy. 
He had a targeted liver biopsy ___ and the preliminary path
is not c/w abscess, more suggestive of malignancy. This was
relayed to the oncology team and they will follow up the 
results. 

- cont po cipro for prophylaxis
- oncology will arrange a f/u 

# Pleural Effusion
Has symptomatic new effusion w/ septations. S/p CP placement on
___ with over 1000 ml serosangeonous fluid removed and
symptomatic improvement. Studies c/w simple exudative effusion.
- IP will arrange a f/u

# Pancreatic Ca
He is undergoing palliative FOLFOX w/ oxali desens. Disease has
been under control but imaging c/f progression. 
- liver abscess-vs-met pathology/micro report pending
- cont creon

# PVT: cont apixaban 

# History of idiopathic seizure (word finding difficulties,
slowed speech, hand or finger jumping)
He states he has not had any further episodes of seizures since
the admission for it ___. He is now off zonisamide 

# History of opiate abuse: cont suboxone
# Anemia: likely from antineoplastic therapy 
# L5 Disc herniation: cont flexeril prn, has outpatient f/u

FEN: Regular
ACCESS: PORT
CODE STATUS: Full code, presumed  
DISPO: Onc-hosp, home w/o services
BILLING: >30 min spent coordinating care for discharge
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amoxicillin-Clavulanic Acid ___ mg PO Q12H 
2. Cyclobenzaprine 10 mg PO TID:PRN back pain 
3. Creon 12 1 CAP PO TID W/MEALS 
4. Apixaban 5 mg PO BID 
5. Buprenorphine 1.4 mg SL DAILY 
6. Pantoprazole 40 mg PO Q24H 
7. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO BID 
RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day 
Disp #*28 Tablet Refills:*0 
2.  Apixaban 5 mg PO BID 
DO NOT RESUME UNTIL ___ IN AFTERNOON  
3.  Buprenorphine 1.4 mg SL DAILY  
4.  Creon 12 1 CAP PO TID W/MEALS  
5.  Cyclobenzaprine 10 mg PO TID:PRN back pain  
6.  Pantoprazole 40 mg PO Q24H  
7.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Sepsis
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
 
Mr. ___,

It was a pleasure caring for you in the hospital. You were 
admitted for fever workup and found to have imaging findings 
concerning for possible metastatic disease that is progressing 
but discussions at tumor board feels these are more likely 
abscess. To help investigate this further, you had a liver 
biopsy done on ___. You can resume your apixaban 24 hours after 
your liver biopsy on ___. Your oncology team will follow up on 
the results. If you have any abdominal pain, especially in your 
right upper abdomen, or any dizziness and lightheadedness, this 
could be a sign of internal bleeding in the liver and you will 
need to seek immediate medical attention.

You also had a pleural effusion and you had the fluid drained 
from your lung with a chest tube. Interventional Pulmonology 
will call you with a follow up appointment. 

Wishing you best health,
Dr. ___ your ___ team
 
Followup Instructions:
___
","['0FB13ZX' '0W9930Z' 'A41.9' 'D64.81' 'C78.7' 'T45.1X5A' 'I81.' 'E43.'
 'F11.20' 'C25.0' 'Z96.659' 'J90.' 'Z68.21' 'Z51.5' 'M51.26' 'D18.03'
 'Z92.21']","['A41.9' 'D64.81' 'C78.7' 'T45.1X5A' 'I81.' 'E43.' 'F11.20' 'C25.0'
 'Z96.659' 'J90.' 'Z68.21' 'Z51.5' 'M51.26' 'D18.03' 'Z92.21']",['0FB13ZX' '0W9930Z'],"['Excision of Right Lobe Liver, Percutaneous Approach, Diagnostic'
 'Drainage of Right Pleural Cavity with Drainage Device, Percutaneous Approach'
 'Sepsis, unspecified organism'
 'Anemia due to antineoplastic chemotherapy'
 'Secondary malignant neoplasm of liver and intrahepatic bile duct'
 'Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter'
 'Portal vein thrombosis'
 'Unspecified severe protein-calorie malnutrition'
 'Opioid dependence, uncomplicated'
 'Malignant neoplasm of head of pancreas'
 'Presence of unspecified artificial knee joint'
 'Pleural effusion, not elsewhere classified'
 'Body mass index (BMI) 21.0-21.9, adult' 'Encounter for palliative care'
 'Other intervertebral disc displacement, lumbar region'
 'Hemangioma of intra-abdominal structures'
 'Personal history of antineoplastic chemotherapy']",17,1961,17,2,,1,5,0
" 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
lovastatin / NSAIDS (Non-Steroidal Anti-Inflammatory Drug)
 
Attending: ___.
 
Chief Complaint:
Hematemesis
 
Major Surgical or Invasive Procedure:
EGD - ___
 
History of Present Illness:
Patient is a ___ w/ obesity s/p Roux-en-Y gastric bypass, known 
large gastrojejunal ulcer, severe PVD s/p multiple vascular 
interventions (most recently s/p BKA on ___, and chronic 
back/extremity pain on methadone who presents to the ED with 
hematemesis. 

Of note, the patient was discharged from ___ after a 
hospitalization ___ during which she underwent L BKA for 
severe wound infection.  She then went to her rehab facility & 
had ___ episodes of hematemesis prompting return to ___.  

On admission, she denied any BRBPR, melena, chest pain, 
lightheadedness, dizziness, abdominal pain, fevers or chills.

In the ED, she had continued hematemesis so was intubated 
emergently for airway protection.  She was sedated w/ fentanyl   
Her initial vital signs were T 98.1, HR 97, BP 121/68, RR18 O2 
98%.  Her HGB was 6.6 from 8.2 so she was transfused 2U pRBCs. 
GI, ACS & Vascular Surgery were consulted for management. 

On arrival to the ICU, the patient remained intubated & sedated. 
 She was HDS.  
 
Past Medical History:
Nephrolithiasis  
 Recurrent lower extremity cellulitis  
 Hypertension  
 Hyperlipidemia  
 Type 2 diabetes  
 Peripheral vascular disease with bilateral foot ulceration and  

 left lower extremity osteomyelitis  
 GERD  
 Peripheral neuropathy  
 Chronic lower back pain and lower extremity pain on methadone  
 Hysterectomy  
 Roux-en-Y gastric bypass in ___  
 Cholecystectomy  
 Right hip ORIF  
 Right common femoral artery endarterectomy with patch 
angioplasty  
 Skin graft to right foot  
 Left common femoral endarterectomy with patch angioplasty  
 Debridements to feet for ulceration  
 Prior popliteal to proximal tibial artery bypass status post  
 thrombosis with thrombectomy and stent placement ___  
 
Social History:
___
Family History:
Pt denies significant family history other than sister having 
cardiac disease requiring open heart surgery.
 
Physical Exam:
ADMISSION EXAM
========================
VITALS:  Reviewed in metavision
GENERAL: Intubated, sedated.
HEAD: NC/AT.
CARDIAC: RRR, S1S2 w/o m/r/g. 
RESPIRATORY: Clear anteriorly.
EXTREMITIES: Warm, pulses intact.

DISCHARGE EXAM
========================
VS: 
24 HR Data (last updated ___ @ 806)
    Temp: 99.7 (Tm 99.7), BP: 150/81 (114-154/56-81), HR: 75
(73-83), RR: 18, O2 sat: 94% (94-100), O2 delivery: RA  
Gen: Chronically ill appearing woman in NAD who appears well thi
smorning
HEENT: MMM. EOMI
Neck: No LAD
CV: RRR, No m/r/g
PULM: LCTAB
ABD: S/NT/ND
EXT: WWP, NO ___ edema, s/p left BKA with no minimal surrounding
erythema, staples and sutures in place.
Neuro: A&ox3, following commands, moving all four extremities

 
Pertinent Results:
ADMISSION LABS
=============================
___ 06:08AM BLOOD WBC-8.8 RBC-3.06* Hgb-8.2* Hct-26.3* 
MCV-86 MCH-26.8 MCHC-31.2* RDW-18.8* RDWSD-58.4* Plt ___
___ 04:50AM BLOOD Neuts-84.0* Lymphs-10.5* Monos-3.0* 
Eos-0.1* Baso-0.5 Im ___ AbsNeut-9.16*# AbsLymp-1.14* 
AbsMono-0.33 AbsEos-0.01* AbsBaso-0.05
___ 04:50AM BLOOD ___ PTT-28.3 ___
___ 06:08AM BLOOD Glucose-75 UreaN-11 Creat-1.1 Na-140 
K-4.7 Cl-103 HCO3-26 AnGap-11
___ 04:50AM BLOOD ALT-7 AST-10 AlkPhos-82 TotBili-0.2
___ 06:08AM BLOOD Calcium-7.7* Phos-2.5* Mg-1.9
___ 10:25AM BLOOD ___ pO2-175* pCO2-41 pH-7.36 
calTCO2-24 Base XS--1
___ 04:54AM BLOOD Lactate-1.4 Na-134 K-3.8

RELEVANT STUDIES
=============================
___ EGD:
Blood in the esophagus. Unable to visualize most of stomach 
mucosa. Not able to visualize known two large ulcers due to 
large blood clot that was unable to be displaced. Jejunal limbs 
not seen due to blood. Duodenum not visualized due to anatomy. 
Procedure aborted due to poor visibility, large blood. Otherwise 
normal EGD to stomach

___ EGD
Duodenum not seen due to post surgery anatomy.
The alimentary limb was explored for 20 cm without blood or 
bleeding. Two jejunal diverticula were seen, without evidence of 
bleeding.
No active bleeding was seen. No visible vessels or high risk 
stigmata were seen. Previous RNYGB of the stomach
Ulcers in the gastrojejunal anastamosis
An OG tube was present at the initiation of the procedure. This 
was removed.
A dobhoff was blindly placed through the right nare into the 
esophagus. It was manually advanced, and once in place 
endoscopically it appeared to be entering the alimentary limb.
Otherwise normal EGD to 20 cm into alimentary jejunal limb

___ EGD
Esophagus: Normal esophagus. 
Stomach:  
 Lumen: Evidence of a previous RNYGB was seen.  
 Excavated Lesions Two ulcers ranging in size from 5 mm to 9 mm 
were found at the gastrojejunal anastamosis. The linear ulcer on 
the anastamotic scar was notably decreased in size. The round 
ulcer between the jejunal limbs appeared slightly decreased in 
size. There was no spontaneous bleeding or stigmata of bleeding. 
  
 Other Two staples were encountered at the site of the 
anastamotic ulcer.   The two staples were successfully removed 
using a jumbo forceps. Very minimal oozing was noted, which 
stopped without intervention.   
Duodenum:  
 Other duodenum not visualized due to post surgical anatomy.  
Impression: Duodenum not visualized due to post surgical 
anatomy.
Ulcers in the gastrojejunal anastamosis
Two staples were encountered at the site of the anastamotic 
ulcer. (foreign body removal)
Previous RNYGB of the stomach
Otherwise normal EGD to gastro-jejunal anastamosis 

DISCHARGE LABS
=============================
___ 08:40AM BLOOD WBC-8.7 RBC-3.21* Hgb-9.1* Hct-29.3* 
MCV-91 MCH-28.3 MCHC-31.1* RDW-16.7* RDWSD-55.1* Plt ___
___ 08:40AM BLOOD Glucose-183* UreaN-21* Creat-1.3* Na-139 
K-4.6 Cl-103 HCO3-23 AnGap-13
 
Brief Hospital Course:
Ms. ___ is a ___ year of female with a history of obesity 
s/p Roux-en-Y gastric bypass, known large gastrojejunal ulcer, 
severe PVD s/p multiple vascular interventions (most recently 
s/p BKA on ___, and chronic back/extremity pain on methadone 
who presented with hematemesis ___ GJ anastomosis ulcer. 

# Acute blood loss anemia:
# Hematemesis:
# GJ Ulcer:
Patient presented from her rehabilitation facility with 
hematemesis. HGB had dropped from 8.2 to 6.6. Of note, patient 
was hospitalized at ___ from ___ for BKA. She received 4 
units pRBC during her MICU stay with appropriate response. She 
was placed on IV PPI which was transitioned to PO PPI after 
stabilization of H/H. During prior hospitalization, patient 
underwent 5 EGDs for UGIB with known gastrojejunal ulcer that 
could not be intervened upon due to large, adherent clot 
present. GI, Bariatric Surgery & ACS were consulted for 
management. GI performed EGD ___ & saw large blood in the 
stomach w/o further visualization.  Repeat EGD ___ which 
showed 2 excavating ulcers at the GJ anastomotic junction. She 
was hemodynamically stable and transferred to the floor where 
she had no further signs of bleeding. Bariatrics was consulted 
as below. EGD performed on ___ that removed two staples 
without complication. Discharge Hb/Hct 9.___.3. 

# History of RNY Gastric Bypass:
# Severe protein calorie malnutrition
Poor nutrition likely impairing ulcer healing and would make 
surgery higher risk. Albumin is currently 1.7. Per bariatric 
surgery team, the albumin needs to improve to 4 before reversal 
of gastric bypass. They have recommended enteral feeding but the
patient refuses placement of dobhoff tube. Dobhoff was initially 
placed under endoscopic guidance in the ICU but this came out. 
She refused further dobhoff placement. Given this barrier, she 
was given protein shakes three times daily. Nutrition was 
consulted and she was started on vitamin D and B12. Discharge 
albumin 1.8.

# Respiratory compromise given hematemesis:
She was intubated on admission given continued hematemesis. Once 
bleed stablilized, extubated successfully ___. 

# PVD s/p BKA: 
Home aspirin and clopidogrel were held upon admission given 
concern for ongoing, active bleeding. Vascular Surgery stated no 
utility in further ASA & clopidogrel in the setting of repeated 
bleeds. Continued statin therapy. 

# Chronic Pain: Home methadone held when on fentanyl for 
sedation. She was then restarted on home methadone.

TRANSITIONAL ISSUES
===================
[] Ensure follow up with her previous Bariatric surgeon at 
___ for discussion  and planning of reversal
[] Continue to closely monitor nutrition status and continue 
aggressive nutrient and protein supplementation. Trend weekly 
albumin. If albumin is not sufficiently improving on aggressive 
PO supplementation, would consider re-addressing enteral 
feedings.
[] Aspirin and Plavix stopped because of recurrent marginal 
ulcer bleeds. Would recommend stopping these medications until 
RNY reversal or further discussion with vascular and bariatric 
surgery. Can consider repeat EGD in 8 weeks to evaluate for 
healing of ulcers and considering restart of aspirin at this 
time in consultation with vascular surgery, GI, and bariatric 
surgery.
[] BID high dose PPI for 8 weeks beginning ___ then 
continue daily high dose PPI indefinitely
[] Minocycline had been prescribed for surgical site erythema 
but was stopped as this appeared improved to the vascular 
surgery team during this admission. If erythema returns, restart 
minocycline. 
[] Ensure follow up with Dr. ___ in vascular surgery in 2 
weeks.
[] NSAIDs should be avoided in this patient. NSAIDs added to  
allergy list.
[] consider adding back atenolol if need for blood pressure. 
Alternatively, consider metoprolol or increasing her current 
doses of HCTZ or lisinopril if renal function allows

- Communication: ___  son ___ 
- Code: Full, confirmed  
 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Clopidogrel 75 mg PO DAILY 
2. Cyanocobalamin 50 mcg PO DAILY 
3. Gabapentin 600 mg PO BID 
4. Hydrochlorothiazide 12.5 mg PO DAILY 
5. Lisinopril 10 mg PO DAILY 
6. Methadone 30 mg PO QAM 
7. Methadone 20 mg PO QPM 
8. Methadone 30 mg PO QHS 
9. Simvastatin 10 mg PO QPM 
10. Acetaminophen 1000 mg PO Q6H 
11. HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN Pain - Severe 
12. Minocycline 100 mg PO BID 
13. Pantoprazole 40 mg PO Q12H 
14. Aspirin 81 mg PO DAILY 
15. Atenolol 25 mg PO DAILY 

 
Discharge Medications:
1.  Multivitamins W/minerals 1 TAB PO DAILY  
2.  Vitamin D ___ UNIT PO 1X/WEEK (___)  
3.  Vitamin D 1000 UNIT PO DAILY  
4.  Cyanocobalamin 50 mcg PO DAILY  
5.  Gabapentin 600 mg PO BID  
6.  Hydrochlorothiazide 12.5 mg PO DAILY  
7.  Lisinopril 10 mg PO DAILY  
8.  Methadone 30 mg PO QAM 
RX *methadone 10 mg 3 tablets by mouth QAM and QHS Disp #*80 
Tablet Refills:*0 
9.  Methadone 20 mg PO QPM 
RX *methadone 10 mg 2 tablets by mouth Daily at 1400 Disp #*20 
Tablet Refills:*0 
10.  Methadone 30 mg PO QHS  
11.  Pantoprazole 40 mg PO Q12H  
12.  Simvastatin 10 mg PO QPM  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Upper gastrointestinal bleed
Marginal ulcer

Secondary:
s/p below the knee amputation

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to ___ with an upper gastrointestinal bleed. 
You were monitored in the medical intensive care unit and had 
multiple endoscopies. We found that you had two ulcers. You will 
be placed on proton pump inhibitor twice daily for 8 weeks then 
will continue this lifelong. You will stop aspirin and Plavix.

You were seen by the bariatric surgery team and they recommended 
aggressive nutrition. You will need to follow up with your 
bariatric surgery to further discuss having reversal of your 
bypass because of the ulcers in your stomach.

It was a pleasure taking care of you. We wish you the best in 
your health.

Sincerely,
Your ___ Team
 
Followup Instructions:
___
","['5A1945Z' '3E0G76Z' '0DJ08ZZ' '0BH17EZ' '02HV33Z' 'M54.9' 'Z98.84'
 'E11.51' 'E43.' 'K28.4' 'Y92.9' 'K91.89' 'K21.9' 'Z87.891' 'K57.10'
 'E78.00' 'D62.' 'I10.' 'Y83.2' 'Z89.512' 'E55.9' 'Z68.24' 'Z79.02'
 'E11.42' 'G89.29' 'I95.9']","['M54.9' 'Z98.84' 'E11.51' 'E43.' 'K28.4' 'Y92.9' 'K91.89' 'K21.9'
 'Z87.891' 'K57.10' 'E78.00' 'D62.' 'I10.' 'Y83.2' 'Z89.512' 'E55.9'
 'Z68.24' 'Z79.02' 'E11.42' 'G89.29' 'I95.9']",['5A1945Z' '3E0G76Z' '0DJ08ZZ' '0BH17EZ' '02HV33Z'],"['Respiratory Ventilation, 24-96 Consecutive Hours'
 'Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening'
 'Extirpation of Matter from Jejunum, Via Natural or Artificial Opening Endoscopic'
 'Inspection of Upper Intestinal Tract, Via Natural or Artificial Opening Endoscopic'
 'Insertion of Endotracheal Airway into Trachea, Via Natural or Artificial Opening'
 'Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach'
 'Dorsalgia, unspecified' 'Bariatric surgery status'
 'Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene'
 'Unspecified severe protein-calorie malnutrition'
 'Chronic or unspecified gastrojejunal ulcer with hemorrhage'
 'Unspecified place or not applicable'
 'Other postprocedural complications and disorders of digestive system'
 'Gastro-esophageal reflux disease without esophagitis'
 'Personal history of nicotine dependence'
 'Diverticulosis of small intestine without perforation or abscess without bleeding'
 'Pure hypercholesterolemia, unspecified' 'Acute posthemorrhagic anemia'
 'Essential (primary) hypertension'
 'Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure'
 'Acquired absence of left leg below knee'
 'Vitamin D deficiency, unspecified'
 'Body mass index (BMI) 24.0-24.9, adult'
 'Long term (current) use of antithrombotics/antiplatelets'
 'Type 2 diabetes mellitus with diabetic polyneuropathy'
 'Other chronic pain' 'Hypotension, unspecified']",18,1824,26,2,,1,5,0
" 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
Progressive neurologic weakness
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ y.o. F with recent diagnosis of recently diagnosed (dx 
___ Stage IIIB/IV R. pancoast adenocarcinoma(no LN biopsy to 
determine whether stage IV but has enlarged LN on imaging), c/b 
invasion of brachial plexus and C7-T2 + T4 lesion who is being 
admitted from clinic on ___ for urgent chemotherapy and 
radiation iso concern for progressive neurologic symptoms. 

Ms. ___ reports a ___ history of mild, shooting, tingling 
R. shoulder pain that radiated down the arms, but attributed 
this to a known R. rotator cuff injury. In ___, she noticed 
b/l swelling in both of her eyes, which she attributed to a URI; 
however, the R. eye remained ""droopy."" She put off seeing a 
doctor, but began experiencing similar symptoms in her L. upper 
extremity and scheduled an apt with a new PCP ___ ___. Before 
she could do so, (___) she began experiencing severe 
bilateral, shooting upper extremity pain that also caused 
numbing and tingling of the palms and fingers. She subsequently 
presented to ___ ED for these symptoms and was admitted from 
___. During this hospitalization, she was diagnosed with R. 
apical pancoast adenocarcinoma. At discharge, she was supposed 
to have EBUS, TBNA to identify mediastinal lymph node 
involvement.

She reports that in the past week, she began experiencing 
worsening of the shooting bilateral arm pain, numbness and 
tingling in both hands. She specifies that the shooting, burning 
pain starts at her mid-upper arms and radiates all the way down 
to her fingertips; the pain is worse on the R>L. The pain is 
constant throughout the day and can reach ___ at times. At 
the beginning of the week, she was able to brush her teeth with 
her R. hand, but was not able to grip her toothbrush this 
morning with her R. hand. She was seen by Dr. ___ Dr. 
___ in clinic on ___ and was subsequently admitted for urgent 
chemotherapy and radiation in the setting of progressive 
neurologic symptoms. 

She denies headache, nausea, vomiting, diarrhea, constipation, 
CP, sob, blurry vision. She denies any change in sweating, and 
reports she does not sweat too much to begin with. Of note, she 
also reports ~20lb unintentional weight loss in the past 3 
months. 

*Of note, she has avoided unfortunate experiences with the 
medical system and avoided medical providers for the past ___ 
years as a result. Her father was started on chemo trial for 
colon cancer and died of a complication with the medication. She 
also reports her mother was misdiagnosed multiple times in the 
past. 

 
Past Medical History:
None
 
Social History:
___
Family History:
Mother with ___ CA, father with colon CA.
 
Physical Exam:
Admission Exam:
===============
GENERAL: Conversational, friendly female. NAD. 
HEENT: NCAT. Mild drooping of R. upper eyelid. R. pupil larger 
than L. pupil. R. pupil sluggish, minimally reactive to light. 
MMM.  
NECK: Supple, trachea midline. No cervical lymphadenopathy 
appreciated.   
LUNGS: Decreased breath sounds in R. lung, decreased breath 
sounds in L. lower lung base, otherwise CTA.  
HEART: RRR, normal s1, s2. no mrg.
ABD: BS+. nd, nt.
EXT: No lower extremity edema.
SKIN: No appreciable skin lesions or excorications. 
NEURO: A&Ox4. CN II-XII intact. LUE ___ strength, R deltoid 
strength ___, R. biceps strength ___, R. triceps strength ___, 
R. finger abduction ___. LLE ___ strength, RLE ___ strength. 
Reflexes 2+, symmetric b/l. Light touch and are intact in 
fingers and toes. 

Discharge Exam:
===============
24 HR Data (last updated ___ @ 823)
    Temp: 98.7 (Tm 99.2), BP: 118/75 (110-118/68-75), HR: 79
(79-95), RR: 18 (___), O2 sat: 92% (92-94), O2 delivery: Ra   
GENERAL: Conversational, friendly female. NAD. Wearing C-collar
in bed.
HEENT: NCAT. Mild drooping of R. upper eyelid. R. pupil smaller
than L. pupil. R. pupil sluggish, minimally reactive to light.
MMM.  
LUNGS: Decreased breath sounds in R. lung, decreased breath
sounds in L. lower lung base, otherwise CTA.  
HEART: RRR, normal s1, s2. no mrg.
ABD: BS+. nd, nt. No rebound tenderness or guarding.
EXT: No lower extremity edema.
SKIN: No appreciable skin lesions or excorications. 
NEURO: A&Ox4. CN II-XII intact. LUE ___ strength, R deltoid
strength 4+/5, R. biceps strength ___, R. triceps strength ___,
R. finger abduction 4+/5. LLE ___ strength, RLE ___ strength.
Reflexes 2+, symmetric b/l. Light touch and are intact in 
fingers
and toes. 
ACCESS: PIV 
 
Pertinent Results:
Admission Labs:
==============

___ 07:30AM BLOOD WBC-8.0 RBC-4.29 Hgb-12.7 Hct-39.1 MCV-91 
MCH-29.6 MCHC-32.5 RDW-13.6 RDWSD-45.8 Plt ___
___ 07:30AM BLOOD Neuts-85.4* Lymphs-11.1* Monos-2.7* 
Eos-0.1* Baso-0.3 Im ___ AbsNeut-6.57* AbsLymp-0.85* 
AbsMono-0.21 AbsEos-0.01* AbsBaso-0.02
___ 07:30AM BLOOD Glucose-105* UreaN-17 Creat-0.6 Na-138 
K-5.1 Cl-100 HCO3-24 AnGap-14
___ 07:30AM BLOOD ALT-14 AST-16 AlkPhos-62 TotBili-0.5
___ 07:30AM BLOOD Calcium-9.5 Phos-4.2 Mg-2.3

Reports:
=======
___ PET:
IMPRESSION:  Large, infiltrative, right apical mass with 
destruction of the adjacent upper thoracic spine vertebral 
bodies, posterior elements, and posterior right first through 
third ribs.  Probably separate FDG avid osseous lesions in T3 
and T4 abut and perhaps slightly efface the spinal canal. A 
right upper lobe pulmonary nodule is FDG avid and concerning for 
metastasis or a second primary.  A left upper lobe pulmonary 
nodule is not FDG avid.  Severe centrilobular emphysema. 

Discharge Labs:
===============
___ 07:20AM BLOOD WBC-7.1 RBC-3.86* Hgb-11.7 Hct-35.1 
MCV-91 MCH-30.3 MCHC-33.3 RDW-13.8 RDWSD-46.1 Plt ___
___ 07:20AM BLOOD Plt ___
___ 07:20AM BLOOD Glucose-119* UreaN-23* Creat-0.7 Na-136 
K-4.9 Cl-100 HCO3-27 AnGap-9*
___ 07:20AM BLOOD TotBili-0.5
___ 07:20AM BLOOD Calcium-9.5 Phos-4.2 Mg-2.3 UricAcd-4.3
 
Brief Hospital Course:
Hospital Course:
Ms. ___ is a ___ y.o. female with a recent diagnosis of 
recently diagnosed (dx ___ Stage IIIB/IV R. pancoast 
adenocarcinoma(no LN biopsy to determine whether stage IV but 
has enlarged LN on imaging with contralateral parenchymal lung 
nodules on CT scan), c/b invasion of brachial plexus and C7-T2 + 
T4 lesion who was admitted on ___ from clinic on ___ for 
urgent chemotherapy and radiation iso concern for permanent 
neurologic damage. She began C1D1 cispltain/pemetrexed + 
radiation on ___.

#Right pancoast adenocarcinoma
#Nerve root compression 
Ms. ___ was diagnosed with R. pancoast adenocarcinoma during 
her last hospital admission (___). Prior to this, she had 
not seen a provider ___ ___ years. Per Dr. ___ 
oncologist), her clinical stage is IIIB (T4N2M0) at minimum, but 
given concerning contralateral parenchymal lung nodules on CT 
scan, it is likely that she is stage 4. PET scan will determine 
the need for bronchoscopy and biopsy of mediastinal nodes. She 
began C1D1 of cisplatin + permextred on ___ and began the 
first of her radiation treatments (total 14 treatments) on 
___. She will follow up with Dr. ___ Dr. ___ in 
clinic for a total of ___ cycles of cisplain/pemetrexed and 
continue her radiation treatments (total 14 radiation tx) as 
planned. Prior to discharge, she reported improvement in her 
bilateral arm pain and improvement in R. hand numbness. Notably, 
she was able to use her R. hand to brush her teeth, which she 
was unable to do prior to admission. She was discharged on 
dexamethasone 4mg qAM, Bactrim, PPI, folic acid 1mg qd given 
pemetrexed use.

#RUE weakness
#Brachial plexopathy
#Bilateral arm pain:
As above, she will continue chemotherapy + radiation treatment. 
Her neurologic symptoms improved prior to discharge and she was 
discharged on dexamethasone 4mg qAM. She was continued on 
Tylenol and gabapentin for her pain.

# C7 vertebral compression fracture
# Destructive changes of T1 and T2 vertebral bodies, right sided 
facet joints at the C7-T1 and T1-2 levels
# Anterolisthesis of C7 on T1
She has known tumor invasion of C7-T2, and C7 vertebral 
compression fracture ___ tumor invasion. On her most recent
admission (___), spine surgery, hem/onc and radiation 
oncology made a decision to stabilize her compression fracture
with a brace (as opposed to posterior fusion spine stabilization 
surgery which would have required delaying chemo and radiation 
in order for her to recover/heal from surgery). Per Ortho, she 
will need to wear her C-collar at night and wear CTO brace at 
all other times. She is aware and amenable to this plan. 
Tentative plan to perform spine surgery 6 weeks after 
chemoradiation. 

# Biopsychosocial issues: 
Ms. ___ expressed concerns about her son, as he recently lost 
his brother (also her son) and father (ex-husband). She reports 
being less concerned about dying and more concerned about 
ensuring her son is set up with the business before she passes. 
They own an ___ together. Social Work and 
Palliative Care saw her while she was hospitalized, and she will 
have follow up with Palliative Care as an outpatient.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 
2. Gabapentin 800 mg PO QID 
3. Ibuprofen 600 mg PO Q8H 
4. Lidocaine 5% Patch 1 PTCH TD QAM 
5. Nicotine Patch 14 mg TD DAILY 
6. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1.  Dexamethasone 4 mg PO QAM 
RX *dexamethasone 4 mg 1 tablet(s) by mouth every morning Disp 
#*17 Tablet Refills:*0 
2.  FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth once daily Disp #*17 
Tablet Refills:*0 
3.  Ondansetron 4 mg PO Q8H:PRN nausea 
RX *ondansetron 4 mg 1 tablet(s) by mouth every 8 hours as 
needed for nausea Disp #*51 Tablet Refills:*0 
4.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN BREAKTHROUGH 
PAIN Duration: 3 Days 
RX *oxycodone 5 mg 1 tablet(s) by mouth every 6 hours as needed 
for breakthrough pain Disp #*12 Tablet Refills:*0 
5.  Senna 8.6 mg PO BID:PRN Constipation - First Line 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice daily as 
needed Disp #*34 Tablet Refills:*0 
6.  Sulfameth/Trimethoprim SS 1 TAB PO DAILY 
RX *sulfamethoxazole-trimethoprim [Bactrim] 400 mg-80 mg 1 
tablet(s) by mouth Take one tablet once daily. Disp #*17 Tablet 
Refills:*0 
7.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  
8.  Gabapentin 800 mg PO QID  
9.  Ibuprofen 600 mg PO Q8H  
10.  Lidocaine 5% Patch 1 PTCH TD QAM  
11.  Nicotine Patch 14 mg TD DAILY  
12.  Omeprazole 40 mg PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
==================
R. pancoast adenocarcinoma

Secondary Diagnosis:
====================
C7 vertebral compression fracture
RUE weakness

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms ___,

It was a pleasure caring for you at ___.

WHY WAS I IN THE HOSPITAL?
-You were in the hospital because you were having worsening of 
your arm pain and R. hand numbness. 

WHAT HAPPENED TO ME IN THE HOSPITAL?
-You were found to have a tumor in the top of your lung
-You started chemotherapy and radiation for this tumor.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
- Continue to take all your medicines and keep your 
appointments, especially your Oncology and Radiation 
appointments!
- The pain medicine can give you constipation. Please use the 
senna as needed to make sure you are having daily soft bowel 
movements. 
- The Bactrim is for preventing a type of pneumonia while you 
are on steroids. 
- The Omeprazole is for preventing stomach irritation while on 
steroids. 
- Continue to wear your brace when out of bed and your collar 
while in bed. 

We wish you the best!

Sincerely,
Your ___ Team
 
Followup Instructions:
___
","['3E04305' 'Z80.0' 'Z51.11' 'C79.51' 'Z88.2' 'C78.02' 'C34.11' 'F17.210'
 'G90.2' 'Z80.3' 'G95.89']","['Z80.0' 'Z51.11' 'C79.51' 'Z88.2' 'C78.02' 'C34.11' 'F17.210' 'G90.2'
 'Z80.3' 'G95.89']",['3E04305'],"['Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach'
 'Contact Radiation of Chest'
 'Family history of malignant neoplasm of digestive organs'
 'Encounter for antineoplastic chemotherapy'
 'Secondary malignant neoplasm of bone'
 'Allergy status to sulfonamides status'
 'Secondary malignant neoplasm of left lung'
 'Malignant neoplasm of upper lobe, right bronchus or lung'
 'Nicotine dependence, cigarettes, uncomplicated'
 'Collapsed vertebra, not elsewhere classified, cervicothoracic region, initial encounter for fracture'
 ""Horner's syndrome"" 'Family history of malignant neoplasm of breast'
 'Spondylolisthesis, cervicothoracic region'
 'Other spondylosis with myelopathy, cervicothoracic region'
 'Other specified diseases of spinal cord']",19,1899,11,2,,1,5,0
" 
Name:  ___.                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
abdominal pain
 
Major Surgical or Invasive Procedure:
___:  ERCP

___:  laparoscopic cholecystectomy

 
History of Present Illness:
___/ PMH of DM and HLD presents with upper abd pain since
yesterday. Describes a ___ aching pain. Pain lasted about ___
hours yesterday, then improved. He felt better this morning, but
then pain began again after eating today. Endorses nausea and 
one
episode of emesis today but denies diarrhea, CP. Says he has
abdominal pain with deep inspiration. Denies recent leg 
swelling.
Did travel to ___ 1 month ago. Wife describes him looking
jaundice today and states that he has been having significant
chills and rigors at home.

BPs trending down to SBP in ___ despite 3 L of fluid 

per ERCP fellow:
FICU, add zosyn, ERCP tomorrow

In the ED, 
- Initial Vitals: T 98.9, HR 82, BP 140/70, RR 18, PO2 95% RA 
- Exam: appears cold, RUQ and epigastrum tenderness
- Labs: wbc 7.7, hbg 13.3, plt 151, ANC 86.9%, INR 1.3, Cr 1.3,
HCO3 19, AG 20, ALT 213, AST 215, AP 123, Tbili 4.6, Dbili 3.3,
lipase 50, lactate 3.9->2.1, UA protein 30/trace ketone,
urine/blood cultures pending 

- Imaging:
*EKG: sinus rate ___, normal axis and intervals, no acute
ischemic changes

*RUQ US: 
1. Distended gallbladder with mobile sludge and wall edema is
suspicious for acute cholecystitis.
2. Possible sludge in the extrahepatic biliary ducts. No 
definite
evidence of an obstructing stone.
3. Echogenic liver consistent with steatosis. Other forms of
liver disease including steatohepatitis, hepatic fibrosis, or
cirrhosis cannot be excluded on the basis of this examination.

* CXR: Left posterior basilar opacity with volume loss, query
pneumonia versus atelectasis 

- Consults: ERCP

- Interventions:
IV Morphine Sulfate 4 mg 
IVF  NS 1000 mL ___ Stopped (1h ___  
IV CefTRIAXone 1 gm 
IV Acetaminophen IV 1000 mg 
IV MetroNIDAZOLE 500 mg  
IVF  LR ( 1000 mL ordered) 
IVF  NS 1000 mL ___ Stopped (1h ___  
IV Piperacillin-Tazobactam (4.5 g ordered) 
(3L total)

On arrival to the ICU, patient reports some mild abdominal
discomfort. Had significant aching abdominal pain along the 
upper
quadrants all of yesterday and then resolved over night. Pain
returned in the AM after eating breakfast and developed rigors.
Nauseous in the car ride to the hospital and 1x emesis with no
hematemesis. Regular BMs without diarrhea. Also reporting a 
cough
for the last ___ days without significant sputum production, but
""wet sounding"". Some dyspnea with exertion. 

 
Past Medical History:
-DM
-HLD
- inguinal hernia s/p mesh 
- Rotator cuff surgery ___

 
Social History:
___
Family History:
- no history of gallbladder/liver disease. Distant relative has
bad pancreatitis 

 
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
VS: T99.2 HR: 86 BP: 92/55 RR: 17 Sat: 95% RA  
GEN: resting in bed in NAD
EYES: mild scleral icterus
HENNT: MMM 
CV: RRR with no MRG 
RESP: No increased WOB. Bibasilar crackles 
GI: +BS. Mildly distended. Tympanitic to percussion. Soft.
Ventral hernia that is reducible. Mild tenderness to palpation 
in
the RUQ/epigastrium. B/l inguinal hernia scars  
SKIN: WWP. no peripheral edema 
NEURO: alert and oriented. Moving all extremities with purpose;
Face symmetric. 

 
Pertinent Results:
ADMISSION LABS:
===============

___ 04:16PM BLOOD WBC-7.7 RBC-4.52* Hgb-13.3* Hct-41.3 
MCV-91 MCH-29.4 MCHC-32.2 RDW-13.1 RDWSD-43.3 Plt ___
___ 04:16PM BLOOD Neuts-86.9* Lymphs-9.0* Monos-2.6* 
Eos-0.7* Baso-0.3 Im ___ AbsNeut-6.67* AbsLymp-0.69* 
AbsMono-0.20 AbsEos-0.05 AbsBaso-0.02
___ 04:16PM BLOOD ___ PTT-25.3 ___
___ 04:16PM BLOOD Glucose-175* UreaN-18 Creat-1.3* Na-137 
K-4.5 Cl-98 HCO3-19* AnGap-20*
___ 04:16PM BLOOD ALT-213* AST-215* AlkPhos-123 
TotBili-4.6* DirBili-3.3* IndBili-1.3
___ 04:16PM BLOOD Lipase-50
___ 04:16PM BLOOD cTropnT-<0.01
___ 04:16PM BLOOD Albumin-4.3 Calcium-9.4 Phos-2.7 Mg-1.8
___ 04:41PM BLOOD Lactate-3.9*

MICRO:
=====
___ 4:16 pm BLOOD CULTURE

   Blood Culture, Routine (Preliminary): 
      GRAM NEGATIVE ROD(S). 
         Identification and susceptibility testing performed on 
culture # 
         ___-2619L (___). 

   Aerobic Bottle Gram Stain (Final ___:    GRAM NEGATIVE 
ROD(S). 

   Anaerobic Bottle Gram Stain (Final ___:    GRAM 
NEGATIVE ROD(S). 

___ 4:55 pm BLOOD CULTURE

   Blood Culture, Routine (Preliminary): 
      ESCHERICHIA COLI.    FINAL SENSITIVITIES. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 
      GRAM NEGATIVE ROD(S).    SECOND MORPHOLOGY. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------   <=2 S
AMPICILLIN/SULBACTAM--   <=2 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

   Aerobic Bottle Gram Stain (Final ___: 
      Reported to and read back by ___. ___ ON ___ AT 
0530. 
      GRAM NEGATIVE ROD(S). 

   Anaerobic Bottle Gram Stain (Final ___:    GRAM 
NEGATIVE ROD(S). 

 
___ 6:30 pm URINE
                           **FINAL REPORT ___

   URINE CULTURE (Final ___:    < 10,000 CFU/mL. 

IMAGING:
========
RUQUS (___)
1. Distended gallbladder with mobile sludge and wall edema is
suspicious for acute cholecystitis.
2. Possible sludge in the extrahepatic biliary ducts. No 
definite
evidence of an obstructing stone.
3. Echogenic liver consistent with steatosis. Other forms of
liver disease including steatohepatitis, hepatic fibrosis, or
cirrhosis cannot be excluded on the basis of this examination.

CXR: ___
Left posterior basilar opacity with volume loss, query
pneumonia versus atelectasis 

ERCP ___
CBD was 12mm diameter, left and right hepatic ducts and 
intrahepatic branches were evaluated and appeared moderately 
dilated. The gallbladder not well visualized. Several small 
filling defects suggestive of sludge and stones. Sphincterotomy 
and extraction of sludge, stones, and pus. Plastic stents placed 
in CBD and PD. 

 
Brief Hospital Course:
BRIEF HOSPITAL COURSE:
======================
Mr. ___ is a ___ year-old male with HLD and T2DM who presented 
with one day of RUQ pain, direct hyperbilirubinemia, fevers, 
rigors, and imaging consistent with acute cholangitis and found 
to have Ecoli bacteremia. Pt was fluid resuscitated and started 
on zosyn. S/p ERCP with sphincterotomy with visualized pus, 
stones, and sludge and stent placement. Plan for laparoscopic 
cholecystectomy this admission. 

# Sepsis with Ecoli bacteremia 
# Cholangitis: 
# Acute cholecystitis:
Patient presented with epigastric, RUQ pain with elevated Dbili, 
elevated ALT/AST, and febrile in the ED to 103.2, though initial 
WBC was normal. RUQ with evidence of sludge and gallbladder 
edema consistent with acute cholecystitis and mild dilation of 
intra and extrahepatic ducts (up to 14mm) concerning for 
cholangitis. Was mildly hypotensive in the ED and received 3.5L 
of IVF and started on zosyn (Day 1: ___. ERCP on ___ with 
sphincterotomy showed pus, stones, and sludge. Stent was placed. 
Blood cultures grew pan-sensitive Ecoli and antibiotics were 
narrowed to linezolid and ciprofloxacin for 14 day course total 
post op (including IV antibiotics given in patient). ACS 
conducted lap cholecystectomy on ___. Patient will follow 
up with ERCP for stent removal in 4 weeks. 

# ___: 
Presented with Cr elevated to 1.3. Unknown baseline, but patient 
does not report any known kidney disease. Following fluid 
resuscitation, Cr decreased to 1.0, likely at baseline. 

# Coagulopathy: 
Patient presented with INR of 1.3 which uptrended to 1.4. Likely 
from decreased PO intake but given steatosis on RUQUS, cannot 
rule out cirrhosis. History of drinking in the past. Would 
follow up dedicated cirrhosis evaluation as outpatient. INR 
downtrended to 1.1. 

# Mild Anemia: 
Hgb downtrended from 13.3 to 10.9 iso receiving IVF. No signs of 
active bleeding. 

CHRONIC ISSUES
=============
# DM: 
Home metformin was held while inpatient and ISS was started. 

# HLD: 
Held home rosuvastatin given elevated liver enzymes. 

TRANSITIONAL ISSUES:
====================
[] f/u with ERCP in 4 weeks for stent removal (ERCP on ___
[] RUQUS with steatosis; would follow up cirrhosis workup

Surgical Course:

The patient underwent laparoscopic cholecystectomy on ___, 
which went well without complication (Please see operative 
report for details). After a brief, uneventful stay in the PACU, 
the patient arrived on the floor tolerating clear liquid diet, 
on IV fluids, and IV medication for pain control. The patient 
was hemodynamically stable.

Pain was well controlled. Diet was progressively advanced as 
tolerated to a regular diet with good tolerability. The patient 
voided without problem. During this hospitalization, the patient 
ambulated early and frequently, was adherent with respiratory 
toilet and incentive spirometry, and actively participated in 
the plan of care. The patient received subcutaneous heparin and 
venodyne boots were used during this stay.

At the time of discharge, the patient was doing well, afebrile 
with stable vital signs. The patient was tolerating a regular 
diet, ambulating, voiding without assistance, and pain was well 
controlled. The patient was discharged home without services. 
The patient received discharge teaching and follow-up 
instructions with understanding verbalized and agreement with 
the discharge plan.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Rosuvastatin Calcium 20 mg PO QPM 
2. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 
3. Aspirin 81 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever  
2.  Docusate Sodium 100 mg PO BID  
3.  Senna 8.6 mg PO BID:PRN Constipation - First Line  
4.  Aspirin 81 mg PO DAILY  
5.  MetFORMIN XR (Glucophage XR) 500 mg PO DAILY  
6.  Rosuvastatin Calcium 20 mg PO QPM  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Sepsis
Cholangitis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital with abdominal pain. You 
developed a low blood pressure despite intravenous fluids and 
because of this, you were transferred to the intensive care unit 
for management. You were also reported to have elevated liver 
enzymes. You underwent imaging and found to have cholecystitis 
and you were started on a course of zosyn. You underwent an ERCP 
where a sphincterotomy was done with removal of sludge, stones 
and pus. Plastic stents were placed in the CBD and PD. You will 
have a follow up appointment with endoscopy to remove the 
stents. You were then taken to the operating room where you had 
removal of the gallbladder. During your hospitalization, you 
were found to have bacteria in your blood. The infectious 
disease service was consulted and you were started on a course 
of antibiotics.

Please have your blood work done at the ___ floor lab prior to 
your scheduled follow up appointment.

You have done well since surgery and are preparing for discharge 
home with the following instructions:      
 
ACTIVITY:
 
o Do not drive until you have stopped taking pain medicine and 
feel you could respond in an emergency.
o You may climb stairs. 
o  You may go outside, but avoid traveling long distances until 
you see your surgeon at your next visit.
o  Don't lift more than ___ lbs for 4 weeks. (This is about 
the weight of a briefcase or a bag of groceries.) This applies 
to lifting children, but they may sit on your lap.
o You may start some light exercise when you feel comfortable.
o You will need to stay out of bathtubs or swimming pools for a 
time while your incision is healing. Ask your doctor when you 
can resume tub baths or swimming.
 
HOW YOU MAY FEEL: 
o  You may feel weak or ""washed out"" for a couple of weeks. You 
might want to nap often. Simple tasks may exhaust you.
o  You may have a sore throat because of a tube that was in your 
throat during surgery.
o  You might have trouble concentrating or difficulty sleeping. 
You might feel somewhat depressed.
o  You could have a poor appetite for a while. Food may seem 
unappealing.
o  All of these feelings and reactions are normal and should go 
away in a short time.  If they do not, tell your surgeon.
 
YOUR INCISION:
o Tomorrow you may shower and remove the gauzes over your 
incisions. Under these dressing you have small plastic bandages 
called steri-strips. Do not remove steri-strips for 2 weeks. 
(These are the thin paper strips that might be on your 
incision.) But if they fall off before that that's okay).
o Your incisions may be slightly red around the stitches. This 
is normal.
o You may gently wash away dried material around your incision.
o Avoid direct sun exposure to the incision area.
o Do not use any ointments on the incision unless you were told 
otherwise.
o You may see a small amount of clear or light red fluid 
staining your dressing or clothes. If the staining is severe, 
please call your surgeon.
o You may shower. As noted above, ask your doctor when you may 
resume tub baths or swimming.
 
YOUR BOWELS:
o Constipation is a common side effect of narcotic pain 
medications. If needed, you may take a stool softener (such as 
Colace, one capsule) or gentle laxative (such as milk of 
magnesia, 1 tbs) twice a day. You can get both of these 
medicines without a prescription.
o If you go 48 hours without a bowel movement, or have pain 
moving the bowels, call your surgeon. 
 
PAIN MANAGEMENT:
o It is normal to feel some discomfort/pain following abdominal 
surgery. This pain is often described as ""soreness"". 
o Your pain should get better day by day. If you find the pain 
is getting worse instead of better, please contact your surgeon.
o You will receive a prescription for pain medicine to take by 
mouth. It is important to take this medicine as directed. o Do 
not take it more frequently than prescribed. Do not take more 
medicine at one time than prescribed.
o Your pain medicine will work better if you take it before your 
pain gets too severe.
o Talk with your surgeon about how long you will need to take 
prescription pain medicine. Please don't take any other pain 
medicine, including non-prescription pain medicine, unless your 
surgeon has said its okay.
o If you are experiencing no pain, it is okay to skip a dose of 
pain medicine.
o Remember to use your ""cough pillow"" for splinting when you 
cough or when you are doing your deep breathing exercises.
If you experience any of the following, please contact your 
surgeon:
- sharp pain or any severe pain that lasts several hours
- pain that is getting worse over time
- pain accompanied by fever of more than 101
- a drastic change in nature or quality of your pain
 
MEDICATIONS:
Take all the medicines you were on before the operation just as 
you did before, unless you have been told differently.
If you have any questions about what medicine to take or not to 
take, please call your surgeon.

 
Followup Instructions:
___
","['0F7D8DZ' '0F798DZ' '0FT44ZZ' '0FC98ZZ' 'A41.51' 'D64.9' 'E11.9'
 'Z87.891' 'K80.62' 'E78.5' 'I10.' 'K80.46' 'D68.4' 'Z79.84' 'R65.21'
 'N17.9' 'D69.59']","['A41.51' 'D64.9' 'E11.9' 'Z87.891' 'K80.62' 'E78.5' 'I10.' 'K80.46'
 'D68.4' 'Z79.84' 'R65.21' 'N17.9' 'D69.59']",['0F7D8DZ' '0F798DZ' '0FT44ZZ' '0FC98ZZ'],"['Dilation of Pancreatic Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic'
 'Dilation of Common Bile Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic'
 'Resection of Gallbladder, Percutaneous Endoscopic Approach'
 'Extirpation of Matter from Common Bile Duct, Via Natural or Artificial Opening Endoscopic'
 'Sepsis due to Escherichia coli [E. coli]' 'Anemia, unspecified'
 'Type 2 diabetes mellitus without complications'
 'Personal history of nicotine dependence'
 'Calculus of gallbladder and bile duct with acute cholecystitis without obstruction'
 'Hyperlipidemia, unspecified' 'Essential (primary) hypertension'
 'Calculus of bile duct with acute and chronic cholecystitis without obstruction'
 'Acquired coagulation factor deficiency'
 'Long term (current) use of oral hypoglycemic drugs'
 'Severe sepsis with septic shock' 'Acute kidney failure, unspecified'
 'Other secondary thrombocytopenia']",20,2393,17,2,,1,5,0
" 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROSURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Right SDH vs. ___
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ (AKA ___ is a ___ yo male with history
of developmental delay, stroke, DM, HTN, who is transferred to
___ from ___ on ___ with a TBI. 
He was found down at his group home and was more confused than
baseline. He was unable to ambulate or get into wheelchair
without assistance. 

Neuro exam at ___ was significant for Ox0 (unclear baseline), 
___
BUE, ___ BLE and pinpoint pupils. His RR was ___, so was
intubated due to concern for potential deterioration. Head CT 
was
done which showed a right occipital EDH vs SDH. He was
subsequently transferred to ___ ED for neurosurgery 
evaluation.
 
Past Medical History:
-Developmental delay (per ___ notes)
-HTN
-HLD
-Depression
-DM II with diabetic retinopathy, nephrophathy, and diabetic
neuropathy               
-Osteoporosis
-Hip fracture x2
-Toe osteomyelitis ___
-CVA ___
-PVD
 
Social History:
___
Family History:
Non-contributory
 
Physical Exam:
On Admission:
-------------
Physical Exam:

O:  T: 97.0   BP: 136/74   HR: 60  RR: 9   O2 Sat: 100% ETT

GCS at the scene: 10 @ OSH

GCS upon Neurosurgery Evaluation:  10T (E3V1M6)        
   Time of evaluation: 19:40

Airway: [x]Intubated   [ ]Not intubated

Eye Opening: 
 [ ]1 Does not open eyes
 [ ]2 Opens eyes to painful stimuli
 [x]3 Opens eyes to voice
 [ ]4 Opens eyes spontaneously

Verbal:
 [x]1 Makes no sounds
 [ ]2 Incomprehensible sounds
 [ ]3 Inappropriate words
 [ ]4 Confused, disoriented
 [ ]5 Oriented

Motor:
 [ ]1 No movement
 [ ]2 Extension to painful stimuli (decerebrate response)
 [ ]3 Abnormal flexion to painful stimuli (decorticate response)
 [ ___ Flexion/ withdrawal to painful stimuli 
 [ ]5 Localizes to painful stimuli
 [x]6 Obeys commands

Exam:

Gen: elderly male intubated and sedated. sedation held for exam
Extrem: warm and well perfused

Neuro:

Mental Status: intubated; EO to voice 

Orientation: intubated 

If Intubated:
  [ ]Cough  [ ]Gag  [x]Over breathing the vent

Cranial Nerves:
I: Not tested
II: Pupils pinpoint. Visual fields unable to assess.
III, IV, VI: midline gaze 
V, VII: Facial appears symmetric 
VIII: Hearing intact to voice.
IX, X: + gag and cough 
XI: unable to assess 
XII: attempts to sick out tongue around tube 

Motor: 
follows commands to squeeze bilateral hands and show thumbs up
bilaterally. wiggles bilateral toes to command. Does not lift
legs antigravity but moves in plane on bed. Briefly holds arms
antigravity if lifted. 

Sensation: difficult to assess 

On Discharge:
-------------
Exam:
Opens eyes: [x]spontaneous [ ]to voice [ ]to noxious
Orientation: [x]Person [ ]Place - ""rehab in ___ [ ]Time
Baseline is oriented to self only and intermittent place
Follows commands: [x]Simple [ ]Complex [ ]None
Pupils:  PERRL 2mm reactive
EOM: [x]Full [ ]Restricted
Face Symmetric: [x]Yes [ ]NoTongue Midline: [x]Yes [ ]No
Pronator Drift [ ]Yes [x]No     Speech Fluent: [x]Yes [ ]No
Comprehension intact [x]Yes [ ]No

Motor:
Pt has difficulty with fine motor exam - following complex
commands 

Moving BUE spontaneously and independently - ___ in strength
Moving BLE spontaneously and independently and equally : ___

Increased tone noted in all four extremities 
 
[x]Sensation intact to light touch

 
Pertinent Results:
Please see OMR for relevant laboratory and imaging results.
 
Brief Hospital Course:
___ year old male with right SDH vs. EDH.

#Right SDH vs. EDH
Patient was admitted for close neurologic monitoring. He was 
extubated and was determined to be at his neurologic baseline. 
He remained neurologically stable throughout his hospitalization 
and at his baseline on day of discharge. 

#Lip swelling
The patient was noted to have swelling of his upper lip, likely 
due to trauma from intubation.  He did not have any respiratory 
compromise and swelling improved over his hospital stay.

#Fever
Patient was febrile on ___, urinalysis was concerning for UTI 
so he was started on 3 day course of IV ceftriaxone. He 
completed 2 days of his ceftriaxone course and was transitioned 
to Ciprofloxacin 500mg BID x 5 days to complete his treatment. 

#Discharge planning
The patient was evaluated by physical therapy who recommended 
discharge to rehab.  Anticipate rehab length of stay less than 
30 days.
 
Medications on Admission:
-Acetaminophen 975 mg PO Q8H:PRN Pain - Mild 
-Atorvastatin 80 mg PO QPM* 
-FLUoxetine 20 mg PO DAILY 
-irbesartan 150 mg oral DAILY* 
-MetFORMIN (Glucophage) 1000 mg PO BID*
-Metoprolol Succinate XL 50 mg PO DAILY* 
-Repaglinide 0.5 mg PO TIDAC*
-Tradjenta (linagliptin) 5 mg oral DAILY*
-amLODIPine 5 mg PO DAILY 
-Aspirin 81 mg PO DAILY 
 
Discharge Medications:
1.  Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever  
2.  Bisacodyl 10 mg PO/PR DAILY:PRN Constipation - Third Line  
3.  Ciprofloxacin HCl 500 mg PO Q12H Duration: 5 Days  
4.  Docusate Sodium 100 mg PO BID  
5.  Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol  
6.  Glucose Gel 15 g PO PRN hypoglycemia protocol  
7.  Heparin 5000 UNIT SC BID  
8.  Insulin SC 
      Sliding Scale

Fingerstick QACHS
Insulin SC Sliding Scale using REG Insulin 
9.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line 
  Reason for PRN duplicate override: Alternating agents for 
similar severity 
10.  Senna 8.6 mg PO BID:PRN Constipation - Second Line  
11.  Tradjenta (linaGLIPtin) 5 mg oral DAILY  
12.  amLODIPine 5 mg PO DAILY  
13.  Aspirin 81 mg PO DAILY  
14.  Atorvastatin 80 mg PO QPM  
15.  Ferrous Sulfate 325 mg PO DAILY  
16.  FLUoxetine 20 mg PO DAILY  
17.  irbesartan 150 mg oral DAILY  
18.  MetFORMIN (Glucophage) 1000 mg PO BID  
19.  Metoprolol Tartrate 25 mg PO BID  
20.  Multivitamins 1 TAB PO DAILY  
21.  Repaglinide 0.5 mg PO TIDAC  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Right subdural hematoma
urinary tract infection 

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Activity
 We recommend that you avoid heavy lifting, running, climbing, 
or other strenuous exercise until your follow-up appointment.
 You make take leisurely walks and slowly increase your 
activity at your own pace once you are symptom free at rest. 
___ try to do too much all at once.
 No driving while taking any narcotic or sedating medication. 
 If you experienced a seizure while admitted, you are NOT 
allowed to drive by law. 
 No contact sports until cleared by your neurosurgeon. You 
should avoid contact sports for 6 months. 

Medications
 Please do NOT take any blood thinning medication (Aspirin, 
Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. 
 You may use Acetaminophen (Tylenol) for minor discomfort if 
you are not otherwise restricted from taking this medication.

What You ___ Experience:
 You may have difficulty paying attention, concentrating, and 
remembering new information.
 Emotional and/or behavioral difficulties are common. 
 Feeling more tired, restlessness, irritability, and mood 
swings are also common.
 Constipation is common. Be sure to drink plenty of fluids and 
eat a high-fiber diet. If you are taking narcotics (prescription 
pain medications), try an over-the-counter stool softener.

Headaches:
 Headache is one of the most common symptom after a brain 
bleed. 
 Most headaches are not dangerous but you should call your 
doctor if the headache gets worse, develop arm or leg weakness, 
increased sleepiness, and/or have nausea or vomiting with a 
headache. 
 Mild pain medications may be helpful with these headaches but 
avoid taking pain medications on a daily basis unless prescribed 
by your doctor. 
 There are other things that can be done to help with your 
headaches: avoid caffeine, get enough sleep, daily exercise, 
relaxation/ meditation, massage, acupuncture, heat or ice packs. 


When to Call Your Doctor at ___ for:
 Severe pain, swelling, redness or drainage from the incision 
site. 
 Fever greater than 101.5 degrees Fahrenheit
 Nausea and/or vomiting
 Extreme sleepiness and not being able to stay awake
 Severe headaches not relieved by pain relievers
 Seizures
 Any new problems with your vision or ability to speak
 Weakness or changes in sensation in your face, arms, or leg
 
Call ___ and go to the nearest Emergency Room if you experience 
any of the following:
 Sudden numbness or weakness in the face, arm, or leg
 Sudden confusion or trouble speaking or understanding
 Sudden trouble walking, dizziness, or loss of balance or 
coordination
 Sudden severe headaches with no known reason
 
Followup Instructions:
___
","['5A1945Z' 'E11.51' 'E11.21' 'E11.319' 'I10.' 'S06.4X0A' 'S06.5X0A'
 'J96.90' 'N39.0' 'Z86.73' 'R62.50' 'W05.0XXA' 'E11.40' 'E78.5']","['E11.51' 'E11.21' 'E11.319' 'I10.' 'S06.4X0A' 'S06.5X0A' 'J96.90' 'N39.0'
 'Z86.73' 'R62.50' 'W05.0XXA' 'E11.40' 'E78.5']",['5A1945Z'],"['Respiratory Ventilation, 24-96 Consecutive Hours'
 'Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene'
 'Type 2 diabetes mellitus with diabetic nephropathy'
 'Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema'
 'Glasgow coma scale score 9-12, in the field [EMT or ambulance]'
 'Essential (primary) hypertension'
 'Epidural hemorrhage without loss of consciousness, initial encounter'
 'Traumatic subdural hemorrhage without loss of consciousness, initial encounter'
 'Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia'
 'Urinary tract infection, site not specified'
 'Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits'
 'Unspecified lack of expected normal physiological development in childhood'
 'Fall from non-moving wheelchair, initial encounter'
 'Type 2 diabetes mellitus with diabetic neuropathy, unspecified'
 'Hyperlipidemia, unspecified']",21,1404,14,2,,1,5,0
